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Abstract
Pelvic floor muscle training for women with pelvic organ
prolapse: the PROPEL realist evaluation
Margaret Maxwello ,1* Karen Berryo ,1 Sarah Waneo ,2 Suzanne Hageno ,3
Doreen McClurgo ,3 Edward Duncano ,1 Purva Abhyankaro ,4
Andrew Elderso ,3 Catherine Besto ,1 Joyce Wilkinsono ,4 Helen Masono ,5
Linda Fenocchio ,5 Eileen Calveleyo ,1 Karen Guerreroo 6
and Douglas Tincelloo 7
1Nursing, Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling, UK
2Department of Sport, Exercise and Rehabilitation, University of Northumbria, Newcastle upon Tyne, UK
3Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University,
Glasgow, UK
4Division of Health Sciences, Faculty of Health Sciences and Sport, University of Stirling, Stirling, UK
5Yunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, UK
6Department of Urogynaecology, Queen Elizabeth University Hospital, NHS Greater Glasgow and
Clyde, Glasgow, UK
7Department of Health Sciences, Centre for Medicine, University of Leicester, Leicester, UK
*Corresponding author margaret.maxwell@stir.ac.uk
Background: Pelvic organ prolapse is estimated to affect 41–50% of women aged > 40 years. A
multicentre randomised controlled trial of individualised pelvic floor muscle training found that pelvic
floor muscle training was effective in reducing symptoms of prolapse, improved quality of life and
showed clear potential to be cost-effective. Provision of pelvic floor muscle training for prolapse has
continued to vary across the UK, with limited availability of specialist physiotherapists to deliver it.
Objectives: This project aimed to study the implementation and outcomes of different models of
delivery to increase the service provision of pelvic floor muscle training, and to follow up treatment
outcomes for the original trial participants.
Design: A realist evaluation of pelvic floor muscle training implementation conducted within three full
case study sites and two partial case study sites; an observational prospective cohort study comparing
patient-reported outcomes pre and post intervention in all five sites; and a long-term follow-up study
linking previous trial participants to routine NHS hospital data.
Setting: The setting for the realist evaluation was pelvic floor muscle training service delivery models
in three NHS sites. The setting for the patient-reported outcome measures study was pelvic floor
muscle training services in five NHS sites.
Methods: Realist evaluation qualitative data were collected at four time points in three case study
sites to understand the implementation models, uptake, adherence and impact. Interviews involved
service managers/leads, consultants, staff delivering pelvic floor muscle training and women receiving
pelvic floor muscle training.
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Main outcomes measures: Patient-reported outcomes were collected at baseline and at 6 and 12 months
across five sites, including the Pelvic Organ Prolapse Symptom Score, health-related quality of life (measured
using the EuroQol-5 Dimensions, five-level version, questionnaire), prolapse severity (measured using
the Pelvic Organ Prolapse Quantification System), urinary incontinence (measured using International
Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form) and need for
further treatment.
Results: A total of 102 women were recruited to the patient-reported outcome measures cohort study
(target, n = 120), and 65 women had matched baseline and 6-month Pelvic Organ Prolapse Symptom
Scores. The mean Pelvic Organ Prolapse Symptom Score was 10.18 (standard deviation 5.63) at
baseline and 6.98 (standard deviation 5.23) at 6 months, representing a statistically significant and
clinically meaningful difference. There was no statistically significant difference between the outcomes
obtained from delivery by specialist physiotherapists and the outcomes obtained from delivery by
other health-care professionals (mean change in Pelvic Organ Prolapse Symptom Score: –3.95 vs.
–2.81, respectively). Services delivered using higher-band physiotherapists only were more costly
than services delivered using other staff mixes. The effect of the original pelvic floor muscle training
intervention, over a post-intervention period of > 10 years, was a reduction in the odds of any
treatment during follow-up (odds ratio 0.61, 95% confidence interval 0.37 to 0.99). The realist
evaluation revealed stark differences in implementation. The site with a specialist physiotherapy
service resisted change because of perceived threats to the specialist role and concerns about care
quality. Pelvic floor muscle training delivery by other health-care staff was easier when there was a
lack of any existing specialist service; staff had prior training and interest in pelvic health; staff had
support, autonomy, time and resources to deliver pelvic floor muscle training as part of their core role;
and surrounding services supported a flow of pelvic floor muscle training referrals.
Limitations: The number of available matched pre and post outcomes for women and the lack of Pelvic
Organ Prolapse Quantification System examinations were limitations of this study.
Conclusions: It is possible to train different staff to effectively deliver pelvic floor muscle training to
women. Women’s self-reported outcomes significantly improved across all service models. Training
should be adequately tailored to differential skill mix needs.
Future work: Future work should include further implementation of pelvic floor muscle training and
should include pre- and post-outcome data collection using the Pelvic Organ Prolapse Symptom Score.
Study registration: This study is registered as Research Registry 4919.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services
and Delivery Research programme and will be published in full in Health Services and Delivery Research;
Vol. 8, No. 47. See the NIHR Journals Library website for further project information.
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Pelvic organ prolapse (or prolapse) affects 40–50% of women aged > 40 years. Previous research[the Pelvic Organ Prolapse PhysiotherapY (POPPY) trial (Hagen S, Stark D, Glazener C, Dickson S,
Barry S, Elders A, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse
(POPPY): a multicentre randomised controlled trial. Lancet 2014;383:796–806)] found that pelvic
floor muscle training can improve women’s prolapse symptoms and quality of life. However, pelvic floor
muscle training for prolapse is not widely available in the UK, and there are few specialist physiotherapists
who are trained to deliver it. We wanted to know whether or not other staff types could deliver pelvic
floor muscle training and still achieve the same outcomes for women, which would mean that more
pelvic floor muscle training could be made available to women. We worked with five NHS sites to train
different staff to deliver pelvic floor muscle training to women with prolapse. Sites had access to different
resources (staff) and their current pathways for prolapse were different.We worked more in depth with
three sites, at four time points, to learn lessons about ‘what worked and why’.
We recruited a total of 102 women (out of a target of 120) and measured their prolapse symptoms, their
self-reported quality of life, whether or not the severity of their prolapse had changed and whether or
not they needed further treatment. We studied the benefits (outcomes) of pelvic floor muscle training
for women and for the services that delivered it. We assessed the costs and benefits of different delivery
methods. Finally, we followed up the original POPPY trial participants to see if pelvic floor muscle
training had prevented treatment in the longer term.
Women’s prolapse symptoms significantly improved at 6 and 12 months following pelvic floor muscle
training. All services successfully delivered pelvic floor muscle training. There was no statistically significant
difference in outcomes between pelvic floor muscle training delivered by specialist physiotherapists and
pelvic floor muscle training delivered by other health-care professionals. Services that used higher-band
physiotherapists only were more costly. Longer-term pelvic floor muscle training still reduced the
likelihood of further treatment.
Conclusion
Pelvic floor muscle training can be successfully delivered by non-specialist health-care professionals
with the relevant background, training and support. This has important implications for delivering
pelvic floor muscle training to the large numbers of women who could benefit from this treatment.
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Parts of this summary have been reproduced from Maxwell M, Semple K, Wane S, Elders A, Duncan E,Abhyankar P, et al. PROPEL: implementation of an evidence based pelvic floor muscle training
intervention for women with pelvic organ prolapse: a realist evaluation and outcomes study protocol.
BMC Health Serv Res 2017;17:843. This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute,
remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/. The text below includes minor additions and formatting
changes to the original text.
Background
Pelvic organ prolapse can affect up to half of the female population aged > 40 years. Surgery has been
the main treatment option for most women, but many women experience an additional prolapse and
around 30% of women have repeat surgery. Repair of one type of prolapse may also predispose the
woman to the development of a different type of prolapse in another compartment of the vagina.
Concerns remain surrounding the use of synthetic mesh in prolapse surgery, which has resulted in
complications and a removal rate of up to 35%.
Given these events, there is an ever more pressing need for evidence-based non-surgical options to be
made available to women. A recent definitive trial, the Pelvic Organ Prolapse PhysiotherapY (POPPY)
trial [Hagen S, Stark D, Glazener C, Dickson S, Barry S, Elders A, et al. Individualised pelvic floor muscle
training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet
2014;383:796–806], has shown that pelvic floor muscle training is an effective and potentially cost-
effective treatment, which should be recommended as a first-line treatment for pelvic organ prolapse.
The POPPY trial constitutes the largest, most rigorous, pragmatic trial of pelvic floor muscle training
for prolapse, and, therefore, provides the necessary evidence to inform future practice.
Despite this evidence, provision of pelvic floor muscle training for pelvic organ prolapse continues to
vary across the UK, with limited numbers of physiotherapists with specialist training in pelvic floor
dysfunction/women’s health. There are approximately 2600 symptomatic women for each specialist
physiotherapist in the UK. If this robust evidence-based treatment is to be implemented, it will require
attention to alternative modes of delivery and service organisation to meet the needs of the large
numbers of women who could benefit from it. Training other relevant health-care staff, such as nurses
involved in women’s health (e.g. continence nurses and urogynaecology nurses), midwives, junior (grade 5)
physiotherapists or other specialist physiotherapists (e.g. musculoskeletal), could be an option for increasing
the necessary provision and improving access to it. However, this might also require service reorganisation,
including the development of operational processes (e.g. triage), as it is likely to be a shared model in
which more severe cases can be prioritised to the specialists and more straightforward cases to the
newly trained staff.
Implementation research can help to understand the mechanisms at play when successful implementation
of this evidence-based intervention is observed. It can also test the different modes of delivery that may
be required for successful ‘real-world’ implementation. This requires working with local NHS sites to allow
them to make decisions about how they want to implement the pelvic floor muscle training intervention
to increase service provision locally, without compromising expected outcomes and quality of care for
women with pelvic organ prolapse.
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An observed reduction in ‘further treatment’ following pelvic floor muscle training was initially established
in the POPPY trial, but this did not allow for lengthy follow-up of trial participants. Recent investment
in Scotland in health data linkage makes it possible to follow up the original POPPY trial participants
using hospital admission and hospital outpatient data sets. This type of knowledge can help inform NHS
managers by predicting the longer-term benefits that they might expect if they implement a pelvic floor
muscle training service.
The research questions were as follows:
1. Can pelvic floor muscle training be successfully delivered using different staff groups/skill mixes and
what are the barriers to and facilitators of successful implementation of pelvic floor muscle training
across different service models and settings?
2. Does the pelvic floor muscle training intervention, as implemented, improve pelvic organ prolapse
symptoms in women?
3. Does the effect differ significantly when delivered by specialist physiotherapists rather than other
health-care professionals?
4. What are the costs associated with the different models of delivery?
5. Are women who were included in the original POPPY intervention in Scotland less likely to receive
further secondary care treatment related to their prolapse during the follow-up period than women
who were in the control condition?
Aim
The first aim was to maximise the delivery of effective pelvic floor muscle training for women with
prolapse, through the study of its implementation in three diverse settings using an evidence-based
pelvic floor muscle training protocol. Implementation of pelvic floor muscle training in diverse settings
will involve developing different service delivery models, incorporating a variety of staff skill mixes
(and, potentially, numbers of sessions) to increase capacity, with the format of delivery being
determined locally.
The second aim was to assess the impact of pelvic floor muscle training on longer-term treatment
outcomes using linked health-care data for the majority of the original POPPY trial participants
(i.e. those based in Scotland).
Methods
The study involved the following research questions.
Research question 1
A realist evaluation was carried out that used case studies of implementation of pelvic floor muscle
training delivery in three different NHS settings. The realist evaluation allowed for substantial local
stakeholder engagement and for local sites to make decisions on how to deliver pelvic floor muscle
training (e.g. using different skills mixes and numbers of sessions). Qualitative data for the realist
evaluation were collected at four time points over an 18-month intervention period to understand
local contexts and decisions regarding the delivery of pelvic floor muscle training for prolapse and
to monitor implementation, uptake, adherence and impact. Interviews were conducted with service
managers/leads, consultants, specialists in women’s health, and staff with the potential to deliver
pelvic floor muscle training. Round 1 (n = 21) and round 2 (n = 46) interviews tracked local decisions
on ‘how to implement pelvic floor muscle training services’ and elicited their ‘theories of change’.
Training in delivering pelvic floor muscle training was then provided to identified staff groups in each
case study site and two further sites (collecting outcome data only). Round 3 (n = 20) interviews
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focused on implementation of services (‘how is it working?’) and round 4 (n = 24) interviews reflected
on the overall experience of service delivery (‘did it work/what worked?’). Rounds 3 and 4 included
interviews with women referred to services.
Dissemination and implementation workshops (England and Scotland) were run at the end of the study
to discuss the applicability of study findings and outcomes with service managers, women’s health-care
professionals, general practitioners and patient and public representatives from across the country,
with discussion of implications for planning of local services and identification of any further key
barriers to, or facilitators of, change.
Research questions 2 and 3
A robust patient-reported outcome measures study, which used the same outcome measures as the
original POPPY trial, was conducted in five NHS sites (three case study sites plus two additional sites)
to observe the outcomes for women receiving the different models of care. Patient outcomes were
collected at baseline and at the 6- and 12-month follow-ups. Patient demographic data (e.g. age, ethnicity,
occupation and educational attainment) were also collected. The primary outcome was the Pelvic Organ
Prolapse Symptom Score. The secondary outcomes were quality-of-life outcomes (measured using the
EuroQol-5 Dimensions, five-level version), pelvic floor-related outcomes (prolapse severity: Pelvic Organ
Prolapse Quantification System), urinary symptoms (measured using the International Consultation on
Incontinence Questionnaire – Urinary Incontinence Short Form) and service-related outcomes (need for
further treatment).
Research question 4
An economic evaluation was carried out to assess the associated costs and outcomes of different
service delivery models for delivering pelvic floor muscle training. In addition, an economic assessment
of the long-term costs associated with accessing further pelvic prolapse treatment over time was
conducted for the original POPPY trial participants who were resident in Scotland.
Research question 5
Long-term follow-up of up to 11 years of the original POPPY trial participants was carried out using
record linkage of hospital and outpatient data (provided by Information Services Division Scotland via
the NHS electronic Data Research and Innovation Service).
Results
Research question 1
Five NHS sites were recruited to deliver pelvic floor muscle training using a range of delivery models.
Site A comprised an exclusively specialist physiotherapy service model that then acted as a comparator
for delivery by ‘other’ staff groups (nurses, physiotherapists), as developed by sites B–E. Successful
implementation of pelvic floor muscle training required adequate training tailored to the differential
needs of skill mix, increased awareness of pelvic floor muscle training among general practitioners and
other health-care professionals, well-co-ordinated and flexible referral systems, wider (multidisciplinary)
team support/buy-in, organisational and managerial support with effective leadership, and a receptive
setting (some community nursing and acute wards may not be appropriate).
In total, 102 women were recruited to the patient-reported outcome measures study from across five
sites. Baseline questionnaires were available from 91 women. Seventy-one women completed the 6-month
follow-up questionnaire, 68 of the baseline questionnaires were matched to 6-month questionnaires,
and 72 women with baseline or 6-month questionnaires also had a clinical assessment form completed.
Only 59 women had baseline and 6-month questionnaires plus a clinical assessment form.
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Research question 2
Research question 2 was analysed using a paired t-test of the Pelvic Organ Prolapse Symptom Scores
at baseline and at the 6-month follow-up. There were 65 women with both baseline and 6-month Pelvic
Organ Prolapse Symptom Scores. The mean Pelvic Organ Prolapse Symptom Score was 10.18 points at
baseline and 6.96 points at the 6-month follow-up. Prolapse symptom severity was significantly lower at
the 6-month follow-up than at baseline. The difference between baseline and 6 months is 3.2 points on
the Pelvic Organ Prolapse Symptom Score (a difference of 2 points represents a clinically meaningful
difference). A significant improvement was still observed at 12 months (although numbers were low).
Research question 3
Research question 3 was analysed using an independent-samples t-test. The mean change from baseline
to the 6-month follow-up in women who were seen by specialist physiotherapists was compared with
the change for women seen by other health-care professionals. Improved outcomes for women following
receipt of pelvic floor muscle training were achieved regardless of who delivered the intervention. There
was no statistically significant difference between the outcomes obtained from delivery by specialist
physiotherapists (mean change in Pelvic Organ Prolapse Symptom Score –3.95 points) and the outcomes
obtained from delivery by other health-care professionals (mean change in Pelvic Organ Prolapse
Symptom Score –2.81 points, t = 0.89, df = 63; p = 0.37).
Additional (secondary) outcomes showed that there was a significant reduction in the number of
health-care visits after the start of the intervention (mean of 1.73 appointments at baseline compared
with 0.96 appointments at 6 months).
Research question 4
The economic analysis assessed the resource costs of each clinical site’s delivery model of pelvic
floor muscle training. Pelvic floor muscle training services that were delivered using higher-band
physiotherapists only were more costly than such services delivered using other staff mixes. The main
differences between sites were the average amount of clinic time for each woman receiving pelvic
floor muscle training and differences in the clinical specialisms of who was providing the treatment.
Utility, measured using the EuroQol-5 Dimensions, five-level version, improved by 0.019, on average,
over 6 months (0.035 for specialist physiotherapists and 0.012 for other clinicians). No statistically
significant difference in improvement in health-related quality of life from baseline to 12 months
between participants treated by specialist physiotherapists and participants treated by other clinical
staff was found [t(df = 23) = –0.602; p = 0.553, two-tailed]. Small participant numbers prevented
assessment of cost-effectiveness.
Research question 5
Research question 5 was analysed using mixed-effects logistic regression on ‘any prolapse-related
secondary care treatment’ during follow-up, with adjustment for baseline prolapse symptom severity,
status of surgery, age group and prolapsed stage, and with random effect of centre (missing prolapse
symptom severity imputed at median). This analysis showed that the effect of the original pelvic floor
muscle training intervention is statistically significant and is associated with a reduction in the odds of
any treatment during follow-up, compared with the control group.
Longitudinal follow-up data for the POPPY trial participants indicated a broadly similar demand for
outpatient and inpatient resource use between treatment and control groups. There was not an
observed difference in estimated resource use between groups at 11 years post pelvic floor muscle
training. Resource use cost estimation is limited because 84% of records in the outpatient data set did
not have sufficient information about condition or procedure.
The dissemination and implementation workshops were attended by 120 participants (72 in London
and 48 in Glasgow) and identified key barriers (and facilitators) in line with those experienced in the
realist evaluation. The presentation of the PROPEL intervention findings allowed for discussion of
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the possibility of different ways to deliver pelvic floor muscle training. This ‘evidence base’ helped the
majority of participants to shift to thinking ‘change’ was possible and to begin action plans to take back
to their local services.
Conclusions
It is possible to train different staff types/skill mixes to effectively deliver pelvic floor muscle training
to women. Women’s self-reported outcomes significantly improved across all service models delivering
pelvic floor muscle training. The PROlapse and Pelvic floor muscle training: implementing Evidence
Locally (PROPEL) intervention has demonstrated how different models and service contexts can affect
implementation, but, if these are addressed in advance, then there will be a greater likelihood of successful
integration with existing care pathways and greater opportunities for ensuring that (non-specialist)
staff delivering pelvic floor muscle training are supported to deliver pelvic floor muscle training with
appropriately triaged patients and appropriate clinical supervision. Services delivered using higher-band
physiotherapists only were more costly than services delivered using other staff mixes.
The realist evaluation, combined with the robust outcomes data, confirms that pelvic floor muscle
training can be successfully delivered using a range of staff/skill mixes and in different NHS settings,
and that outcomes are not compromised by different delivery models. This study supports further
roll-out of delivery of pelvic floor muscle training (beyond delivery by specialist physiotherapists)
by clinicians (nurses, other physiotherapists) who have an interest in women’s health.
Implications for practice
The evidence supports training a broader range of health-care professionals with an interest in
women’s health and/or with a knowledge of physiology/body muscles to deliver pelvic floor muscle
training to women.
Delivery of pelvic floor muscle training by other clinicians was supported by specialist physiotherapists
undertaking triage of women to determine their suitability for pelvic floor muscle training. The role
of the specialist physiotherapist could then be enhanced to provide education and support to other
health-care professionals to enable them to safely deliver pelvic floor muscle training to women,
while managing more complex cases of pelvic floor prolapse themselves.
Increasing the use of and referral for pelvic floor muscle training as a first-line treatment was
facilitated by improved multidisciplinary team working across urogynaecology services and improved
communication with primary care. A review of existing pathways to pelvic floor muscle training could
identify areas for improvement.
Primary care referrals for pelvic floor muscle training as a first-line treatment for pelvic organ prolapse
would probably increase with more awareness-raising (of pelvic organ prolapse and pelvic floor muscle
training) and education for general practitioners and other primary health-care professionals.
Study registration
This study is registered as Research Registry 4919.
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Chapter 1 Introduction, background and aims
Introduction
Pelvic organ prolapse (POP) affects women of reproductive age and beyond; it is a condition seen in up
to 50% of parous women and up to 75% of women attending outpatient gynaecology clinics.1,2 Treatment
options for prolapse include surgery and conservative management [with pessaries or pelvic floor muscle
training (PFMT)]. A high proportion of women go on to have surgical intervention, which is often prone
to failure, with the same prolapse recurring or another prolapse occurring in another location, which can
lead to repeated operations.3 Mesh-related complications are frequently reported, and have a removal
rate of up to 35%.4 In Scotland, in 2014, the use of synthetic mesh implants in the treatment of POP was
suspended; this suspension was subsequently introduced in NHS England in 2018.
These highly publicised suspensions of synthetic mesh implants make the need for non-surgical
options to treat this condition even more pressing.5 Clear evidence of the clinical effectiveness and
potential cost-effectiveness of PFMT in the management of prolapse is now available. This evidence
concludes that PFMT should be recommended as a first-line treatment for POP.6 The Pelvic Organ
Prolapse PhysiotherapY (POPPY) trial was a multicentre randomised controlled trial of the clinical
effectiveness and cost-effectiveness of individualised PFMT compared with a lifestyle-advice leaflet
in women with newly diagnosed symptomatic stage I, II or III prolapse.6 The POPPY trial constitutes
the largest, most rigorous, pragmatic trial of PFMT for prolapse and, as such, provides the necessary
evidence to inform future practice. Individualised PFMT provided by specialist women’s health
physiotherapists (WHPs) was found to be effective in reducing women’s symptoms of prolapse and
in improving prolapse-related quality of life. It also showed potential to be a cost-effective treatment.
However, knowledge of efficacy and effectiveness is not enough to ensure implementation.
Background
In the UK, there is currently limited availability, and variation in the availability, of specialist WHPs
to deliver PFMT to the large numbers of women who may benefit from it.7,8 In the UK, there are
approximately 800 specialist physiotherapists working in women’s health, as registered with the Pelvic,
Obstetric and Gynaecological Physiotherapy (POGP) group. The number of women aged > 40 years in
the UK (based on the 2011 census9) is approximately 15.9 million; taking a symptomatic estimate of
10% into account means that there are approximately 2600 symptomatic women for each specialist
physiotherapist in the UK. It is unlikely that PFMT will be available to meet the demand unless it can
be delivered in other formats, for example by other types of health-care professionals (HCPs).
Implementation science is an emerging field involving complex and multilevel processes.10 It aims
to advance knowledge of implementation by providing generalisable knowledge that will be useful
for other settings and contexts. It can help to identify barriers to implementation, but should also
extend this to how and why implementation processes are effective.11 To do this, we need to study
implementation strategies and the contexts and processes in which implementation strategies are
delivered. Such research is a necessary step in the Medical Research Council’s evaluation of complex
interventions framework.12
Research to improve the implementation of evidence-based PFMT was required. Delivery methods
that can enhance service capacity and increase the availability and choice for women are required, but
these need to be tested to ensure that the outcomes achieved under trial conditions are maintained.
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We needed to know whether or not the NHS could deliver PFMT using different staff skill mixes
and/or different numbers of sessions and still maintain the benefits observed under trial conditions.
We also needed to know how PFMT is implemented in everyday practice and understand the barriers
to and facilitators of successful uptake and delivery. It was anticipated that this knowledge would
enhance the likelihood of PFMT being rolled out more widely if service models could be successfully
tailored to suit different local circumstances and resources, thereby increasing the availability of such
services for the many women who would benefit from this treatment.
In addition, trial follow-up rarely extends to more than 1 or 2 years post trial. An observed reduction
in ‘further treatment’ following PFMT was initially established in the POPPY trial. A record linkage-
based study of longer-term follow-up of the original POPPY trial participants would show whether
surgery is prevented or delayed by the use of PFMT. These data would help inform NHS managers
as to what long-term benefits they might expect if they implemented PFMT.
Aims
Overall aims
l To maximise the delivery of effective PFMT for women with prolapse through the study of its
implementation in three diverse settings. This would involve developing different service delivery
models, such as using different staff skill mixes, with the format of delivery being determined locally.
l To assess the impact of PFMT on longer-term treatment outcomes using linked health-care data for
the majority of the original POPPY trial participants (i.e. those based in Scotland).
Specific aims
l To understand the barriers to and facilitators of implementing PFMT across varying NHS locations
from managerial, delivery staff and women’s perspectives and experiences, and to develop different
models of delivery in response to these.
l To explore the potential for different groups of staff skill mix to deliver PFMTwithout compromising
the achievement of clinical outcomes.
l To explore fidelity or variation to the PFMT protocol (e.g. number of sessions) and the impact of
any variations.
l To establish the levels of support required by non-specialist physiotherapists to deliver PFMT.
l To explore the acceptability and outcomes for women of different delivery models.
l To establish the costs and benefits associated with each model of delivery.
l To contribute to knowledge of how and why implementation processes are successful (or not)
through exploring what works, for whom and in what circumstances.
l To establish whether or not the benefits observed among the POPPY trial participants are
maintained at longer-term follow-up and across different NHS settings.
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Chapter 2 Overview of methodology, study




The study was informed by two theoretical frameworks from implementation science theory: the
realist evaluation framework13 and the reach, effectiveness, adoption, implementation and maintenance
(RE-AIM) framework.14 The realist evaluation approach was used to understand how the intervention
was implemented in different study sites, what contextual factors influenced its implementation and
what ‘mechanisms of action’ lead to successful (or unsuccessful) delivery and outcomes. The RE-AIM
framework was used to determine the overall public health effect of the intervention, using specific
and standard ways of measuring the key indicators of potential impact and the widespread adoption
and sustainability. The combination of both of these frameworks enabled us not only to evaluate
the intervention’s internal and external validity, but also to take account of the context in which the
intervention was delivered and identify the mechanisms that made it work (or not) to produce the
observed outcomes. Realist evaluation is explained in more detail in Chapter 4, alongside its methods,
and the realist evaluation findings are presented in Chapter 5.
The RE-AIM framework
The RE-AIM framework, developed by Glasgow et al.,14 is designed to enhance the quality, speed and
health impact of efforts to translate research into practice, and is based on five dimensions: reach,
efficacy/effectiveness, adoption, implementation and maintenance. Its purpose is to expand the assessment
of interventions beyond efficacy to multiple criteria that may better identify the translational quality and
public health impact of health interventions, balancing the emphasis on internal and external validity.
The RE-AIM framework helped to focus on important outcomes for implementation research at both the
individual (recipient/use) and the organisation/system level (agents of delivery). The specific aspects of the
RE-AIM framework are explained in the following paragraphs, along with the types of data gathered in this
study for each of these aspects, which are presented across the findings chapters (see Chapters 4–6 and 9).
Reach
Reach refers to the absolute number, proportion and representativeness of the target population that is
touched by the intervention. In this study, reach was assessed by exploring whether or not the increased
service capacity resulted in or could lead to changes in the target population (e.g. reaching those with
mild to moderate POP, the number of referrals from various sources and increased accessibility of
PFMT in local areas). Reach was assessed using both qualitative and quantitative data.
Effectiveness
Effectiveness refers to the impact of an intervention on important outcomes. In the context of this
study, effectiveness was explored both quantitatively (i.e. whether or not the different models of PFMT
service delivery remained effective when compared with the outcomes from the original POPPY trial)
and qualitatively (i.e. the experience of improvement reported by women and staff delivering PFMT
and the experience of quality of care reported by women).
Adoption
Adoption refers to the willingness by the target settings, institutions and staff to implement, support
and embed the intervention into their routine practice. In this study, adoption was assessed by the
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extent of uptake of PFMT by staff, the continued participation (or dropout) in the delivery of PFMT
and the level of support provided by services and staff for the adoption of PFMT delivery.
Implementation
Implementation refers to the fidelity and consistency of intervention delivery as intended, and the cost
of the intervention. In this study, implementation was monitored using the qualitative data on how
the intervention was delivered locally and the extent to which it was implemented by the services as
intended, as well as the quantitative data on the service delivery costs for different models of delivery.
Maintenance
Maintenance refers to the extent to which an intervention becomes institutionalised or part of the
organisational practices/policies. At individual level, it refers to long-term outcomes of the intervention.
In this study, the maintenance of intervention effects in individuals and settings over time was
monitored via the outcomes data and the record linkage-based follow-up of the original POPPY trial
participants, who were based in Scotland. It was also assessed through qualitative data on the future
plans of study sites to continue the intervention and to train more staff in PFMT delivery.
Design
This study included the following components.
Realist evaluation
A realist evaluation was carried out that used case studies of implementation of PFMT delivery in
three varying NHS settings (see Chapters 4 and 5). The realist evaluation allowed for substantial local
stakeholder engagement and for local sites to make decisions on how to deliver PFMT [e.g. using
different skill mixes such as specialist physiotherapists, women’s health nurses and junior (band 5)
physiotherapists, as well as different numbers of sessions] (Figure 1). The realist evaluation would elicit
local folk theories around how implementation was supposed to work [context–mechanism–outcome
(CMO) configurations], track how implementation was working (including fidelity to the PFMT protocol)
and lead to an understanding of what influenced outcomes.
Patient-reported outcome measures study
A robust patient-reported outcome measures (PROMs) study, which used the same outcome measures
as the original POPPY trial, was conducted in five NHS sites (three case study sites plus two additional
sites, see Figure 1) to observe the outcomes for women receiving the different models of care (see
Chapter 6). It was intended that, in the skill mix of staff across sites, there would be a mix of specialist
physiotherapists, other physiotherapists and different types of nursing roles. It was also intended
that the skill mix of staff would allow for a comparison of the specialist-delivered outcomes with
the non-specialist-delivered outcomes. This would also allow comparison of the delivery of PFMT by
specialist physiotherapists in the everyday world of the NHS with those observed in trial conditions.
Longer-term follow-up
Longer-term follow-up of up to 6 years of the original POPPY trial participants was carried out using
record linkage of hospital and outpatient data [provided by Information Services Division Scotland via
the NHS electronic Data Research and Innovation Service (eDRIS) (see Chapter 7).
Economic evaluation
An economic evaluation was carried out, which was concerned with the associated costs and outcomes
of different service delivery models for delivering PFMT. In addition, an economic assessment of the
long-term costs associated with accessing further pelvic prolapse treatment over time was conducted
for the original POPPY trial participants, who were resident in Scotland (Chapter 8).
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The applicability of study findings and outcomes
Finally, ‘dissemination and implementation workshops’ (in England and Scotland) were run to discuss
the applicability of study findings and outcomes with service managers/women’s HCPs/general
practitioner (GP)/patient and public representatives from across the country, with discussion of
implications for planning of local services and identification of any further key barriers to or
facilitators of change (see Chapter 9).
PROMs study (n = 5 sites;
three realist evaluation sites +
two additional)
Round 1
• Service planning meetings
• Focus groups
• Interviews with managers
• Interviews with senior
    staff
Round 2
• Service planning meetings
• Interviews with managers
• Interviews with senior staff
• Interviews with staff
• Observation of meetings
Training of staff to deliver PFMT
Round 3
• Interviews with managers
• Interviews with senior
    staff
• Interviews with staff
• Interviews with women
Round 4
• Interviews with managers
• Interviews with senior staff
• Interviews with staff

































             Patient recruitment
Baseline data collection by
clinicians






6-month data collection by
clinicians


















Dissemination for implementation workshops (London and Glasgow)
Long-term follow-up
of the POPPY trial
participants (Scotland)
(n = 293)
Realist evaluation (n = 3 sites)
Staff recruitment (different
skill mixes according to local
resources/services)
FIGURE 1 The PROPEL intervention flow chart. EQ-5D-5L, EuroQol-5 Dimensions, five-level version; ICIQ-UI SF, International
Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form; POP-Q, Pelvic Organ Prolapse Quantification;
POP-SS, Pelvic Organ Prolapse Symptom Score; PROM, patient-reported outcome measure; PROPEL, PROlapse and Pelvic
floor muscle training: implementing Evidence Locally. Reproduced from Maxwell et al.15 This article is distributed under
the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies
to the data made available in this article, unless otherwise stated. This figure includes minor additions and formatting
changes to the original figure.
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Intervention description
The PROlapse and Pelvic floor muscle training: implementing Evidence Locally (PROPEL) intervention
that was being evaluated in this study is fully described using the Template for Intervention Description
and Replication (TIDieR) checklist (see Appendix 1).16 Participants attended an initial assessment and
treatment visit with a PROPEL intervention clinician to determine their personalised PFMT protocol,
and the patient was provided with any additional lifestyle information deemed necessary to assist with
their treatment. Further appointments were scheduled at the patient’s and clinician’s discretion; the
sessions progressed using the PFMT protocol until the clinician or patient decided that no further
appointments were required, at which point the patient was discharged from the service. Alternatively,
if it became apparent that the patient’s condition was more complex than initially thought, the clinician
had the choice to refer the patient to specialist physiotherapy. During each appointment, clinicians
completed a clinician assessment form to record all information.
Training to deliver pelvic floor muscle training
Staff who were identified in round 2 of the realist evaluation as potential staff to deliver the PROPEL
intervention were approached by either specialist physiotherapists or a consultant within their trust. The
staff who were to deliver the PROPEL intervention attended a 1-day training session held within their
site. The training session was developed specifically for the PROPEL intervention and in conjunction with
the POGP. It was delivered by two POGP-registered specialist physiotherapist trainers to a maximum of
five new staff per site. In addition, a member of the research team was present at all training sessions to
ensure that all questions regarding study specifics could be answered. Training manuals were produced
and provided to the participants. Further details on the training are provided in Appendix 2.
Patient and public involvement
The Bladder and Bowel Foundation (BBF) (Kettering, UK) was an initial partner in this research and a
co-applicant that contributed to the study design and provided expertise concerning the involvement in
this study of women with prolapse. The BBF specifically provided input to the discussions on the delivery
options women may receive, on the issues of recruitment of women and on the feasibility of patient data
collection processes. They also provided members’ views of their experiences of health care and how they
would value opportunities for PFMT, and the likelihood of its acceptability to women with POP.
However, the intention that the BBF would continue to be represented throughout the conduct of this
study as a full partner and member of the project management team was not realised, because the BBF
ceased to exist just at the point of the PROPEL intervention commencing.We then worked to identify
another organisation that could step in to fulfil the role of the BBF. On the advice of our Study Steering
Committee (SSC) we approached PromoCon (Worsley, UK), which later became Bladder and Bowel UK,
as an organisation that represented people with bowel and bladder problems, and PromoCon agreed to
become a part of the PROPEL intervention team. However, the process of understanding the organisational
commitment and who would be able to take on the lead role within the PROPEL intervention from within
PromoCon was confounded by the organisation’s own impending changes and its move to forming Bladder
and Bowel UK. Therefore, it took some time within the PROPEL intervention to secure the support of
another patient and public involvement (PPI) organisation; this had an impact on our ability to recruit
individual women with experience of POP to sit on our project management group (PMG) and our SSC.
With the help of Bladder and Bowel UK, we finally recruited two PPI representatives: one became part
of the PMG and the other joined the SSC. We continued to try and recruit further PPI representatives
well into the 2 years after the study initially began, but without any further success. However, the two
women recruited to the PMG and the SSC remained with the study to the end and contributed greatly
to our meetings and how we communicated with both women and HCPs.
OVERVIEW OF METHODOLOGY, STUDY DESIGN, INTERVENTION DESCRIPTION AND PPI
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Although our PPI representatives were not actively involved in data collection or analysis tasks, they
did provide input to project management, commenting on project documentation and reports to the
funder, but, specifically, they were extremely valuable in discussing local site problems. There were
difficulties in getting sites up and running and there were issues concerning staff attrition rates (mainly
as a result of illness or retirement), which all affected the ability of sites to recruit sufficient numbers
of women. Our PPI representatives were sympathetic to these issues, but also offered insight and
sometimes solutions, such as contacting other local women’s groups to raise awareness of the study.
Our PPI representatives had always been intended to support dissemination of these findings to lay
audiences and were included as key participants in our proposed dissemination and implementation
workshops, which were intended, for example, for NHS managers, service leads, urogynaecologists,
and physiotherapists with a remit for POP. One of our PPI partners attended two workshop events
(London and Glasgow) and was a powerful voice not only in the telling of her own experiences, but
also in encouraging managers and HCPs to take the PROPEL intervention findings on board and act on
them. The feedback from the dissemination events overwhelmingly rated the contribution of the PPI
representative as ‘excellent’.
We will continue to work with our PPI representatives in producing further outputs for lay audiences
and will also disseminate these via Bladder and Bowel UK.
The experiences of our PPI representatives of working with the PROPEL intervention are described
as follows:
I welcomed the opportunity, my first, to be involved as PPI representative in this project.
In my view anything that reduces the number of women having to undergo surgery can only be good for
patients. Having increased numbers of skilled staff and reducing the costs involved in surgery would also
be of benefit for NHS trusts.
I did find it difficult to offer any specific input to the project, particularly latterly when I was less able to
attend meetings. I found the experience interesting and would certainly participate as PPI in the future.
PPI representative 1 (PMG)
I feel very privileged to have been a PPI on this study as the subject matter is very relevant to my patient
experience within the NHS. I work within the NHS (in an unrelated field) so have (a little) understanding
of the difficulties faced on a daily basis with staffing and funding issues. But more importantly I have
years of patient experience and know how difficult I personally found it to access women’s health
physiotherapy in my area. Hence, I appreciated being involved in a study that could not only improve
patient outcome, but look at the implementation aspect of providing an NHS service.
Having never been involved in a research project before, I found the team supportive, friendly and above
all willing to listen. It is sometimes difficult partake in discussions when you are not experienced or
qualified in the field, but I felt that the patient voice was heard. I feel my experience with administrating
an online support group for women with pelvic pain and prolapse helped with my ability to voice the
patient point of view.
My highlight was speaking about my patient experience at the dissemination meetings. It was well received
and I felt it emphasised why the research was undertaken and what a difference it could make to patient
outcomes. It was fantastic to hear of the success of the project and that physiotherapy works in terms of
patient improvement and cost savings. I look forward to being involved in the next study. Thanks to the
PROPEL team for all their hard work.
PPI representative 2 (SSC)
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Chapter 3 Description of case study sites and
implementation of training
Introduction
The PROPEL intervention initially aimed to include three diverse sites across the UK in which to
develop new models of PFMT service delivery. These three sites, A, B and C, had been identified during
the funding application process and were keen to be involved in the study from this stage. It became
apparent during the recruitment of women to the PROMs study and from the delays in sites to
implement the new models that we would find it difficult to reach our recruitment target through
these three original sites. Through one of our co-applicants who had previously been on the executive
committee of the POGP, we sent out an invitation to around 20 women’s health services throughout
Scotland and England. We had a number of positive responses, which resulted in the recruitment of
two further ‘light-touch’ sites to the study. By this stage in the study, round 1 of data collection for
the realist evaluation had been completed in sites A, B and C and the decision was made, with the
agreement of the PMG, not to include these two new sites in the full realist evaluation, but to gain
some reflection on their experiences of setting up and delivering PFMT in their regions. This decision
was made to avoid further delays in recruiting women to the PROMs study and to maximise follow-up
of women, while at the same time adding to our knowledge of ‘what works’ for implementation.
Overview of sites
Site A
This site had two components for delivering PFMT to women with prolapse in a secondary care setting:
1. community continence service
2. two hospital-based women’s physiotherapy services.
In both settings, the teams delivering PFMT were composed of band 7 [Agenda for Change (AfC)] and
band 6 (AfC) specialist WHPs. Service planning meetings (SPMs) were held with the community and
hospital teams separately, as they functioned under different management. Clinicians from these three
teams had previously taken part in the POPPY trial.
Community
Initially, the community lead indicated that there was a need for an increase in capacity and was keen
for continence nurses to be involved and be trained to deliver the PROPEL intervention. In addition, the
community lead had indicated that they wanted to use group sessions for women with prolapse to educate
them about PFMT before they were referred on for one-to-one treatment. After discussion with the team,
it emerged that there was strong resistance to clinical groups other than physiotherapists being trained to
deliver PFMT. In addition, not all of the physiotherapists in the team felt that they had the capacity to take
part in the PROPEL intervention. Ultimately, two physiotherapists from the community agreed to participate.
Hospital
At the first SPM, the lead of the hospital service indicated that their preference was to not change
their model of PFMT service delivery, citing staff shortages. After discussion among the core research
team, the decision was made that we would use this as an opportunity. A total of nine specialist WHPs
were recruited from the two hospital-based teams to deliver the PROPEL PFMT intervention to women
with prolapse. This meant that they could continue with their normal service while the research team
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were able to collect data on the outcomes of PFMT, as delivered by specialist WHPs in a real NHS
setting outside the constraints of a trial setting. It was agreed that they would continue to deliver the
same specialist service to women recruited to the PROPEL intervention, including any adjunct therapies
that they would prescribe normally. Nine specialist WHPs took part in the study, initially to recruit
women to the focus groups in round 1 of the realist evaluation with a view to deliver PFMT through
the PROPEL intervention in the two hospital teams. Six months into the project, the service lead
approached the research team with fears that, because of further staff shortages, they were unsure
if they would be able to continue to be involved in the PROPEL intervention. A number of meetings
followed during which the research team provided the site with options that would enable them to
continue their involvement in the PROPEL intervention, in a decreased capacity if necessary. This
resulted in the loss of one of the hospital-based teams’ participation and a reduction in members of
the team taking part in the remaining team.
At the end of the service planning process at this site, it was confirmed that five specialist WHPs from
the hospital team and two from the community team would take part in the PROPEL intervention.
The benefit of using this model of service delivery were twofold. First, we would be able to see if the
outcomes obtained by specialist physiotherapists in the PROPEL intervention were comparable with
those seen in the POPPY trial. Second, this specialist model provided us with a comparison group,
similar to that in the POPPY trial, to use as a benchmark for the outcomes achieved by other clinician
groups recruited and trained across the other four study sites.
Site B
Site B was a rural site with a large geographical area and an existing model of PFMT service delivery
by a small number of specialist WHPs in hospital settings. Owing to the large area that this service was
required to cover, they had concerns around the capacity of the existing service and the accessibility
of this service to women. It was these issues that had led them to become involved in the PROPEL
intervention at the outset.
From the outset, the central research team and the local principal investigator (PI) had difficulties
engaging key managerial stakeholders in the service planning process. This was, in part, attributed to
major changes taking place in the urogynaecology service locally in both a physical and organisational
capacity. SPMs took the form of a more bottom-up approach to planning the new model of service
delivery, with one specialist WHP leading the development process for the model that would be used
in the PROPEL intervention. The local PI was very motivated and had previously been involved in
providing additional training in this area with clinicians who had a special interest in this area of service
delivery. Like site A, the service planning took longer than anticipated; consequently, there were delays
in recruiting women to the realist evaluation and the PROMs study. There was significant discussion
about which clinicians would be trained to deliver the PROPEL intervention. During discussion with
the SSC about the groups of clinicians who were being trained to deliver the PROPEL intervention,
we were advised that sites A–E set up a triage step within their referral process for potential PROPEL
intervention participants. In site B, this meant that all women referred with POP received an initial
assessment, which was carried out by a specialist WHP who identified if the woman met the inclusion
criteria for the study. Only at that point were women approached about participating in the study.
This site had the most diverse clinical mix taking part in the study: district nurses, continence lead
nurse specialists, musculoskeletal and general physiotherapists and urogynaecology nurses. The mix
in the staff who were trained meant that the point of delivery of the new model of service was also a
lot more diverse and was much more accessible for the women receiving this intervention. The large
number of clinicians trained at this site and their diverse roles resulted in the point of delivery of
PFMT services moving from a hospital to a community-based setting in many cases. It also meant that
women who consented to take part in the PROPEL intervention could receive their treatment closer to
home, as the clinicians trained for the PROPEL intervention were located across a variety of places in
this site. Eight clinicians were trained to deliver the PROPEL intervention.
DESCRIPTION OF CASE STUDY SITES AND IMPLEMENTATION OF TRAINING
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Site C
This urban site previously delivered limited PFMT services through a small number of specialist WHPs
in a hospital setting. Similar to site B, this site was interested in moving these services to a community-
based setting so that they were more accessible. At the initial SPM, which was the best-attended
meeting at this site, it was highlighted that a community-based urinary continence team, which
included physiotherapists and band 6 and 7 (AfC) nurses, was the preferred model of PROPEL PFMT
intervention service delivery. The lead of this team indicated at this meeting that they would have to
take this proposal to their management before this could be taken forward; however, they were keen
to see this happen. One week following this meeting, the research team were informed by the site’s
research and development department that the proposed community continence team were currently
involved in another research project and would not have the capacity to take part in the PROPEL
intervention alongside this existing project. It was agreed that further possible models of service
delivery would be discussed at the next scheduled SPM.
The next SPM was poorly attended; despite this, further possible models of service delivery were
discussed, which still focused on having a community-based element to the PROPEL PFMT intervention
service delivery. SPM attendees identified community-based physiotherapists, who were not part
of the continence team, as possible participants. They also discussed the possibility of training a
number of urogynaecology nurses who were based in the hospital, to supplement the community
physiotherapists. Following this meeting, the research team received interest directly from a number
of these physiotherapists. Unfortunately, these physiotherapists did not have the support of their
managers and were therefore unable to take this model of service delivery forward.
At this stage in the planning process, the research team flagged up the issues around the slow
progress in setting up a new model of PFMT delivery to the independent SSC in this site. It was
decided that this site would need to be given a deadline to have identified the clinicians who would
be taking part in the PROPEL intervention, so that this site could be taken forward without causing
catastrophic delays to the study. Finally, the decision was made locally that, despite wanting to set up
a community service, this would not be possible at that time; instead, it was decided to follow up with
a model using urogynaecology nurses based in the hospital to deliver the new service delivery model.
Three nurses agreed to be trained to take part in the PROPEL intervention.
Sites D and E
Each of these were urban sites with a wide socioeconomic spread. As discussed previously, these sites
were recruited as ‘light-touch’ sites to be involved in the women’s PROMs study only and not in the
realist evaluation. The result of not having to go through the data collection process around the service
planning for new models of service delivery was that these sites were set up more quickly and started
recruiting only shortly after the original three sites. Site D implemented a model of service delivery
that was made up of four band 6 and 7 (AfC) musculoskeletal physiotherapists. Site E implemented a
model of service delivery that was made up of two band 5 (AfC) nurses and two physiotherapists: one
band 5 and one band 6 (AfC).
Womens’ input into service planning for the PROPEL intervention
The women’s focus group data that were collected in round 1 of data collection for the realist
evaluation were summarised and fed back at a SPM at each of the sites. The focus group study was
designed so that each site had data on the issues that were important to women currently using these
services; this included topics around awareness of women in the existing service, referral pathways
and treatment received. These data were collected and fed back to sites so that the views of women
could be considered in the process of designing a new model of delivering PFMT to women in the
PROPEL intervention.
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Overall, 26 clinicians were initially trained to deliver the PROPEL intervention (Table 1). In total,
six of these withdrew from the study prior to treating any women using the PROPEL intervention
protocol. They cited a number of reasons for this, including injury, lack of confidence, lack of capacity,
organisational issues and moving away from their current post.
Training
Pelvic floor muscle training
Clinicians at sites B–E received the same standardised training as outlined in Appendix 2; assessors
at these sessions completed a checklist to verify the completion of aspects of the training, using the
checklist in Appendix 3. As the staff identified in site A were already fully trained specialist WHPs,
TABLE 1 The PROMs study site summary
Site
Service
context Service model adopted Skill mix trained
A Urban,
POPPY site
No change. Existing primary and secondary care provision of
specialist physiotherapy. Referrals triaged
Specialist physiotherapists
(existing team):
l band 7 WHPs (n = 2)
l band 6 WHPs (n = 6)
B Rural The PROPEL intervention PFMT training was provided to a
variety of clinicians over a large geographical area. This
included clinicians with special interest, district nurses,
continence nurses and physiotherapists. The PROPEL
intervention women were triaged by specialist physiotherapists
prior to referral to the PROPEL intervention service.





band 6 (n= 1)
District nurses (n = 2)
Lead nurse specialist in
continence, band 6 (n= 1)
Urogynaecology (n= 2)
C Urban New provision of PFMT delivery developed for the PROPEL
intervention based in secondary care. Consultant triaged and
referred to the PROPEL intervention service provided by
urogynacology nurses
Urogynaecology nurses:
l trained (n = 3)
l took part in the PROPEL
intervention (n = 2)
D Urban Community health-care setting. Current PFMT service
delivered by small number of specialist physiotherapists.
Four clinicians to deliver the PROPEL intervention service
in a community health-care setting
Musculoskeletal
physiotherapist, 1 × band 5,
2 × band 6 and 1 × band 7
E Urban Current PFMT service delivered by small number of specialist
physiotherapists. Four trained clinicians to deliver the PROPEL
intervention service in a community health-care setting
Urogynaecology nurse (n= 2)
Physiotherapists (band 5,
n= 1 and band 6, n = 1)
Adapted with permission from Abhyankar et al.17 This article is licensed under a Creative Commons Attribution 4.0
International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format,
as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
licence, and indicate if changes were made. The images or other third party material in this article are included in
the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated in a credit line to the data. The table includes minor additions and formatting changes to the original table.
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they were not required to undertake this training. Instead, these clinicians undertook a training session
with members of the PROPEL intervention research team, which focused on the paperwork that they
would be required to complete during the treatment of women recruited locally to the study. These
staff were also given copies of the self-report questionnaires that the women would be receiving, so
that they were familiar with what women in the study would be asked to complete.
Pelvic Organ Prolapse Quantification System training
Although the Pelvic Organ Prolapse Quantification System (POP-Q) is a validated research tool for
objectively measuring the stage of prolapse in women, it is not a measure that is commonly used in
the clinical setting (see Appendix 4).18,19 As seen in Chapter 2, Design, and Figure 1, it was planned to
carry out the POP-Q assessment at baseline and at the 6-month follow-up for each woman recruited
to the PROMs study. It quickly became apparent from meetings with the staff who would be delivering
PFMT locally that the POP-Q assessment was not a commonly used clinical measure, even among the
specialist WHPs.
In site A, the POP-Q training was delivered to the staff delivering the PROPEL intervention by a
consultant urogynacologist who was working in this site. Each clinician taking part in the PROPEL
intervention was given the option of completing a simplified POP-Q staging assessment or a full POP-Q
assessment on women at baseline when they attended their first appointment, and again 6 months after
a woman began her treatment (see Appendix 5).
The specialist WHPs in site B who were involved in triaging women for the PROPEL intervention were
provided with similar training from a urogynaecologist working in another specialist women’s health
centre. After this training had been completed, all POP-Q assessments at this site were carried out by
a band 7 (AfC) specialist WHP at the time of a woman’s triage appointment. On completion of their
PFMT treatment by the newly trained clinicians, women then attended an extra appointment with the
band 7 specialist WHP, who completed their follow-up POP-Q assessment. Owing to the geographical
area and the constraints that this imposed on the specialist physiotherapists, only a proportion of
the women recruited to the PROPEL intervention at this site received these baseline and follow-up
POP-Q assessments.
Similarly in site C, it was the consultant gynaecologist who undertook the baseline and follow-up
POP-Q assessments with women, rather than the newly trained urogynaecology nurses. They were,
therefore, well placed to complete the POP-Q baseline assessment at the triage stage. For their
follow-up POP-Q assessment, women were invited to come back in for an additional appointment
with the consultant after completion of their PFMT treatment.
The POP-Q was a secondary outcome measure. Owing to the difficulties and time delays the research
team encountered in organising the POP-Q training for clinicians, in both sites A and B, the decision
was made by the PMG [and ratified by the National Institute for Health Research (NIHR)] that we
would not carry out the POP-Q assessments on the women recruited in the two light-touch sites.
The delays between clinicians receiving the PFMT intervention training and the recruitment of women
were 4, 2.5 and 4 months in sites A, B and C, respectively. These delays were incurred as a result of
these three sites requiring training to carry out the POP-Q assessments.
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Chapter 4 Realist evaluation methods
Parts of this chapter are adapted with permission from Abhyankar et al.17 This article is licensedunder a Creative Commons Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons licence, and
indicate if changes were made. The images or other third party material in this article are included
in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission
directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/
licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
in a credit line to the data. The text below includes minor additions and formatting changes to the
original text.
Realist evaluation approach
Realist evaluation belongs to the family of theory-based evaluation approaches. Theory-based
evaluations aim to clarify the ‘intervention theory’, that is clarify how intervention activities are
understood to cause or contribute to outcomes and impacts. Realist evaluation was used in this study
to understand how the intervention was implemented in different study sites, what contextual factors
influenced its implementation and what ‘mechanisms of action’ led to successful (or unsuccessful)
delivery and outcomes.
Realist evaluation has emerged in response to the need for knowledge that extends beyond that
obtained by the traditional outcome-focused evaluation approaches that ask the question – is the
intervention effective? Realist evaluation is founded on the premise that interventions are complex
and are introduced into social systems that are also complex. It maintains that no interventions are
universally effective, but that some things work for some people in some contexts. Realist evaluation
therefore asks what is it about the intervention that works, for whom, in what contexts and why.20
Realist evaluation contends that it is not interventions that work; rather, it is the people involved in
interventions who make them work. Interventions introduce opportunities, resources or ideas for
change, but whether or not these actually lead to the intended outcomes depends on how people
react to, interpret and act on these resources. It is people’s reasoning and capacity in response to
the intervention elements that represent the real ‘mechanisms of action’ in any intervention. These
mechanisms of action are, however, contingent on the social context in which people work. Certain
contexts enable people to act, whereas others place limits on people’s behaviour.21 Realist evaluation
thus seeks to explain the complex relationship between the mechanisms activated by the intervention,
the context that influences their workings and the intended and unintended outcomes they produce. The
explanatory proposition of realist evaluation is that interventions work (have successful outcomes – O)
only in so far as they introduce appropriate ideas and opportunities (mechanisms – M) to groups in the
appropriate social and cultural conditions (contexts – C). The task of an evaluation is to identify the
linked patterns of contexts, mechanisms and outcomes (CMO configurations) to explain how particular
outcomes were brought about by certain mechanisms being triggered in certain contexts.20
This study aimed to implement a complex intervention, the delivery of PFMT using different staff skill
mixes, in complex NHS systems consisting of a number of actors, varying resources, diverse geographical
locations and service configurations. The implementation also involved actions and decisions from
people in multiple roles at different levels, for example from service managers and finance directors
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at organisational level to front-line staff delivering and supporting the PFMT intervention, as well
as women receiving PFMT. Given the interplay of multiple factors operating in different personal or
organisational contexts with different priorities and goals, realist evaluation provided an appropriate
framework and methodology to explore and explain the implementation of PFMT.
Realist evaluation typically involves three broad phases. Phase 1 seeks to identify the ‘folk’ theories
about how and why the intervention will bring about change. This involves eliciting ideas about how
the intervention is expected to be implemented and work, what intended and unintended outcomes
are likely, what may be their mechanisms of action and what contextual factors may enable or
constrain these mechanisms. Data are gathered from those involved in the implementation of the
intervention and its key stakeholders. These data are used to build hypotheses about the causal
relationships between specific contexts, mechanisms and outcomes; these are known as the CMO
configurations. Phase 2 involves testing these theories by gathering data on the actual implementation
process; this unfolds the mechanisms and outcomes and impacting contexts. In the third and final phase,
the intervention theories are refined through iterative data analyses and interpretation to provide middle-
range theory statements about why and how the intervention worked, for whom and in what contexts.
Phases and methods of realist evaluation
The realist evaluation was conducted in three broad phases, using a longitudinal, multiple case study design.
The five study sites described in Chapter 3 were considered as ‘cases’, although the full realist evaluation
was conducted in three sites only. Cases were defined at the level of the NHS trust in England and NHS
Health Board in Scotland, as these represent the units through which health services are organised,
governed and delivered in local areas. Defining the ‘cases’ at the level of these broad units helped to
ensure that the influence of contextual conditions at various levels (i.e. from financial, organisational
and managerial level to clinician, practice and patient level) was encompassed in the evaluation.
Data collection
The three phases of the realist evaluation aimed to identify, test and refine a theory explaining how
and why the PROPEL intervention worked (or not). It involved data collection at four time points over
an 18-month implementation period. The methods used in each phase are outlined in the following
sections. Table 2 presents the number and type of data sources collected in rounds 1 to 4.
Phase 1: identifying folk theories of change
Phase 1 took place during the planning stages of the intervention through two rounds of data
collection and aimed (1) to track local decisions on what to implement and how, rationales for service
delivery decision-making and ideas about how implementation is supposed to work and (2) to elicit
folk theories of change from the implementers and key stakeholders of the intervention about how
the intervention was intended to be implemented and work in their areas, for example the likely
outcomes of the intervention, possible mechanisms of action and potential contextual influences.
Rounds 1 and 2: development and operationalisation of the service delivery models
Focus groups with women Focus groups with women who were receiving care for prolapse in each
study site were conducted in round 1, to provide service user input to the local SPMs, where the
models for PFMT service delivery were discussed and decided on. The focus groups explored women’s
experiences of prolapse and treatments, their experiences of local services and care, their preferences
for service delivery models, acceptability of PFMT and their visions for a responsive and woman-centred
service. Women aged ≥ 18 years who were seeking and receiving care for prolapse through the local
gynaecology/women’s health service in each site were eligible to take part. Women were identified
and recruited by either the specialist pelvic floor dysfunction physiotherapists/WHPs or the consultant
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gynaecologists/urogynaecologists in local sites. The initial plan was to hold four focus groups across the
three sites (one site would host two focus groups because of the large geographical size of the service
area), with a minimum of four and a maximum of 10 participants per focus group. However, participant
availability prevented a focus group being held in one location (site C), because of the geographical
location and the inability of participants to travel. Instead, four individual telephone interviews were
conducted with consenting participants in that area, using the same topic guide as for the three focus
groups. The combined use of focus groups and individual interviews for pragmatic reasons may have
lowered the homogeneity in the data collection process, with a potential threat to the trustworthiness
of findings.22 However, the absence of any observed differences in the type of data collected by each
method and the convergence of key themes across the two methods suggests enhanced trustworthiness
of findings.23
TABLE 2 Number of realist evaluation participants (by NHS site)
Round SPMs
Managers/service
leads Senior clinicians Staff delivering PFMT Women
1 Total, n= 12
l site B, n= 4




l site B, n = 3




l site B, n= 1






l site A, n = 1
l site B, n = 2
Interviews, n= 4
(all in site C)
2 Total, n= 26
l site A= 11
l site B= 7
l site C= 4 + 4
(two SPMs)
Total = 6
l site A= 3
l site B = 2
l site C= 1
Total = 3
l site A= 1
l site B= 1
l site C= 1
Total = 11
l site A= 4
l site B= 5
l site C= 2
No interviews in
this round
3 N/A Total, n= 10
l site A, n = 2
l site B, n = 1
l site C, n = 4
l site D, n= 3
Total, n= 4
l site A, n = 1
l site B, n= 1
l site C, n = 2
Total, n = 10
l site A, no interviews
l site B, n= 7 (including
two exit interviews)
l site C, n = 2
l site D, n = 1
Total, n= 18
l site A, n = 7
l site B, n = 8
l site C, n = 3
4 N/A Total, n= 5
l site A, n = 1
l site B, n = 1
l site C, n = 2
l site E, n = 1
Total, n= 2
l site A, n = 1
l site C, n = 1
Total, n = 18
l site A, n = 7
l site B, n= 8
l site C, n = 1
l site D, n = 1
l site E, n= 1
Total, n= 15
l site A, n = 6
l site B, n = 6
l site C, n = 3
N/A, not applicable.
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Focus groups were conducted in private rooms at local hospitals and were facilitated by two researchers.
The focus groups each lasted approximately 1 hour and involved four, five and nine participants. The
telephone interviews lasted approximately 20–30 minutes. Focus groups and interviews were recorded
digitally, transcribed verbatim and summarised by the research team. The summaries were presented at
the SPMs to enable inclusion of service user voice into the decisions about service design.
Service planning meetings The liaison specialist physiotherapist in each site identified and invited local
service managers, clinical leads, consultants and other relevant staff groups to attend a series of SPMs.
The first SPM was convened in round 1, and aimed to familiarise the attendees with the evidence base
for PFMT and discuss its potential benefit for local management of POP. Members of the research
team attended this meeting to explain and reinforce study aims. The planning team then discussed
the current service provision and the local capacity issues, as well as how these might be addressed
with the available or an extended staff pool. Initial options for service delivery models were discussed
with ‘actions’ for any fact-finding, involvement of others or other actions necessary to help finalise
decisions about service models.
A second SPM was convened in round 2 by study sites to finalise the service delivery model to be
implemented, plan the operationalisation of the new model within current service structures and
identify staff groups for training in PFMT delivery. The meeting involved the same attendees as the
first meeting, plus any new members as deemed appropriate by the local service. Members of the
research team attended this meeting to ensure that study aims and objectives were met and to
observe the decision and planning process. Both meetings were audio-recorded to track the decisions
being made as well as the folk theories around how implementation is supposed to work, what may be
the likely outcomes and what contextual factors may impede or facilitate the implementation. The
decisions were finalised over two planning meetings in sites A and B and three meetings in site C.
Semistructured interviews Two rounds of individual semistructured interviews were conducted with a
number of stakeholders in each site to identify local theories of change. Service leads or managers and
senior practitioners (urogynaecology consultants/senior nurses or allied health-care professionals/GPs)
who were likely to be key decision-makers were identified from the SPM attendees and invited to take
part in round 1 and 2 interviews. Further interviewees were identified using a snowballing technique.
The interviews were conducted by a member of the research team, either face to face or via telephone,
and were facilitated by topic guides developed specifically for the purpose of the interview round.
Round 1 interviews explored the contextual detail about the site (e.g. how care is currently organised,
gaps in the service and need for change, and proposals for changes in service delivery), anticipated
barriers to and facilitators of implementation (e.g. resources, capacity issues, training, funding and buy-in
from stakeholders), potential mechanisms (e.g. attitudes towards PFMT delivery by non-specialists and
the challenges to implementation of different proposals) and anticipated outcomes. Round 2 interviews
explored staff views about the operationalisation of the decisions about service delivery models, attitudes
and reactions of various staff towards the new service model, how this will be translated to the staff
groups identified for PFMT training and service delivery, the potential barriers to and facilitators of
implementation of the new model, the involvement of and potential impact on other staff groups or
services, and intended and unintended outcomes. The exception to this was site A, where the staff groups
were interviewed only once, in round 2, as this site was not implementing any changes to its existing
service models. The interviews in this site focused more on understanding how the current service was
organised and working, what worked well and why and what areas needed improvement.
In round 2, additional interviews were also conducted, with the staff being asked about delivering
PFMT under the new service model to explore their views on the new service model, their involvement
in PFMT delivery, their expectations of training and the new role, their concerns and anticipated
problems and how these might be overcome, and the anticipated impact on their professional role.
In site A, which was not implementing any changes, these interviews focused on understanding how
the service was delivered and working, what worked well and why, what needed improvement and
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what it was about their service and care that led to positive outcomes for women. Interviewees were
identified from staff lists provided by local service leads. Interviews were conducted by members of
the research team, either face to face or by telephone, and were facilitated by topic guides that were
relevant to those staff groups.
Phase 2: testing the folk theories
The initial folk theories of change were tested by collecting data on contexts, mechanisms and outcomes
at the operational level in each study site, to explore how the intervention was implemented and worked
in different areas. This was carried out through two further rounds of data collection. Round 3 took
place ‘during’ the implementation stages once staff had begun to deliver PFMT to women under the new
service model, and focused on exploring how the new service model was operating and any problems
that had arisen during implementation. Round 4 took place after the intervention period had ended, as
dictated by the achievement of site-specific recruitment and treatment target, and focused on exploring
whether or not the implementation was perceived to be successful, whether or not/how the intervention
worked, what lessons were learnt from implementation and the plans for continuation of PFMT delivery
locally. In this phase, data were also collected from staff in the light-touch sites D and E, to explore the
implementation process, barriers, facilitators and outcomes in those areas.
Rounds 3 and 4: delivering and reviewing the models
Semistructured interviews Round 3 interviews with service leads/managers explored the process of
referrals to newly trained staff, any anxieties or concerns around training and support, service delivery,
local resources required for delivery and any perceived effect on women, staff and services. Round 4
interviews explored service leads’/managers’ perceptions of success of the models, the models’
sustainability, modifications that may be necessary, key drivers for success, areas and extent of
perceived impact, and future plans for further expansion of services.
Round 3 interviews with consultants/senior nurses/allied HCPs/GPs explored their views on
implementation and the perceived impact on other service areas. Round 4 interviews explored their
views of the overall implementation and impact, key drivers for success and views on continuation or
expansion of services.
Round 3 interviews with staff delivering PFMT explored their experiences and views of implementation,
concerns regarding their role in its delivery, problems experienced in service delivery and perceived
impact on factors such as women’s outcomes and their workload. Round 4 interviews explored their
overall experience of delivering PFMT and the impact they felt that their role had for women and
services, and key drivers of success.
Round 3 interviews with women receiving PFMT from the newly trained staff explored their
expectations and experiences of PFMT treatment, experience of care, and perceived impact on
symptoms and quality of life. Round 4 interviews explored their experience of the intervention,
adherence to therapy appointments and the prescribed PFMT programme; perceptions of treatment,
outcome and care; and intentions to continue with PFMT.
Interviews were conducted via telephone by a member of the research team and were guided by topic
guides that were specific to the participant groups being interviewed.
Data analysis
Round 1 and 2 data analysis
Data from round 1 and 2 interviews and SPMs were transcribed verbatim and analysed using the
thematic framework approach adapted for use in realist evaluations.24,25 Data analysis proceeded in
parallel with data collection. A coding frame was developed in round 1 using data from two transcripts
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(one from a service lead/manager and one from a senior practitioner), the summaries of the first SPM
from sites B and C and the three core concepts from realist evaluation: CMO. Two members of the
research team (PA and JW) read and reread the transcripts to familiarise themselves with the data.
Data from the transcripts were sectioned into ‘meaningful units of analysis’, which were essentially
segments of data containing discrete bits of information. Each unit was assigned a code that reflected
the meaning of the data segment in relation to the main topics covered in the interviews, for example
problems in service, current and potential enablers and barriers, and interim and long-term outcomes.
The codes were initially assigned by two researchers independently, but were subsequently compared
and refined until they accurately described the meaning contained.
Codes from the four transcripts and meeting summaries were then considered together to look
for similarities, which were either merged into one or grouped together under higher-order themes.
The codes were also classified as describing a context, a mechanism or an outcome. Codes describing
any pre-existing factors outside the control of intervention designers, such as social or service
structures, enabling or disabling conditions, resources, relationships, cultures, staff/service capacities
and motivations, were categorised as contexts. Codes that suggested a change in people’s minds and
actions (e.g. reasoning, feelings, behaviours, judgements, decisions and attitudes at individual, interpersonal,
social and organisational levels) in response to the changes introduced by the implementation, as well as
those described as interim outcomes of the intervention, were considered as mechanisms. Finally, codes
that described the intended and unintended consequences of the intervention at the level of women,
staff or services were classified as outcomes.
Following these classifications, an initial coding framework was developed that was then systematically
applied by another researcher with experience in qualitative research to all of the transcripts from
rounds 1 and 2. New codes were added as they emerged from subsequent data. Once all of the
data had been coded, the content of the coding framework was revisited and refined. The coding
framework was used to summarise the data for each study site to capture the site-specific processes
of implementation and theories of change. Specifically, the coded data were used to identify linked
patterns of CMOs and generate initial CMO configurations (i.e. hypotheses about what mechanisms
would be triggered in each site, under what condition/contexts, to achieve what outcomes). Once
the theories of change were identified for each site, these were compared across the sites to note
similarities and differences. Although the sites differed in terms of macro-level contextual factors
(e.g. geographic location, organisation of care and existing service models), a number of micro-level
contextual factors were similar across the sites (e.g. staffing issues, support and buy-in from management
and availability of resources). This meant that it was possible to look for patterns of CMOs that cut
across the site boundaries. Cross-case comparisons were used to then identify an overall folk theory
of how the intervention will work through different mechanisms being trigged in different contexts to
generate diverse outcomes.
Round 3 and 4 data analysis
Data from rounds 3 and 4 were analysed using the thematic framework approach, similar to that
described in phase 1. Briefly, a coding frame was developed using data from four round 3 transcripts
(one from each participant group: service manager, senior practitioner, delivering staff and women,
from across the three sites). Two researchers (PA and another researcher with experience in qualitative
research) independently read and reread the transcripts and coded smaller segments of data. The
codes were compared, discussed and refined until the meaning and content of each was agreed. The
codes were then grouped into higher-order themes according to the similarities and relationships
among them. They were also classified according to the concepts of CMOs, to explore how the
different contexts influenced the implementation of the intervention, what mechanisms of actions
were triggered and what outcomes were produced. Codes were classified as context if they described
something that existed prior to the implementation or something that had developed/emerged/
changed during the intervention, but was unrelated/not attributed to the intervention itself. Codes
were classified as mechanisms if they described activities or actions taken by those implementing the
REALIST EVALUATION METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
20
intervention/touched by the intervention, including their thought processes, feelings, decisions and
reactions. Codes were classified as outcomes if they described something that happened as a result of
the intervention, whether intended or unintended and whether higher-level outcomes or indicators of
higher-level outcomes. The initial coding frame was applied systematically to all data from rounds 3
and 4 (by TA), adding further codes or categories as they emerged from the data.
Once all of the data had been coded, the next step was to identify CMO patterns in the data. Initially,
this process was carried out at the level of individual study sites to provide a ‘story of implementation’
by understanding the outcomes of implementation in each site, their underlying mechanisms of action
and the contextual factors triggering those mechanisms. Data from each transcript were summarised
and tabulated using a framework consisting of rows that indicated a data source and columns that
indicated the CMOs. The data summaries were compared across the participants to develop overall
CMO configurations for the site in the next phase of analysis.
The next phase of analysis focused on ‘testing’ the initial theories of change identified in phase 1
for their adequacy in explaining the observed CMO patterns. This involved explicitly comparing the
observed CMO patterns (how and why the intervention actually worked or not) with the hypothesised
CMO patterns (how and why it was expected to work). The analytical process was outcome led; that is,
we began with the groups of outcomes that were anticipated in phase 1 folk theories to result from
the intervention (e.g. women’s health outcomes, reach of intervention) and looked for evidence in the
phase 2 data on how much or how well those outcomes were achieved in each site. An attempt was
also made to map these outcomes to the elements of the RE-AIM framework to begin an assessment
of the impact, adoption and sustainability of the intervention. We then sought to explain the observed
outcomes in each site, by looking for the possible linked mechanisms and contextual factors that
appeared to trigger those mechanisms. These constituted the site-specific CMO configurations.
Theory refinement
Phase 3: refining intervention theories
Once the site-specific CMOs were developed that explained when, why and for whom certain
outcomes were achieved (or not), cross-case comparisons were performed to refine the CMOs and
develop middle-range theories about the intervention. For each outcome, we compared and contrasted
the CMO models emerging from all three sites, as well as the two light-touch sites. The analysis was
carried out a higher level of abstraction, transcending the individual sites. The CMOs were refined
by identifying the facilitating or impeding contextual factors that were common across the sites, and
re-examining the linked mechanisms in relation to each outcome. This meant that a particular CMO
was now able to explain the workings of the intervention in more than one site where the specific
contextual factors were present.
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Chapter 5 Findings of the realist evaluation
Parts of this chapter are adapted with permission from Abhyankar et al.17 This article is licensedunder a Creative Commons Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons licence, and
indicate if changes were made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission
directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/
licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
in a credit line to the data. The text below includes minor additions and formatting changes to the
original text.
Phase 1: folk theories of change – how was the intervention expected to work?
In rounds 1 and 2, participants in each site described the wider context in which their service operated
in, the current configuration of the service for prolapse care, the perceived gaps in service and the
key drivers for change. This description was followed by an account of proposed service models and
implementation plans, anticipated and unanticipated outcomes, explanations of how the intervention was
expected to work and the existing and potential barriers and facilitators likely to affect implementation.
The PROPEL intervention introduced an opportunity to deliver PFMT using different staff skill mixes
to a wider population of women with prolapse than that currently reached by specialist physiotherapy
services. The PROPEL intervention provided an opportunity for sites to reconfigure local service
and referral pathways, and supported provision of training in PFMT delivery to new staff skill mixes.
The PROPEL intervention also provided some limited resources to support the new models of service
delivery, such as specialist physiotherapist time to support those newly trained while they engaged in
recruiting and delivering PFMT to the study population. Across the three sites, the intervention was
expected to affect three key sets of outcomes: (1) have an impact on public health by way of widening
the reach and accessibility of PFMT to the target group in local areas, (2) have an impact on women’s
health by way of improvements in prolapse symptoms and quality of life and/or reduction in surgeries
and (3) have an impact on services by way of shortened waiting lists for PFMT and a reduction in
specialist workload, so that their resources can be focused on more complex cases.
The context and organisation of prolapse care varied significantly across the three sites. Several contextual
factors were identified in round 1 and 2 data that seemed likely to influence the implementation of the
intervention, which, in turn, would affect the achievement of anticipated outcomes. In the following
section, we describe the context in each site before articulating the initial CMOs that emerged from data
explaining how the intervention was likely to work and what factors were expected to facilitate or impede
the implementation.
Context of care in study sites
Site A
Site A was a large urban area with primary and secondary provision of specialist physiotherapy services
for women with prolapse. It was a previous participant in the POPPY trial, and several POPPY trial
physiotherapists were providing input into prolapse care. The service had been well established for
over a decade and offered PFMT to women with prolapse through specialist physiotherapists working
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in the acute and community settings. The staff expressed pride in the service, describing it as providing
gold-standard care. The reasons for this were cited as:
l all specialist physiotherapists being highly trained in PFMT for prolapse
l having good working relationships and flow of communication with nurses, consultants, pain clinics
and incontinence services
l having a team approach to practice and respect for each other among different professionals
l having adequate levels of staffing and resources to deliver the service.
Improvements were seen to be needed in raising awareness among GPs about prolapse and PFMT to
enable direct referrals, in improving waiting times and referral pathways and in improving follow-up
care. The team’s motivation for taking part in the study was to showcase their gold-standard service,
rather than implement any changes.
Site B
Site B, in contrast to site A, had a large geographic spread in remote and rural areas with limited
availability of specialist physiotherapy services. The incontinence service worked closely with the
physiotherapy service, but was seen mainly as a ‘pad provision’ service that needed to become more
holistic and proactive in assessing and treating urinary incontinence. Both services suffered from
shortages of staff; specialist physiotherapists were few in number and the continence service lacked
a clinical lead at the time of the study. The geographic spread of the area meant that the patients
and staff had to travel long distances for care, which was compounded by shortages of staff. Despite
the challenges, there were high levels of motivation among the staff; many had a special interest in
women’s health and the service had a history of training musculoskeletal physiotherapists in delivering
PFMT on a needs basis. Nurses and physiotherapists were enthusiastic about being trained in PFMT
delivery and were supported and encouraged by their managers.
Site C
Site C was an urban area with limited specialist physiotherapy provision available for prolapse, where
women were triaged by the urogynaecology consultants. There was said to be a lack of co-ordination
between primary care and secondary care services with regards to incontinence and prolapse. There
was enthusiasm about the PROPEL intervention among acute and community nurses, management and
some consultants, and there was a perceived need for service redesign.
Theories about how the intervention would work, for whom and in what contexts
Four sets of CMO configurations were identified from the data, which contained folk theories around
how each of the intended outcomes would be brought about and what may facilitate or impede these
processes (Figure 2). The data also revealed an unintended outcome that was expected to affect
implementation. Each CMO is described briefly and illustrated via a diagram.
Context–mechanism–outcome configuration 1: widening the reach of pelvic
floor muscle training through increased local provision of care
It was anticipated that using different staff skill mixes to deliver PFMT would widen the reach and
accessibility of PFMT in local areas because it would increase the number of referrals to PFMT and
increase the provision of PFMT in the community, closer to women’s homes, through adoption of a
community model of service delivery. This mechanism was dependent on whether or not adequate
facilities (e.g. private rooms in clinics) were available to carry out internal assessments and deliver
PFMT, whether or not there was strong leadership in services to support the work and whether or not
GPs and other potential referrers were aware of PFMT and new referral options. In sites B and C, there
were concerns that a lack of appropriate facilities may be a challenge to successful implementation.
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Context–mechanism–outcome configuration 2: improving women’s health
outcomes through holistic and proactive care
The intervention was also expected to improve women’s symptoms, improve quality of life and reduce the
need for surgeries. This would be achieved by enabling the newly trained staff to perform more holistic
assessments of urinary incontinence and pelvic health issues, and provide proactive treatment in the form
of PFMT by enabling them to tailor the treatment and advice based on accurate internal assessments and
by informing women of the correct PFMT technique.Whether or not these mechanisms would materialise
depended on whether or not there was adequate support from the service leads and/or management
in terms of ensuring that there was dedicated time for staff to deliver PFMT; whether or not there was
a sufficient workforce to deliver existing and new services, and whether or not they had manageable
workloads; whether or not ongoing support by specialist physiotherapy staff was available to newly
trained staff; and whether or not the differential training needs of different skill mixes (e.g. nurses vs.
physiotherapists) were acknowledged and addressed. In sites B and C, the staff shortages and existing
staff roles and workload were expected to act as barriers to successful implementation.Worries were
also expressed about the impact on the workload of the newly trained staff if the demand for the number
of referrals increased as a result of greater awareness of PFMT among GPs and women.
C1a – Adequate facilities
to deliver PFMT
C1b – Leadership to
support implementation
C1c – Awareness of
PFMT among referrers
M2a – Holistic assessment
of pelvic floor issues and
proactive treatment
M2b – Tailoring of
treatment







Perceptions of threat 
to specialist role;




C2b – Ongoing expert
support to staff
C2c – Differential training
needs addressed










PFMT, care closer to
women’s homes
(through adoption of a
community model)
O1















FIGURE 2 The CMO configurations 1–4. C, context; M, mechanism; O, outcome. Reproduced with permission from
Abhyankar et al.17 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits
use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless
indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence
and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/
by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/)
applies to the data made available in this article, unless otherwise stated in a credit line to the data. The figure includes
minor additions and formatting changes to the original figure.
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Context–mechanism–outcome configuration 3: improving service organisation
through joined-up working
The intervention was expected to improve service delivery by reducing specialist workload and shortening
waiting lists. This was expected to result from more joined-up working between physiotherapy teams and
nursing teams in the community and acute settings. This was possible only if there were an adequate number
of staff trained to deliver PFMT and if the referral pathways were straightforward. There were some concerns
that the pressure to reduce the waiting lists may actually lead to inappropriate referrals to newly trained
staff, which, in turn, would increase rather than decrease the waiting times and the specialist workload.
Context–mechanism–outcome configuration 4: implementation difficulties
due to role protection issues
In addition to the intended mechanisms and outcomes, the interviewees anticipated a fourth, rather
unintended, mechanism that had already started to unfold and affect the implementation processes
during the initial stages, leading to some undesirable outcomes. With the intervention bringing the
prospect of training other skills mixes, particularly staff in the lower banding/grade, this triggered
perceptions of threat to the role of practitioners specialising in pelvic health or PFMT and activated
feelings of role protection among these staff. A reluctance was sensed among the specialist staff,
particularly in sites A and C, to train nurses of a lower band to perform the higher-skilled tasks
(e.g. deliver PFMT, which has been a specialist job), as it was felt to be causing a disservice to the
specialist profession. This reluctance was also observed in the form of some ‘hostility’ at the SPMs.
The feelings of role protection were said to be always present, but these were observed to resurface
and intensify as a result of the PROPEL intervention. This mechanism of ‘role protection’ hindered and
delayed the process of implementation in sites A and C, and prevented the adoption of a community
model of PFMT delivery involving band 5 community nurses. Site A continued their service through
hospital- and community-based specialist physiotherapists without making any changes to the service
model, whereas site C had to abandon the plans for training nurses or physiotherapists in the
community and adopted a hospital-based model involving hospital-based urogynaecology nurses.
Phase 2: testing the folk theories
The way in which the PROPEL intervention was implemented and worked in each site is presented in
Tables 3–5 in the form of site-specific CMOs. These CMOs report the outcomes of the implementation
that were observed in each site and attempt to explain how and why these outcomes were achieved,
for whom and in what contextual conditions. The outcomes include those that were expected in the
initial theories of change, as well as those unintended and unanticipated.
TABLE 3 Impact of the PROPEL intervention on the reach of PFMT
Context Actor Mechanism Outcome
Site A
l High level of training
among specialist
physiotherapists
l Adequate number of
specialist physiotherapists
in community and hospital






l No change in referral
processes or delivery
of PFMT
l Direct referral routes from
consultants/GPs to specialist
physiotherapists (and back)





l No change in the number
and profile of the patient
group treated






l Increased waiting times for
PFMT appointments
l Slow turnover of patients
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TABLE 3 Impact of the PROPEL intervention on the reach of PFMT (continued )










of muscle training and
exercise prescription
as a result of
physiotherapy training




l Newly trained CLN




l Uptake of training
was easier and faster
among these staff, which
eased their transition to
PFMT delivery




l Reach of PFMT widened




l Saved women long trips,
travelling time and
inconvenience
l No prior gynaecology/
pelvic floor experience
l Participation in the
PROPEL intervention was
not voluntary: ‘told to
get involved’
l High level of existing
workload (for ANP)




l Nurses’ training needs
were different from those
of the physiotherapists,
which were not addressed.
They also did not have
same level of autonomy as
musculoskeletal/general
physiotherapists over their
caseload (remain at ‘beck
and call’ of GPs)
ANP and community
nurse for continence
l ANP perceived mismatch
between her expectations
of the role and what it
actually involved
l ANP unable to juggle
the PFMT caseload as a




felt that it was pitched at
a higher level. Insufficient




l Perception that assessment/
treatment of POP is outside
the scope of community
nurses. Internal assessments
deemed inappropriate in
home settings and PFMT
deemed inappropriate for
people with dementia: both
of which form a substantial
part of the community
nurse’s role
l Early withdrawal from
the PROPEL intervention
l Unable to provide PFMT
in the local community
l Housebound patients






among GPs by specialist
physiotherapists (prior to
and during the PROPEL
intervention via, for







l GPs reported to be more
aware of the PFMT service
(but not in all areas of
the site)
l Women reported a change
in GPs’ actions and attitude
to PFMT: GPs were more
positive about PFMT,
referred actively and quicker




friends to access PFMT
through self-referral
l Perceived increase in GP
referrals to new service
l Referrals for continence
treatment, not just
management
l Increased local visibility
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TABLE 3 Impact of the PROPEL intervention on the reach of PFMT (continued )
Context Actor Mechanism Outcome
l Limited capacity of newly
trained staff





l Potentially eligible patients
not referred to the PROPEL
intervention to avoid long
waiting times (2 months for
the PROPEL intervention
compared with 3 weeks for
specialist physiotherapist
clinics)




l Shortage of doctors and
increased patient volume
posed workload issues
l Busy clinics with many
junior doctors who are less
exposed and experienced
in gynaecology
l Doctors/consultants l Referrals to PFMT were
not a priority and often
forgotten. Difficulty talking
to patients about the
PROPEL intervention
in busy clinics
l Clinicians not referring
patients to PFMT
adequately: remained
uninterested and distant to
the PROPEL intervention
l Referrals were not opened
to all of the urogynaecology
team (e.g. nurses and
physiotherapists who see UI
or prolapse patients)
l Research nurses were
brought in to minimise the
requirements that were
placed on doctors for patient
recruitment and referrals
l Very few referrals to
newly trained staff during
the study period, which
limited the reach
of PFMT
l Lack of PFMT awareness
among GPs and women
l GPs
l Women
l No efforts were dedicated to
raise awareness among GPs,
women or communities
l GPs continued to refer
patients to gynaecology
l Fewer referrals to the
PROPEL intervention staff.
PFMT failed to reach the
wider local community
l Less perceived need for
the PROPEL intervention





l Perception of threat to their
specialist role
l Protective feelings about
specialist professions
l Reluctance to train
lower-grade nurses or
physiotherapists
l Concerns that staff of lower
banding provided with ad
hoc training may negatively
affect women’s care, as their
complex care needs may not
be addressed appropriately
l Prevention of a community
model being adopted
l Failure to extend reach of
PFMT in the community
l Care not available closer
to home
Site D (light-touch site)
l Variety of referral routes








l Good awareness of service
l Implementation
team
l PFMT rolled out to the
whole musculoskeletal
physiotherapist team
l Clinical research team
e-mailed gynaecology to
encourage referrals for the
PROPEL intervention/PFMT






l Widened the reach of
PFMT through increased
staff skill mix
l Increased knowledge of
the physiotherapist team
more generally
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TABLE 3 Impact of the PROPEL intervention on the reach of PFMT (continued )
Context Actor Mechanism Outcome
l The service promotes




about the role of the
physiotherapist team
l Service culture that
is favourable to
implementation; staff were




PFMT prior to the PROPEL
intervention; they received





in a good supportive
environment with informal
peer support
l The lead physiotherapist is
passionate about women’s




l The PROPEL intervention
training appropriate to those
with little or no experience
but also a refresher
for others
l Referrals could be made




l Active support from the lead
physiotherapist and senior
physiotherapist colleagues
for the PROPEL intervention
l Increased provision
of PFMT
l The PROPEL intervention
was seen as the new gold
standard for prolapse
management and PFMT
Site E (light-touch site)
l Prior to the PROPEL
intervention, there was
limited provision of
PFMT owing to a lack of
awareness and training
of HCPs
l Keen interest in widening
access to PFMT
l Already providing PFMT





between the referrers and
the staff providing PFMT
l Variety of referral routes














l Improved understanding of
the assessment of prolapse
l Training for the PROPEL
intervention was appropriate
for the level of staff
knowledge and skills
(including nursing staff)
but also very thorough
l Adequate ongoing support
provided by the specialist
physiotherapist
l Widened reach of PFMT
though widened skill mix





among staff about PFMT
as a treatment option
ANP, advanced nurse practitioner; CLN, continence link nurse; UI, urinary incontinence.
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TABLE 4 Impact of the PROPEL intervention on women’s symptoms, quality of life and care experience
Context Actor Mechanism Outcome
Site A
l The POPPY trial site,











plans) and teach correct
PFMT technique




l Increased ownership of
treatment among women
and awareness of their own
role in treatment. Women
feel accountable to
physiotherapists (knowing



























seen as highly skilled
and knowledgeable,
approachable and relaxed.
They also put women at
ease, take embarrassment
away and provide follow-up
l Women can and do discuss
other treatment options
with physiotherapists
l Personalised approach to
treatment planning (setting
personal expectations








keen interest in both
continence problems and
receiving PFMT training
l Anticipation of seeing
more prolapse patients as
a result of the CLN role




l The CLN now understands




l The CLN undertakes
a holistic assessment
of pelvic floor issues
(e.g. incontinence).
Extended and applied
the knowledge and PFMT
to wider set of patients
(e.g. incontinence), not
just those with prolapse




l Improved detection and
outcomes for a wide
range of pelvic health
issues
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TABLE 4 Impact of the PROPEL intervention on women’s symptoms, quality of life and care experience (continued )
Context Actor Mechanism Outcome
l Management provided








l Training enabled the
staff to provide better
explanations to women
about prolapse and PFMT









l The staff corrected
women’s PFMT technique;
they encouraged them
to develop a more
disciplined personalised
PFMT routine
l Greater realisation among
women of the importance
of PFMT to avoid
symptoms worsening/
surgery/pessary












ways of keeping fit
l Women felt empowered













l Improved symptoms of
incontinence
l Improved quality of life






l Increased confidence and







and relaxed, spent more
time explaining exercises











l Adherence to PFMT
appointments
continued
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
31
TABLE 4 Impact of the PROPEL intervention on women’s symptoms, quality of life and care experience (continued )
Context Actor Mechanism Outcome
Site C
l There were delays in
management decisions
about the place of
PFMT delivery
l Long gap between PFMT
delivery training and
actual treatment delivery
l Newly trained PROPEL
intervention nurses
l Nurses experienced an
initial loss of confidence
in delivering PFMT
l Perception that they were
‘thrown in the deep end’;
they felt apprehensive
about seeing their first
patients
l The low confidence
was sensed by women;
staff seen as ‘finding
their way’

















l Specialist clinics were
busy; part-time working
meant that less time and
staff were available to
provide support




l Physiotherapists did not
provide active support and
PROPEL intervention
nurses did not request
support
l There was a
misunderstanding about
the need for/availability of
support (physiotherapists
felt that nurses were
competent and did not
need support; nurses felt
that physiotherapists
were busy, so did not
ask for support)




check on delivery for the
first patient
l Nurses resorted to doing
joint clinics to support
each other, which boosted
their confidence
l Nurses perceived that
there was no one else to
give support
l Despite women being
motivated to avoid
surgery

















l Women had no perceived
improvement in symptoms
l Women required surgery,
which was planned
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TABLE 4 Impact of the PROPEL intervention on women’s symptoms, quality of life and care experience (continued )
Context Actor Mechanism Outcome





l Perception that the
physiotherapists work













l The PROPEL intervention
training led staff to offer
better explanations to
patients and have better
results from internal
examinations





l Staff now apply PFMT to
women for other issues









l Reported reduction in
the need for surgery by
the last PFMT session;
women planned to
discuss the cancellation




improved quality of life
l Positive feedback from
women following
treatment
Site E (light-touch site)
l Good peer support




(e.g. availability of time,
staff, rooms and facilities)














l Greater compliance with
PFMT among women
l Improved coping among
women with their
symptoms
l Active support from
specialist physiotherapists
l Clinical as well as
subjective improvement






occasion; women felt that
symptoms had reduced
CLN, continence link nurse.
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TABLE 5 Impact of the PROPEL intervention on service delivery
Context Actor Mechanism Outcome
Site A
l Additional paperwork for
the PROPEL intervention
l Added the aspect of
recruitment of women to
the study (despite being
no change in service
delivery, women were




l Staff struggled with
additional, unfamiliar
paperwork
l There was extra work
for staff, as they had to
make adaptations to the
recruitment processes to
increase recruitment
(e.g. changing letter wording,
giving study information
face to face at the first
appointment and telephoning
women prior to sending out
study information in the
post). This was perceived as
time-consuming
l Increased anxiety and
workload
Site B





meant that time slots that










to manage the patient
appointment diary. This was
perceived as an inefficient
use of time
l Unfilled slots could not
be reallocated to routine
musculoskeletal patients;
time was spent carrying
out other administration
work instead




l There was a perception of
delays in musculoskeletal
patients being treated













PFMT clients and contribute
less time for core
musculoskeletal clients




l Limited capacity of
newly trained staff







l Potentially eligible patients
were not referred to the
PROPEL intervention to
avoid long waiting times
(2 months in the PROPEL
intervention compared with
3 weeks for specialist
physiotherapist clinics)
l Less reduction in specialist
workload
l Long waiting times of
2 months for the PROPEL
intervention appointments






l Adequate spacing of
referrals


















l PFMT delivery was
adopted into practice
to some extent
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TABLE 5 Impact of the PROPEL intervention on service delivery (continued )
Context Actor Mechanism Outcome
Site C
l The PROPEL intervention
nurses worked in the
urogynaecology
surgical ward
l The ward was short-
staffed and busy. Any
staff away from the ward
had a knock-on effect
on both staffing and
patient care
l The PROPEL intervention
nurses had management
responsibilities on the
surgical ward and there
was no backfill available
l There was little flexibility






l Ward planning became
difficult as a result of the ad
hoc nature of the PROPEL
intervention appointments
l There were upset/unhappy
ward colleagues when the
PROPEL intervention nurses
left the ward
l There was a struggle for the
PROPEL intervention nurses
to juggle two roles. This was
sensed by patients too
l Had to sometimes deliver
the PROPEL intervention on
their days off





l The PROPEL intervention
nurses decided to stop at
eight patients




l Only one private
room was available;
the rest were two- to
four-bedded bays
l Clinic rooms were
always busy
l Post-operation ward,
where there was a focus
on recovery
l Difficulty in finding clinic
spaces
l Difficulty delivering PFMT,
as both time and space
were constrained
l PFMT was not given
priority in this setting
l The nurses’ perception was
that there was no one else
to give support
l Doubts surrounding the
appropriateness of the
setting and context to
PFMT delivery
l Doubts surrounding
usefulness of training to
post-operation nurses




l The ward clerk was brought





tasks were very occasionally
forgotten/delayed
l Nurses set their own
appointment times with
women to ensure
that there was clarity
l Ward manager/sister
stepped in to support and
provide cover for the
PROPEL nurses
l Reduced pressure on the
PROPEL intervention
nurses
l Prevented a negative
effect on patient care and
the ward





l Provision of time within
their work schedule for
the PROPEL intervention;
1 day per week was
allocated for the PROPEL
intervention work
l A capacity/capability study
was carried out by the
research service with the
physiotherapist service prior
to implementation of the
PROPEL intervention.
This confirmed that the
physiotherapist service was
suitable for and happy
about involvement
l The service coped well with
the PROPEL intervention
implementation
l No perceived increase
in waiting list for the
physiotherapist from the
PROPEL intervention
l No negative effect on
service delivery
continued
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Phase 3: refined intervention theory – how did the PROPEL intervention
work, for whom and in what contexts?
The site-specific CMOs were compared and contrasted in a cross-case analysis to develop refined
theories about the intervention. At this stage, the outcomes were also mapped explicitly to the
indicators of impact that were suggested by the RE-AIM framework. During this process, we classified
the specific outcomes of the PROPEL intervention as being related to one of the RE-AIM framework
indicator areas, and sought to explain the patterns of outcomes observed in the theory-testing phase
by comparing and contrasting their linked patterns of mechanisms and of triggering contexts in
different sites. We first looked for the common patterns of mechanism and outcome links and then
identified the contexts in which they were contingent. In the following sections, we present the refined
CMOs that represent a middle-range theory about the impact that the PROPEL intervention had, what
mechanisms of action brought about that impact, for whom and in what contexts.
TABLE 5 Impact of the PROPEL intervention on service delivery (continued )
Context Actor Mechanism Outcome
l Specific rooms were set
aside for the PROPEL
intervention patients
l Dedicated time for
training and supervision




encouraged to input to
the service
l Staff able and allowed to
manage their own caseloads
and manage their own
patient bookings
l No perception of additional
workload as a result of the
PROPEL intervention




l specific rooms were
allocated for the PROPEL
intervention patients




l provision of time for the
PROPEL intervention,




pathway and waiting and
follow-up times
l PFMT was seen as core
work, not something
additional/extra
l Shorter waiting times
offered for PFMT as a lure
for inclusion in the
PROPEL intervention
l No significant disruption
to routine service
l No increase in workload
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Reach: impact on access to pelvic floor muscle training
In the PROPEL intervention, ‘reach’ referred to the extent to which the PROPEL intervention, the
delivery of PFMT by different HCPs, reached the target population that it was intended to reach. It
was hypothesised that the intervention would widen the access to PFMT by increasing the awareness
of and referrals to PFMT and increasing the availability of trained staff who were delivering care close
to women’s homes in the community. The extent to which this was achieved following implementation
of the intervention varied across the study sites, depending on the presence or absence of two key
contextual factors: (1) the receptiveness of the clinical setting and (2) the level of awareness of PFMT
among potential referrers. The CMOs were refined based on this knowledge and are described in the
following paragraphs and illustrated in Figures 3 and 4.
The access to PFMTwidened in areas where the service was receptive to the PROPEL intervention
(Figure 3). This included the staff and management having a keen interest in pelvic health issues and
women’s health, the service already having started providing additional training to other staff to
increase their capacity and having good peer support networks in place. This was mainly observed in the
case of musculoskeletal and general physiotherapists, and some nurses. In these contexts, the PROPEL
intervention training enhanced staff’s knowledge of prolapse and their skills and confidence in its
assessment and treatment. The transition to doing internal assessments and PFMTwas easier and
faster for these skill mixes as a result of their basic physiotherapy training or continued professional
development training in pelvic health assessment and management. Nursing staff who dealt with
urinary incontinence extended their knowledge and skills beyond prolapse and applied this to women
with incontinence and other pelvic health issues. Their enhanced knowledge led them to become more
holistic in the assessment of pelvic issues and proactive in providing treatment.
C M O
• Receptive service
• Prior staff training
• Good peer support
• Keen interest in pelvic
    health
• Enhanced POP
    knowledge and
    assessment/treatment
    skills
• Holistic assessment of
    incontinence
Reach not extended to
community
• Widened reach and
    access to PFMT
• More women treated
• In local areas
• No prior experience
    in pelvic health
• High workload
• Different training
    needs of nurses
• Lack of adequate
    support
• Community setting
• Training insufficient for
     nursing background
• Drop in confidence
• Staff withdrawal
FIGURE 3 Refined CMOs explaining the impact of the PROPEL intervention on access to PFMT: role of receptiveness of
service. C, context; M, mechanism; O, outcome. Reproduced with permission from Abhyankar et al.17 This article is licensed
under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to
the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted
by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated in a credit line to the data. The figure includes minor additions and formatting changes to the
original figure.
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However, different sets of mechanisms and outcomes were observed in the case of nurses working in the
community who had no prior experience or training in pelvic health. A key underlying mechanism was low
levels of adoption by community nursing staff, which was reflected in their withdrawal from the study.
For the district nurse, the training was felt to be inadequate to address their knowledge and skill gap,
as they did not have the level of understanding of physiology that physiotherapy training provided. This
lowered their confidence and led to withdrawal from the study. For the advanced nurse practitioner for
incontinence, their existing workload and a mismatch of expectations from their role led to withdrawal.
The community setting was considered inappropriate for prolapse assessment and PFMT delivery; internal
assessments were not feasible in people’s homes or care homes and PFMTwas deemed unsuitable for
older people and those with dementia, both of whom comprised the main aspect of the community nursing
role. As a result, contrary to original intentions, PFMT failed to be extended to community settings.
Another reason for the difference in the reach of PFMTwas the level of awareness of PFMT services
among professionals who could refer women to PFMT (Figure 4). In contexts where the teams made an
effort to raise other HCPs’ awareness of PFMT, there was good communication and co-ordination among
referrers and there were favourable attitudes to PFMT, access to care was widened. This was because
there were a variety of direct referral routes available: GPs and consultants were referring patients to
these services, as well as women who were more aware of PFMT spreading the word in community. In
contrast, the referrals were restricted in areas where not much effort had been made to raise awareness
among potential referrers, which meant that their referral patterns remained unchanged. Referrals were
also restricted because the consultants remained distant and disengaged in the PROPEL intervention, and
other possible referral routes were not exploited (e.g. through urogynaecology nurses). Referral involved
study recruitment, which was difficult to do in busy, short-staffed clinics. The process of referral to the
PROPEL intervention was seen as being more complex than routine referrals hence it was often forgotten.
C M O
• Efforts to raise HCP
    awareness
• Good communication
    and co-ordination among
    referrers
• Positive attitude to
    PFMT
• Variety of referral
    routes
• HCPs more aware and
    referring
• Women more aware
Widened access to
PFMT
• Lack of awareness-raising
• Referral involved study
    recruitment aspects
• Busy clinics, high
    workload
• Referrals seen as too
    complex
• Forgetting to refer
• Fewer referral routes
• GPs not referring
• Fewer referrals to the
    PROPEL intervention
    staff
Limited reach
• Increased referrals
FIGURE 4 Refined CMOs explaining the impact of the PROPEL intervention on access to PFMT: role of team’s awareness
of PFMT services. C, context; M, mechanism; O, outcome. Reproduced with permission from Abhyankar et al.17 This article
is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation,
distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third
party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available
in this article, unless otherwise stated in a credit line to the data. The figure includes minor additions and formatting
changes to the original figure.
FINDINGS OF THE REALIST EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
38
Effectiveness: impact on symptoms, quality of life and care experience
Effectiveness in the context of the PROPEL intervention was concerned with the impact of PFMT
delivery by different staff skill mixes on women’s symptoms, quality of life and experience of care.
It was anticipated that the PROPEL intervention would improve women’s symptoms and quality of
life, and reduce the need for surgery by improving their PFMT technique, providing better tailoring of
treatment and improving holistic assessment of urinary incontinence and related issues. The outcome
study revealed that there was a significant improvement in outcomes after the intervention compared
with before, but there were no significant differences in outcomes across the five sites and across
different delivering staff and across different service models. This suggested that the outcomes were
comparable regardless of which study site PFMT was delivered in, by whom and through which model.
However, the staff’s and women’s perceptions of their outcomes were found to differ from the actual
clinical evidence of improvement and across different sites, owing to differences in implementation
processes. The refined CMOs below explain these differences in perceived outcomes (Figure 5).
• Adequate level of training
• Expert support available
• Appropriate referrals
    through triage
• Better explanations to
    women
• Feedback from internal
    assessments
• Improved PFMT technique
    and adherence
• Improved self-management
• Tailoring of treatment
• Person-centred approach
• Improved symptoms of
    POP and UI
• Greater subjective
    experience of improvement
• Positive experience of care
• Lifestyle advice from staff
• Improved bladder control
• Confidence to resume
    activities
• Time gap between
    training and delivery
• Physiotherapist team
    located separately
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FIGURE 5 Refined CMOs explaining the impact of the PROPEL intervention on women’s health. C, context; M, mechanism;
O, outcome; UI, urinary incontinence. Reproduced with permission from Abhyankar et al.17 This article is licensed under
a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to
the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated in a credit line to the data. The figure includes minor additions and formatting changes to the
original figure.
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Many women and staff reported improvements in their prolapse symptoms (e.g. muscle control and
strength) and incontinence problems. In some cases, the experience of improvement was greater than
the clinical evidence. When improvements in symptoms were reported, the underlying mechanisms
appeared to include women receiving better explanations of prolapse and the role of PFMT from the
delivering staff, receiving feedback on their performance from internal assessments, provision of a
tailored and structured PFMT routine, receiving advice on the correct PFMT technique and receiving
techniques for exercising regularly, all of which improved women’s adherence to exercises. The
reported improvements in quality of life resulted from staff enabling women’s self-management of
their symptoms by offering tips and advice on lifestyle, which helped to improve women’s bladder
control and increase their confidence to resume previous activities. There was an overall person-centred
approach, as staff were seen as approachable and motivational, to dedicate enough time, to reduce
women’s embarrassment and to make women comfortable during their visits. This resulted in a positive
and satisfactory experience of care. All of the above mechanisms were triggered in contexts where the
staff were adequately trained and confident, where the staff had expert support available throughout
and when the referrals were appropriate for the level of care they provided.
In contrast, certain contextual factors failed to trigger the mechanisms that led to perceptions of
improvement in symptoms, quality of life and care. This was particularly the case when the staff
delivering PFMT were located in an acute ward setting. Both the delivering staff and the women
reported less improvement in symptoms, despite the clinical improvement that was observed in the
PROMs study indicating otherwise. A number of factors present in these contexts seemed to trigger
certain mechanisms that led to a lesser experience of improvement. First, there was a time gap
between training and PFMT delivery that led to an initial loss of confidence among delivering staff.
Second, the specialist physiotherapy team was located separately and there was a lack of clarity and
communication on both sides about the delivering staff’s support needs. This triggered another
mechanism, whereby the staff resorted to supporting each other by doing joint clinics, which helped
with care and their confidence.
Adoption: impact on service delivery
Adoption refers to the willingness of institutions and staff to implement an intervention and to support
the intervention’s adoption into routine practice. In this study, one of the indicators of adoption, the
uptake and continued participation (or drop out) by staff, was already reflected in the mechanism,
leading to wider (or restricted) reach of PFMT to target populations. Another indicator of the extent
to which the intervention was adopted into practice is the effect of the PROPEL intervention on the
services in which PFMT was delivered by other skill mixes. Favourable impact on service outcomes
would indicate higher levels of adoption, whereas unfavourable impact would indicate lower levels
of adoption. It was hypothesised that the intervention would reduce waiting times and specialist
workloads by creating more joined-up working between acute services and community services.
Although there was little evidence for this mechanism in the theory-testing phase, a number of other
outcomes and their underlying mechanisms ensued, for instance, to impact workloads and pressures
on delivering staff, as well as their professional colleagues, the organisation and functioning of the
services and the perceived support from wider team (Figure 6).
The intervention was better integrated and adopted into the routine service in some areas than in
others, and had little disruptive impact on workload, service organisation or waiting times in such
areas. This was observed particularly in contexts where practitioners, mainly physiotherapists and, in
some settings, nurses, had some degree of autonomy over managing their bookings and caseloads and
the wider team supported their involvement in PFMT delivery. Their service management also provided
support by allowing dedicated time for PFMT delivery, making rooms available for assessment and
treatment, and providing adequate staffing resources. This triggered the mechanism wherein PFMT
was seen as part of their core role, rather than as an add-on. It also enabled the staff to juggle their
own caseload to allow for the prolapse patients.
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Contrary to this, service disruption was reported in some areas in the form of disturbed ward organisation,
delays in treating routine patients, and increased pressure on delivering staff, particularly in the cases of
nurses in the acute ward setting and the community setting. This was because PFMT delivery in these
settings was seen as an add-on and not given a priority or due recognition. Staff had to juggle two roles
and required additional administrative support. Team colleagues were perceived to be discontent with
staff’s involvement in PFMT, as they often had to provide cover for the PROPEL intervention staff in their
day jobs. This resulted in doubts about the extent to which such an intervention may be supported by
the wider team. Several unfavourable factors in the context played a role in triggering these mechanisms.
First, delays in implementation and inflexibility of the patient booking systems meant that slots for the
PROPEL intervention patients remained unfilled during early phases and led to delays in the treatment of
routine patients, as slots could not be allocated to them. Second, existing workload pressures in the service
areas, as well as a lack of dedicated time for PFMT, a lack of appropriate facilities and inadequate staffing
resources, put additional pressure on delivering staff.
Implementation: impact on implementation plans
Implementation refers to the extent to which the PROPEL intervention was delivered/implemented as
intended by the services. During the implementation phase, the services in sites A, B and C considered
and debated various models of service delivery and potential staff skill mixes, with the overall intention
of widening access to PFMT in local communities. Whether or not this intention was accomplished was
determined by the strength of the tendency of staff groups to protect professional roles and boundaries
(which could prevent change), which was triggered in certain contextual conditions (Figure 7).
In remote and rural contexts, where there were significant staff shortages and service was inaccessible
in many areas, there was heightened awareness of the service needs among the implementers, at least
at the implementation stage, which led to an increased readiness to adopt a community model and
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FIGURE 6 Refined CMOs explaining the impact of the PROPEL intervention on service delivery. C, context; M, mechanism;
O, outcome. Reproduced with permission from Abhyankar et al.17 This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium
or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons licence, and indicate if changes were made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not
included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated in a credit line to the data. The figure includes minor additions and formatting changes to the original figure.
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train nursing staff in the community. However, in other contexts with adequate specialist capacity
where there was less of a need for such an intervention, the implementers were less convinced of the
requirement for the PROPEL intervention. This triggered feelings of threat to their role and protective
feelings about their role among the specialist or higher-grade staff. These staff were also concerned
that training lower-grade staff may not address women’s complex care needs adequately and would
have a negative effect on standard of care. These feelings resulted in preventing the adoption of a
community model, resistance to train lower-grade nurses and significant delays in implementation.
Summary of findings from the realist evaluation
In summary, an outcome evaluation of the PROPEL intervention, showed that women’s outcomes
improved regardless of the service model and skill mix through which PFMT was delivered. The realist
evaluation provided more insights into the extent to which, how and why the intervention worked
(or not) in diverse contexts that differed in their geographical locations, service organisation, type of
service model used, skill mix trained and availability of support structures and resources. Findings from
the realist evaluation suggest that implementation of PFMT that is delivered by different clinicians in
the context of the UK NHS would probably be successful if:
l the training of PFMT delivery is adequately tailored to the needs of the different skill mix
l there is awareness about prolapse and PFMT among women, GPs and other HCPs
l the referral systems are open, flexible and well co-ordinated
l there is sufficient buy-in at organisational levels and strong managerial support in terms of
resources, training, time, autonomy and staffing
l the wider team supports the delivery of PFMT through different staff skill mixes
l the tendencies to protect professional roles and boundaries (and thereby prevent change) are
acknowledged, addressed and managed effectively and balanced with the population needs.
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FIGURE 7 Refined CMOs explaining the impact of the PROPEL intervention on implementation plans. C, context;
M, mechanism; O, outcome. Reproduced with permission from Abhyankar et al.17 This article is licensed under a Creative
Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy
of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
in a credit line to the data. The figure includes minor additions and formatting changes to the original figure.
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Chapter 6 The patient-reported outcome
measures study
This chapter describes the methods and results of the quantitative analysis of self-reported outcomedata collected from the PROPEL intervention participants. This section of the report addresses
original research questions 2 and 3.
Primary research questions
l Does the intervention, as implemented, improve POP symptoms in women at the 6-month follow-up?
(research question 2).
l Does the effect of the intervention on POP symptoms at the 6-month follow-up differ when the
intervention is delivered by specialist physiotherapists compared with when it is delivered by other
HCPs? (research question 3).
Secondary research aims
l Applying the primary research questions to POP symptoms at the 12-month follow-up (research
question 2).
l Applying the primary research questions to secondary outcomes, including other pelvic floor-related
outcomes (severity of prolapse and incontinence) and service-related outcomes (number of health
service contacts) (research question 2).
Study design
The study was an observational prospective cohort study that compared PROMs pre and post intervention.
The PROMs study was concerned with answering the specific aims to explore the differences in clinical
outcomes with the different skill mixes and to understand the variations of PFMT protocol. Furthermore,
data from the PROMs study were used to establish the costs and benefits of each model.
Recruitment of patients
Women with stages I–III POP who were referred to a local service were recruited to the study. All
participants were required to have an internal exam by a specialist clinician (i.e. physiotherapist, GP or
consultant) to determine their eligibility for the study. Women were determined to be eligible if they
met the following criteria.
Inclusion criteria
The inclusion criteria were women who:
l were aged ≥ 18 years
l presented with symptomatic stage I, II or III prolapse of any type and who were suitable to be
referred for PFMT
l were willing to take part in the research and comply with necessary data collection.
Exclusion criteria
The exclusion criteria were women who:
l were pregnant or < 1 year postnatal
l had prolapse greater than stage III
l had pelvic cancer, cognitive impairment or neurological disease (as indicated by referral source or
patient/carer reported at assessment consultation).
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Outcome measures
The primary outcome measure was the Pelvic Organ Prolapse Symptom Score (POP-SS), which consists
of seven items that relate to the frequency of different prolapse symptoms, each with a five-point
Likert scale response set (0–4). The total is the sum of the seven questions and the possible scores
range from 0 to 28, with higher scores indicating greater symptom severity. The POP-SS was treated as
a continuous variable.
Secondary outcome measures consisted of two pelvic floor-related outcomes. These were (1) objective
prolapse severity stage (measured using the POP-Q) (which was treated as an ordinal scale) and
(2) urinary symptoms [measured using the International Consultation on Incontinence Questionnaire –
Urinary Incontinence – Short Form (ICIQ–UI SF)].26 The ICIQ-UI SF score was calculated as the sum
of the first three items (relating to frequency, volume of leakage and interference with everyday life).
The ICIQ-UI SF score was treated as a continuous scale with a possible range from 0 to 21, with higher
scores indicating worse symptoms.
Service-related outcomes were also included as secondary outcome measures, specifically the need for
further treatment, defined as the number of NHS contacts during the follow-up period. These outcome
measures were treated as count data.
Sample size
We assumed that the minimum clinically important difference in the POP-SS was 2 points and that
the standard deviation (SD) of the differences in POP-SS between baseline and follow-up was 5.5 points
(close to what has been observed in the POPPY trial). A sample size of 120 paired observations (with
two-sided alpha = 0.05) would, therefore, provide 80% power to detect important differences in POP-SS.
Analysis methods
In research question 2, paired t-tests were conducted to compare POP-SSs at baseline with those at
6-month follow-up.
In research question 3, independent-samples t-tests were used to compare the mean change in POP-SS
from baseline to 6-month follow-up in women who were seen by specialist physiotherapists with the
mean change in women who were seen by other HCPs.
In addition, for research question 2, a linear mixed model was used to estimate the change in POP-SS
between baseline and 6 months, adjusted for covariates. This model had ‘POP-SS’ as a dependent
variable, ‘measurement time point’ as an independent variable, and ethnicity, parity, age and body mass
index (BMI) change during follow-up fitted as fixed effects in the multilevel model, as well as a random
effect for participant.27
In addition, for research question 3, a linear mixed model was used to estimate the difference in change
in POP-SS (from baseline to 6 months) between women treated by specialist physiotherapists and those
who were treated by other HCPs, adjusted for covariates. This model had ‘change in POP-SS between
baseline and follow-up’ as a dependent variable, and a factor variable for ‘professional delivering the
intervention’ as an independent variable. Other covariates, for example baseline POP-SS, ethnicity, parity,
age and BMI, were fitted as fixed effects in the multilevel model, along with a random effect for site.27
The same methods were repeated for the secondary outcomes when sufficient data were available.
Further tests for the presence of a dose–response relationship between the intervention and the
outcomes were performed by testing for a relationship between outcomes and level of adherence.
Adherence was measured as the time spent doing pelvic floor exercises during the previous month.
A sensitivity analysis was also carried out to test the effect of excluding participants who had surgery
during follow-up.
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Participant flow
A total of 102 women were recruited to the study. Baseline questionnaires were available from
91 women, and 71 women completed the 6-month follow-up questionnaire, for whom 68 questionnaires
were matched to baseline questionnaires. Seventy-two participants with baseline or 6-month follow-up
questionnaires also had a clinical assessment form. Eight participants had a clinical assessment form
only, and 59 participants had baseline and 6-month follow-up questionnaires plus a clinical assessment
form. Participant flow is summarised in Figure 8.
Baseline characteristics
The baseline characteristics of the sample are summarised in Tables 6 (continuous measures) and 7
(categorical measures). The ‘6 months’ and ‘12 months’ columns show the effect of missing data on the
distribution of these characteristics at each follow-up point, by summarising the baseline data for those
who responded only at 6 months and 12 months, respectively. Overall, the distribution of participant
characteristics is stable from baseline to the 6-month follow-up.
Results
Primary outcome results (Pelvic Organ Prolapse Symptom Score)
The distribution of scores on the primary outcome (POP-SS) was explored visually in a histogram
(Figure 9). Before intervention, that is, at baseline, there were 88 POP-SSs available. The distribution
of these scores is shown in Figure 9. Similarly, the POP-SSs available at the 6-month follow-up were
examined to evaluate the distribution of the scores. At 6 months post intervention, 68 POP-SSs were
available. The distribution of these scores is shown in Figure 10.
Results for women who had paired data available at baseline and 6-month follow-up
The primary comparison is between the scores at baseline and the scores at 6-month follow-up
among the women for whom both sets of observations are available. There were 65 women with both
baseline and 6-month POP-SSs. Initially, we examined the distribution of the scores at baseline and














FIGURE 8 The PROMs study participant flow.
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TABLE 6 Distribution of baseline characteristics for participants available at each measurement point (continuous measures)
Variable Baseline 6 months 12 months
Age (years)
Mean (SD) 57.5 (11.5) 59.1 (11.2) 58.6 (12.4)
Range 32.1–78.6 32.5–79.2 33.0–79.5
Total (n) 87 70 30
BMI (baseline report) (kg/m2)
Mean (SD) 27.1 (4.6) 27.0 (4.5) 26.6 (4.4)
Range 17.9–42.6 17.9–42.6 17.9–35.6
Total (n) 76 58 24
Number of months aware of having prolapse (baseline report)
Mean (SD) 46.3 (94.6) 43.6 (87.0) 30.3 (47.9)
Range 1–504 1–480 2–240
Total (n) 85 63 27
Number of months of bothersome symptoms of prolapse (baseline report)
Mean (SD) 23.77 (43.31) 25.24 (49.31) 19.62 (25.06)
Range 1–324 1–324 2–120
Total (n) 82 62 29
Do your prolapse symptoms interfere with physical activity? (e.g. walking, housework or exercise) 0 points (not at all) to
10 points (a great deal) (baseline report)
Mean (SD) 4.34 (3.35) 4.06 (3.31) 3.52 (3.05)
Range 0–10 0–10 0–10
Total (n) 90 67 31
Do your prolapse symptoms interfere with social activity? (e.g. going out of the house, shopping or work) 0 points (not at all)
to 10 points (a great deal) (baseline report)
Mean (SD) 3.39 (3.33) 3.30 (3.33) 2.87 (3.07)
Range 0–10 0–10 0–10
Total (n) 90 67 31
Does your prolapse give you problems with personal hygiene? 0 points (not at all) to 10 points (a great deal) (baseline report)
Mean (SD) 2.81 (3.16) 2.51 (2.89) 2.32 (2.86)
Range 0–10 0–10 0–10
Total (n) 90 67 31
Overall, how much do your prolapse symptoms interfere with your everyday life? 0 points (not at all) to 10 points
(a great deal) (baseline report)
Mean (SD) 4.42 (3.05) 4.13 (3.01) 3.52 (2.74)
Range 0–10 0–10 0–10
Total (n) 90 67 31
Overall, how much do your prolapse symptoms interfere with your sex life? 0 points (not at all) to 10 points (a great deal)
(baseline report)
Mean (SD) 4.21 (3.44) 4.15 (3.27) 4.24 (3.22)
Range 0–10 0–10 0–10
Total (n) 68 46 21
THE PATIENT-REPORTED OUTCOME MEASURES STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
TABLE 7 Distribution of baseline characteristics for participants available at each measurement point (categorical measures)
Variable Baseline, n (valid %) 6 months, n (%) 12 months, n (%)
Ethnicity
White 78 (97.5) 59 (100) 25 (100)
Asian 2 (2.5) 0 (0.0) 0 (0.0)
Missing 22 43 77
Site
A 30 (29.4) 22 (32.4) 6 (19.4)
B 27 (26.5) 20 (29.4) 15 (48.4)
C 8 (7.8) 5 (7.4) 1 (3.2)
D 20 (19.6) 10 (14.7) 7 (22.6)
E 17 (16.7) 11 (16.2) 2 (6.5)
Missing 0 34 71
Education
University or college degree 24 (29.6) 19 (32.2) 8 (25.8)
University or college less than degree level 21 (25.9) 13 (22.0) 3 (9.7)
Upper secondary school qualification 8 (9.9) 6 (10.2) 6 (19.4)
Lower secondary school qualification 15 (18.5) 11 (18.6) 4 (12.9)
None of the above 13 (16.0) 10 (16.9) 4 (12.9)
Missing 21 43 71
Ring or pessary (baseline report)
Yes 3 (3.3) 2 (2.94) 0 (0.0)
No 88 (96.7) 66 (97.1) 31 (100)
Missing 11 34 71
Constipation (baseline report)
Yes 31 (37.8) 23 (38.3) 10 (37.0)
No 51 (62.2) 37 (61.7) 17 (45.9)
Missing 20 42 75
Chest/respiratory symptoms (baseline report)
Yes 13 (16.0) 8 (13.3) 4 (14.8)
No 68 (84.0) 52 (86.7) 23 (85.2)
Missing 21 62 75
Smoker (baseline report)
Yes 7 (8.6) 6 (10.2) 3 (11.5)
No 74 (91.4) 53 (89.8) 23 (88.5)
Missing 21 43 76
Parity
0 1 (1.3) 1 (1.8) 0 (0.0)
1 13 (16.5) 11 (19.6) 2 (8.0)
2 38 (48.1) 27 (48.2) 13 (52.0)
3 17 (21.5) 11 (19.6) 6 (24.0)
4 7 (8.9) 5 (8.9) 4 (16.0)
≥ 5 3 (3.8) 1 (1.8) 0 (0.0)
Missing 23 46 77
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The primary quantitative research question regarding whether or not there was a significant change in
the POP-SSs between baseline and 6-month follow-up (research question 2) was evaluated with a paired
t-test (Table 8). A Wilcoxon matched-pairs signed-rank test was also significant (p < 0.001). Prolapse
symptom severity was significantly lower at the 6-month follow-up than at baseline. The estimated
difference in POP-SS between baseline and 6-month follow-up is 3.20 points [95% confidence interval
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FIGURE 10 Histogram of the primary outcome, POP-SS: full sample.
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FIGURE 12 Histogram of the primary outcome, POP-SS paired data: 6 months.
TABLE 8 Paired t-test of POP-SSs between baseline and 6 months
Variable n Mean Standard error SD 95% CI Paired means t-test
POP-SS (points) at baseline 65 10.18 0.70 5.63 8.79 to 11.58 t= 5.3142, df = 64; p < 0.001
POP-SS (points) at 6 months 65 6.98 0.65 5.23 5.69 to 8.28
Difference (points) 65 3.20 0.60 4.85 2.00 to 4.40
CI, confidence interval; df, degrees of freedom.
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Estimating the effects of the intervention from the mixed-effects model
The effect of the intervention was also evaluated with linear mixed models (Table 9). Linear mixed
models allow computation of appropriate standard errors for correlated, repeated-measures data
and estimate subject-specific conditional effects with adjustment for covariates.27 The first model
had POP-SS as a dependent variable and time as an independent variable (baseline vs. 6-month
follow-up). That is, the coefficient for ‘time (baseline vs. 6 months)’ in the model estimates the
conditional difference in means on the POP-SS between baseline and 6-month follow-up. A random
effect of participant was included in the model to control for repeated measures. The second model
also included parity and age, as assessed at baseline, and BMI, as measured at baseline and 6-month
follow-up. The third model included ethnic group. A second random effect of site was also tested
in the models; however, the effect was not significant and so was dropped and is not included in
the results presented. We recognise that the degrees of freedom (df) in the described models are
very low. The models are presented for illustration only, as they were part of the planned analysis.
The estimated effect is very similar to the paired t-test, which estimated the treatment effect as
a 3.20-point improvement in POP-SS, and here the fully adjusted model estimates the effect as a
3.48-point improvement.
Next, we began to explore the second research question by examining how the baseline POP-SSs varied
by site (Table 10). The mean POP-SSs ranged from 9.57 points (SD 5.52 points) in site E to 15.71 points
(SD 3.25 points) in site C.




Model 1 Model 2 Model 3
Time (effect of the intervention) –3.34 (–4.46 to –2.22) –3.50 (–4.96 to –2.06) –3.48 (–4.93 to –2.04)
Parity (baseline) 1.03 (–0.04 to 2.10) 0.88 (–0.23 to 2.00)
BMI (change from baseline) 0.11 (–0.15 to 0.38) 0.11 (–0.15 to –0.38)
Age (baseline) –0.01 (–0.10 to 0.12) 0.01 (–0.10 to 0.13)
Ethnic group: white 0
Ethnic group: Asian 6.80 (–3.86 to 17.45)
Ethnic group: missing 1.21 (–2.47 to 4.88)
Random effect of participant estimate 16.34 (10.60 to 25.18) 14.42 (8.07 to 25.76) 13.79 (7.68 to 24.76)
Total (n) 91 56 56







POP-SS, mean (SD) Mean difference (95% CI)
A 22 10.50 (5.95) 6.55 (4.34) –3.95 (–6.11 to –1.80)
B 19 9.16 (5.00) 6.53 (5.54) –2.63 (–5.28 to 0.02)
C 5 16.00 (2.74) 12.2 (3.63) –3.80 (–6.49 to –1.11)
D 10 9.90 (5.63) 6.40 (4.93) –3.50 (–7.67 to 0.67)
E 9 8.67 (6.22) 6.78 (6.92) –1.89 (–4.67 to 0.89)
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Table 10 indicates that the effect of the intervention is significant when considering either site A
or site C alone only. This analysis, however, does not allow us to compare effects across sites. The
comparison by site was conducted in a general linear model. POP-SS at 6 months was the dependent
variable. The effect was estimated by an interaction term between ‘site’ and ‘baseline POP-SS’. The
interaction term and the main effect of ‘site’ were not statistically significant. That is, we cannot
reject the null hypothesis of no difference in effect of the intervention between sites. This result
was expected, given that the study was not powered to detect between-site differences.
Comparison of intervention delivery by specialist physiotherapists versus delivery
by other health-care professionals
The second quantitative research question (research question 3) concerned whether or not the effect
of the intervention varied according to whether it was delivered by specialist physiotherapists or other
HCPs. The sample was divided into two groups: women who were seen by specialist physiotherapists
and women seen by another HCP. The difference in the change in POP-SS between baseline and
6-month follow-up was compared between the two groups; the results are shown in Table 11.
There is no evidence to reject the null hypothesis of there being no difference between the intervention
delivered by specialist physiotherapists and the intervention delivered by other HCPs. In the mixed-effect
model, the effect of ‘being seen by a specialist’ was not significant before and after adjustment of covariates
and random effect of centre.
Secondary research questions
The Pelvic Organ Prolapse Symptom Score at 12 months
The difference in the mean POP-SS between baseline and 12-month follow-up was assessed using a
paired-samples t-test (Table 12). At the 12-month follow-up, POP-SSs were available for 30 women
only. The scores at 12-month follow-up were, on average, significantly lower than those at baseline,
with a difference over time of 2.73 points (95% CI 0.99 to 4.48 points; p = 0.003).
TABLE 12 Paired t-test: mean POP-SSs at baseline and at 12-month follow-up
Variable Total (n) Mean Standard error SD 95% CI
Baseline POP-SS (points) 30 9.70 1.00 5.48 7.65 to 11.75
12-month follow-up POP-SS (points) 30 6.97 0.92 5.05 5.08 to 8.85
Difference (points) 30 2.73 0.85 4.68 0.99 to 4.48
TABLE 11 Independent-samples t-test of change in POP-SSs between baseline and 6-month follow-up comparing those




from 0 to 6 months Standard error SD 95% CI
Seen by specialist physiotherapist 22 –3.95 1.03 4.86 –6.11 to –1.79
Seen by other HCP 43 –2.81 0.74 4.86 –4.31 to –1.32
Combined 65 –3.20 0.60 4.85 –4.40 to –2.00
Difference 1.14 1.27 –1.41 to 3.69
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
51
International Consultation on Incontinence Questionnaire – Urinary Incontinence
Short Form at 6 months
Table 13 summarises the change in the ICIQ-UI SF score from baseline to 6-month follow-up. Paired
data were available for ICIQ-UI SF scores for 39 women at baseline and 6-month follow-up. The
change in ICIQ-UI SF score is also significant between baseline and 6-month follow-up (p = 0.0028).
Stage of prolapse (Pelvic Organ Prolapse Quantification System) at 6-month follow-up
There were 34 POP-Q scores available at baseline and 27 POP-Q scores available at the 6-month
follow-up. From these scores, most women were deemed to be at stage II of prolapse. At baseline,
eight women (23.5%) were at stage I, 25 women (73.5%) were at stage II and one woman (2.9%) was
at stage III of prolapse. At the 6-month follow-up, 12 women (44.4%) were at stage I, 14 women
(51.9%) were at stage II and one woman (3.7%) was at stage III of prolapse.
There were 26 women with a POP-Q score at both baseline and 6-month follow-up. A Wilcoxon
matched-pairs signed-rank test was used to test the equality of the distributions at baseline and
at 6-month follow-up; there was no significant difference between the distributions (p = 0.0956).
Number of visits to a health-care professional
Figure 13 shows the distribution of health-care visits in the 6 months before baseline; there was a
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FIGURE 13 Graph of the distribution of health-care visits 6 months before baseline.
TABLE 13 Paired t-test of ICIQ-UI SF score from baseline to 6-month follow-up
Variable Total (n) Mean Standard error 95% CI Paired means t-test
Baseline ICIQ-UI SF score 39 7.77 0.53 6.69 to 8.84 t = –3.1947, df= 38;
p = 0.0028
6-month follow-up ICIQ-UI SF score 39 6.23 0.51 5.20 to 7.26
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The mean number of health-care visits in the 6 months between baseline and 6-month follow-up was
0.92 visits (SD 1.33 visits, range 0–4 visits, n = 65 participants) (Figure 14). The distribution of the count
of health-care visits is not normally distributed; therefore, a non-parametric matched-samples test was
employed to test the difference in distributions between baseline and the 6-month follow-up.
Table 14 summarises the number of appointments for women with paired data before and after the
intervention (n = 59). There was a significant reduction in the number of health-care visits after the
start of the intervention (Wilcoxon signed-rank test z = 3.663; p < 0.001).
Association between adherence and prolapse symptoms
Adherence was assessed as the self-reported frequency of performing pelvic floor exercises. At the
6-month follow-up, one woman (1.45%) reported that she did not do pelvic floor exercises, two women
(2.90%) reported that they did them a few times per month, one woman (1.45%) did them a few times
per week, six women (8.70%) did them once per week, 10 women (14.49%) did them once per day and
49 women (71.01%) reported that they did pelvic floor exercises a few times per day.
Most women reported performing pelvic floor exercises a few times per day. We compared the
change in the POP-SS from baseline to 6-month follow-up between women who performed pelvic
floor exercises a few times per day and women who performed pelvic floor exercises less frequently
(i.e. once per day or less); we found no evidence of a difference between these groups. The mean
change in the POP-SS for those performing exercises a few times per day (n = 49) was a reduction
of 3.75 points, and the mean change in those performing pelvic floor exercise less frequently (n = 19)
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FIGURE 14 Number of GP and nurse appointments between baseline and the 6-month follow-up questionnaire.
TABLE 14 Number of health-care appointments before and after the intervention
Appointments by period Total (n) Mean (SD) Median (IQR) Range
Total appointments in the 6 months prior to baseline 59 1.73 (1.51) 2 (1–2) 0–10
Total appointments between baseline and 6-month follow-up 59 0.96 (1.36) 0 (0–2) 0–4
IQR, interquartile range.
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
53
independent-samples t-test (t = 1.2642, df = 61; p = 0.2110). The non-parametric correlation between
the pelvic floor exercise frequency and the change in POP-SS between baseline and 6-month follow-up
is also not significant (Spearman’s rho = –0.135; p = 0.2912).
Sensitivity analyses
In total, four women reported having surgery between baseline and the 6-month follow-up, and three
women had a pessary. The primary outcome analysis was repeated with these cases excluded as a
sensitivity analysis. Table 15 shows the result of a paired t-test comparing before scores with after
scores on the POP-SS, with the women who had treatment (i.e. surgery or pessary) in the 6 months
after baseline excluded. The result remains statistically significant.
TABLE 15 Paired t-test of the difference in POP-SS between baseline and 6-month follow-up, with women receiving a
pessary or surgery during follow-up excluded
Variable Total (n) Mean Standard error SD 95% CI
Baseline POP-SS (points) 58 10.17 0.76 5.77 8.66 to 11.69
6-month follow-up POP-SS (points) 58 7.03 0.71 5.37 5.62 to 8.45
Difference (points) 58 3.14 0.67 5.09 1.80 to 4.48
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Chapter 7 The POPPY trial participant data
linkage study
This chapter describes the long-term follow-up of participants in the POPPY trial by linkingparticipants’ trial data with hospital admissions data.
Methodology
Brief description of the POPPY trial/sample
The multicentre randomised POPPY trial showed PFMT to be an effective treatment for POP. The
current analysis examines the follow-up data on secondary care usage for trial participants in Scotland
(n = 293 women).
Primary research question (research question 5)
Are women who were randomised to the POPPY trial intervention in Scotland less likely to receive
further secondary care treatment related to their prolapse during the follow-up period than women
who were randomised to the control group?
Trial design
The trial was a parallel-group, multicentre, randomised controlled trial with data linkage follow-up.
Linkage approval process
An application was made to the Public Benefit and Privacy Panel for Health and Social Care in 2017.
Following a Tier 1 review (April 2017), the application was initially referred for a Tier 2 (out-of-
meeting review) review but was subsequently referred to a Tier 2 panel (November 2017) that
required the PI to attend this meeting to respond to questions. Approval was obtained from the Tier 2
Public Benefit and Privacy Panel (PBPP Application 1617-0049/Semple: Using linked data to follow up
longer-term outcomes of POPPY trial participants) in January 2018. NHS National Services Scotland’s
eDRIS then carried out the linkage of the POPPY trial data with the SMR0028 and SMR0129 data sets
(Scottish Morbidity Records for outpatients and inpatients, respectively). Anonymised linked data files
were made available for analysis via the National Safe Haven.
Linked data set
The data set contained International Statistical Classification of Diseases and Related Health Problems,
Tenth Revision (ICD-10)30 diagnosis codes, Office of Population Censuses and Surveys Classification of
Interventions and Procedures (OPCS)31 procedure codes and the time since randomisation for any
outpatient attendances, day cases or inpatient episodes with at least one of the following diagnosis or
procedure codes relating to pelvic floor disorders:
l pelvic organ prolapse diagnosis (N81 Female genital prolapse or N99.3 Prolapse of vaginal vault)
l urinary incontinence diagnosis (N39.3 Stress UI, N39.4 Overflow/Reflex/Urge UI or R32 Unspecified
UI including enuresis)
l faecal incontinence diagnosis (K62.2 Anal prolapse, K62.3 Rectal prolapse or R15
Faecal incontinence)
l pelvic organ prolapse procedure [P18 Other obliteration of vagina including colpocleisis, P22-P24
Vaginal prolapse and vault repairs, P26 Introduction of supporting pessary into vagina, Q07-Q08
Excision of uterus or Q54 Operations on other ligament of uterus (including uterine suspension)]
l urinary incontinence procedure (M51-M58 Operations to support outlet of female bladder)
l faecal incontinence procedure (A70 Neurostimulation of peripheral nerve or H57 Other operations
on the anal sphincter to control continence).
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Primary outcome
The primary outcome measure was the occurrence of any related secondary care treatment for
pelvic floor disorders during follow-up, using routinely collected individually linked hospital episode
data (defined as OPCS4 procedure code P18, P22-P24, P26, Q07-Q08, Q54, M51-M58, A70 or H57
as main operation or other operation or ICD-10 diagnosis code N81, N99.3, N39.3, N39.4, R32,
K62.2, K62.3 or R15 as main or other condition). The primary outcome measure was expressed
as a binary variable.
Secondary outcomes
Secondary outcome measures included the participant receiving a related operation, the participant
receiving treatment specifically for prolapse, the participant experiencing urinary incontinence and faecal
incontinence, the participant receiving a pessary or neurostimulation, and the time to first treatment.
All outcomes were treated as binary variables, with the exception of the time-to-event outcome.
Timing of the study outcome assessments
The follow-up period was from initial randomisation to the original POPPY trial on 26 September 2007
to the date of data linkage (May 2018), that is approximately 11 years. Randomisation date was
recorded with reduced precision in the linked data set to prevent re-identification of participants.
Statistical analysis
Baseline patient characteristics were reported. Categorical data were presented using counts and
percentages and continuous data were presented using the number of patients, mean, median, SD,
minimum, maximum and interquartile range, as appropriate. The variables included:
l age – categorised as 25–44 years, 45–64 years, or 65–79 years
l parity – number of births at baseline
l BMI – at baseline
l prolapse symptom severity (POP-SS) at baseline
l stage of prolapse (POP-Q), categorised as stage I, II or III
l motivation for prolapse surgery, levels 1 and 2
l intervention status at baseline for the POPPY trial – physiotherapy (PFMT) or control (lifestyle
advice leaflet).
Mixed-effects logistic regression was conducted to estimate treatment effects [odds ratios (ORs) and
95% CIs], with the binary outcome measure as the dependent variable and the intervention group
status as the binary independent variable. Analyses were adjusted for the same variables as used in
the original POPPY trial analysis [baseline symptom severity (POP-SS), prolapse stage (POP-Q) and
motivation for prolapse surgery]. In addition, treatment centre was included as a random effect and
age group was included as an additional covariate, because over an 11-year follow-up period the effect
of age may increase. Cox regression was used to analyse time-to-event data. A sensitivity analysis of
the primary outcome was conducted to examine the effect of missing data.
Results
The baseline characteristics of participants included in the analysis are summarised in Tables 16 and 17.
The distribution of characteristics is similar to that of the full POPPY trial sample.
During the follow-up period, 15 participants (5%) died (Table 18). The mortality rate was 5% in
both groups.
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TABLE 16 Baseline characteristics of participants available for follow-up (categorical variables)
Variable Intervention (physiotherapy), n (%) Control (lifestyle advice leaflet), n (%) Total, n (%)
Status of surgery
1 18 (12.1) 15 (10.4) 33 (11.3)
2 131 (87.9) 128 (89.6) 259 (88.7)
Stage of prolapse
I 18 (12.1) 17 (11.8) 35 (12.0)
II 107 (71.8) 108 (75.0) 215 (73.4)
III 24 (16.1) 19 (13.2) 43 (14.7)
Age group (years)
25–44 20 (13.4) 23 (16.0) 43 (14.7)
45–64 92 (61.7) 91 (63.2) 183 (62.5)
65–79 37 (24.8) 30 (20.8) 67 (22.9)
Parity
0 or 1 19 (12.8) 15 (10.4) 34 (11.6)
2 70 (47.0) 59 (41.0) 129 (44.0)
3 41 (27.5) 49 (34.0) 90 (30.7)
4 17 (11.4) 17 (11.8) 34 (11.6)
Missing 2 (0.7) 4 (2.8) 6 (2.1)
Total 149 (50.9) 144 (49.1) 293 (100)
TABLE 17 Baseline characteristics of participants available for follow-up (continuous variables)
Variable Intervention (physiotherapy) Control (lifestyle advice leaflet) Total (n)
BMI









Prolapse symptom severity (POP-SS)
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Women receiving treatment during follow-up
The overall proportion of women receiving any treatment was 48.1% (141/293): 43.6% (65/149) in the
intervention group and 52.8% (76/144) in the control group (Table 19). This corresponds to a number
needed to treat of 11; that is, 11 women would need to receive the physiotherapy intervention in
order to prevent one further treatment during follow-up.
The mixed-effects logistic regression on ‘any treatment during follow-up’ (primary outcome measure)
with adjustment for baseline prolapse symptom severity, motivation for prolapse surgery, age group
and prolapse stage, with a random effect of centre and missing prolapse symptom severity imputed
at median, estimates a significant treatment effect (OR 0.61, 95% CI 0.37 to 0.99; p = 0.047). The
estimated parameters from the model are shown in Table 19.
The likelihood ratio test for the mixed-effects logistic regression model compared with a model with
fixed effects only (likelihood ratio test χ2 = 2.74; p = 0.0489) indicated that the random effect of centre is
required. The 95% CI for the coefficient for the effect of the intervention does not include zero; therefore,
the effect of the intervention is statistically significant and is associated with a reduction in the log-odds
of any treatment during follow-up. The adjusted OR of 0.61 corresponds to a relative risk reduction of
0.80, indicating that the probability of the need for further treatment is 20% lower in the group receiving
the physiotherapy intervention than in the control group after adjustment for covariates.
The sample is relatively small; therefore, missing POP-SS values were imputed at the median.
The complete-case analysis is shown for comparison in Table 19.
Women receiving conservative treatment during follow-up
The rates for conservative treatment (defined as receiving either a pessary or a neurostimulation in either
an outpatient or an inpatient setting) were 12.8% in the intervention group and 16.7% in the control group.
There was no difference between groups (χ2 = 0.896; p = 0.344) and the linear mixed model (Table 20)
corroborates this finding, by estimating an OR of 0.66 (95% CI 0.33 to 1.33; p= 0.244). There is no
evidence that the intervention reduced the need for conservative treatment during follow-up.
TABLE 18 Number of participants who died during the follow-up period by intervention status
Variable Intervention (physiotherapy), n (%) Control (lifestyle advice leaflet), n (%) Total, n (%)
Alive 141 (94.6) 137 (95.1) 278 (94.9)
Died 8 (5.4) 7 (4.9) 15 (5.1)
Total 149 (100) 144 (100) 293 (100)










Intervention 0.61 (0.37 to 0.99) 0.59 (0.36 to 0.98) 0.047
Prolapse symptom severity 1.05 (1.00 to 1.09) 1.05 (1.00 to 1.10) 0.037
Status of surgery 0.53 (0.24 to 1.19) 0.53 (0.23 to 1.21) 0.126
Stage of prolapse: II (reference category stage I) 2.03 (0.90 to 4.66) 1.89 (0.82 to 4.35) 0.091
Stage of prolapse: III (reference category stage I) 3.00 (1.07 to 8.41) 2.84 (1.00 to 8.07) 0.036
Age band 45–64 years (reference category < 45 years) 1.82 (0.86 to 3.86) 1.95 (0.90 to 4.22) 0.116
Age band 65–79 years (reference category < 45 years) 4.62 (1.90 to 11.36) 4.99 (1.97 to 12.62) 0.001
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The rates for receiving any related operation (OPCS4 code P18, P22–P24, P26, q07–Q08, Q54,
M51–M58, A70 or H57) were 32.9% (49/149) in the intervention group and 36.1% (52/144) in the
control group. The rates are lower for this outcome than for the primary outcome measure, as this
outcome counts the procedures specified above only, rather than any treatment for or diagnosis of
pelvic floor disorders. The linear model to compare groups is summarised in Table 21 (OR 0.78, 95% CI
0.47 to 1.32; p = 0.356). When the outcome measure is limited to any prolapse procedure, the results
are very similar. The proportion of participants having any prolapse surgery is 32.8% (49/149) in the
intervention group and 34.0% (49/144) in the control group, which is very similar to the proportions
quoted above because nearly all of the women who had a procedure had treatment that included a
prolapse procedure. Frequencies for the outcome of any urinary incontinence surgery (M51–M58) and
the outcome of any faecal incontinence surgery (H56–57) cannot be reported because of low numbers.
In summary, there is no evidence that the intervention reduced the need for these types of treatment
during follow-up.
Analysis of time to first treatment
We examined whether or not there was any difference between the intervention group and the
control group in the time until treatment during follow-up. That is, we investigated whether or
not the intervention was effective in delaying any further prolapse treatment. First, we examined
whether or not the overall follow-up periods were similar between the intervention group and the
control group. The time in follow-up (i.e. the time at risk and under observation) was found to be
comparable between the groups. The mean time in follow-up in the intervention group was 9.36 years
(SD 262.5 days) and the mean in the control group was 9.32 years (SD 267.9 days).
The survival function for the intervention group and the control group is shown in Figure 15. The
survival function shows how the proportion of women in the two groups who had not received any
further treatment declined over time.
TABLE 20 Mixed-effects model on the probability of pessary/neurostimulation during follow-up
Variable OR (95% CI) p-value
Intervention 0.66 (0.33 to 1.33) 0.244
Prolapse symptom severity score at baseline (missing imputed at median) 0.94 (0.88 to 1.01) 0.086
Preference for surgery 2.34 (0.46 to 11.84) 0.303
Stage of prolapse II (reference category stage I) 0.75 (0.24 to 2.33) 0.619
Stage of prolapse III (reference category stage I) 0.92 (0.24 to 1.31) 0.906
Age band 45–64 years (reference category < 45 years) 2.87 (0.65 to 40.14) 0.122
Age band 65–79 years (reference category < 45 years) 13.09 (1.59 to 107.75) 0.017
TABLE 21 Mixed-effects model on the probability of any related operation during follow-up
Variable OR (95% CI) p-value
Intervention 0.78 (0.47 to 1.32) 0.356
Prolapse symptom severity score at baseline (missing imputed at median) 1.08 (1.03 to 1.13) 0.001
Preference for surgery 0.46 (0.20 to 1.05) 0.066
Stage of prolapse II (reference category stage I) 2.24 (1.16 to 5.79) 0.097
Stage of prolapse III (reference category stage I) 3.54 (1.15 to 10.92) 0.028
Age band 45–64 years (reference category < 45 years) 1.72 (1.32 to 3.91) 0.197
Age band 65–79 years (reference category < 45 years) 2.79 (1.09 to 7.14) 0.032
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A Cox regression was used to test whether or not women in the control group were likely to receive
treatment sooner than women in the intervention group. The Cox regression model (Table 22), which
was stratified by preference for surgery and included 264 subjects and 125 failures, estimated that
there was a significant hazard ratio in favour of the intervention group of 0.65 (95% CI 0.46 to 0.94;
p = 0.020). This indicates that the intervention did delay the need for further treatment and that,
during follow-up, women in the treatment group had a 35% lower hazard for treatment.
When the outcome was restricted to time to surgery (Table 23), the number of failures was 91 and the
hazard ratio was 0.71 (95% CI 0.47 to 1.08; p = 0.112).
Missing data
The results of the sensitivity analysis of the primary outcome (any treatment) to examine the potential
effect of missing data are summarised in Table 24. This analysis used a mixed-effects model similar to
the main analysis, but with multiple imputation by chained equations. Two variables only were missing
data (BMI and POP-SS). The data were checked for missing completely at random by logistic regression
of missingness in these variables against the values of covariates included in the above analyses.
Missingness in POP-SS was predicted by centre and missingness in BMI was predicted by age group,
with missing data most likely in the youngest age group. Data were assumed to be missing at random.26
Follow-up time (days)



































FIGURE 15 Kaplan–Meier survival estimates by intervention status.
TABLE 22 Cox regression on time to any treatment
Variable HR (95% CI) p-value
Intervention 0.65 (0.46 to 0.94) 0.020
Prolapse symptom severity score at baseline (missing imputed at median) 1.06 (1.02 to 1.09) 0.001
Stage of prolapse II (reference category stage I) 1.48 (0.77 to 2.85) 0.245
Stage of prolapse III (reference category stage I) 2.40 (1.13 to 5.13) 0.023
Age band 45–64 years (reference category < 45 years) 1.66 (0.88 to 3.10) 0.115
Age band 65–79 years (reference category < 45 years) 2.58 (1.29 to 5.17) 0.008
BMI 0.95 (0.91 to 0.99) 0.014
HR, hazard ratio.
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Missing data were imputed through chained equations, with BMI imputed through regression and
POP-SS imputed as truncated regression. The variables in the imputation models included all of those
in the analysis models. No auxiliary variables were included. There were 100 imputed data sets created
with a burn-in of 10. Trace plots were inspected to confirm the stability of the chain at the specified
burn-in. The result is similar to the main analysis, but with a slightly lower OR of 0.60 in favour of
PFMT (95% CI 0.37 to 0.99; p = 0.046).
Summary of findings
The data linkage study provides evidence that PFMT reduces the overall long-term risk of requiring
hospital treatment for pelvic floor disorders, over a post-intervention period of > 10 years. There is
also evidence that PFMT extends the time for which hospital treatment is not required.
TABLE 23 Cox regression on time to inpatient surgery in days, stratified by preference for surgery
Variable HR (95% CI) p-value
Intervention 0.71 (0.47 to 1.08) 0.112
Prolapse symptom severity score at baseline (missing imputed at median) 1.08 (1.04 to 1.12) < 0.001
Stage of prolapse II (reference category stage I) 1.47 (0.67 to 3.22) 0.335
Stage of prolapse III (reference category stage I) 2.65 (1.09 to 6.44) 0.031
Age band 45–64 years (reference category < 45 years) 1.56 (0.78 to 3.15) 0.211
Age band 65–79 years (reference category < 45 years) 2.22 (1.00 to 4.91) 0.049
BMI 0.95 (0.91 to 1.00) 0.036
HR, hazard ratio.
TABLE 24 Mixed-effects model on any treatment during follow-up with multiple imputation by chained equations
Variable OR (95% CI) p-value
Intervention 0.60 (0.37 to 0.99) 0.046
Prolapse symptom severity score at baseline 1.05 (1.00 to 1.10) 0.034
Preference for surgery 0.53 (0.24 to 1.19) 0.126
Stage of prolapse II (reference category stage I) 2.03 (0.89 to 4.64) 0.093
Stage of prolapse III (reference category stage I) 3.00 (1.07 to 8.641) 0.037
Age band 45–64 years (reference category < 45 years) 1.84 (0.87 to 3.89) 0.112
Age band 65–79 years (reference category < 45 years) 4.70 (1.92 to 11.48) 0.001
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
61

Chapter 8 Economic evaluation of pelvic floor
muscle training
Introduction
The economic evaluation for the PROPEL intervention was concerned with the associated costs and
outcomes of different service delivery models for delivering PFMT. In addition, an economic assessment
of the long-term costs that were associated with accessing further pelvic prolapse treatment over time
was conducted for the original POPPY trial participants, who were resident in Scotland. The multicentre
randomised POPPY trial had found that individualised PFMTwas effective in reducing the symptoms of
prolapse, provided improvements in quality of life and showed potential to be cost-effective in women.6
Objectives of the research
The research objectives were to:
l provide estimates of the costs of each service delivery model involved in the PROPEL intervention
l determine the patient outcomes following PFMT using the EuroQol-5 Dimensions, five-level version
(EQ-5D-5L), for each delivery model
l estimate the long-term costs associated with accessing further pelvic prolapse treatment over time
to inform estimates of the potential cost-effectiveness of PFMT.
Methods
Models of provision
The comparator site for the purpose of the economic evaluation was site A, which operated with the
same PFMT delivery model before and after the PROPEL intervention.
Resource use and costs
Perspective
The perspective of the primary economic analysis was the UK NHS. In all cases, resource use and costs
relate to consultations in primary and secondary care for prolapse or prolapse-related symptoms only.
Resource use data
The PROPEL intervention service delivery models for pelvic floor muscle training
Associated resource use data for the delivery of PFMT per site were obtained from the clinical centres.
Cost categories included were staff costs (AfC band and specialism) and activity data (e.g. the number
of treatment sessions and duration of appointments) for the delivery of PFMT. Resource use data for
community-based care and patient resources for further pelvic prolapse treatment were collected
using participant-completed questionnaires. Associated resource implications for the delivery of PFMT
were assessed per site.
The POPPY trial longitudinal follow-up
Follow-up data on secondary care resource use and costs for POP treatment in secondary care
(inpatient and outpatient data) for the POPPY trial participants in Scotland were accessed to estimate
the longitudinal costs. The time period was 11 years (2007–18).
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Health service costs
Costs to the UK NHS were calculated using the national average unit costs for primary care resource use
[Personal Social Services Research Unit (PSSRU)]32 and for secondary care resource use (Scottish Health
Service Costs33 and NHS Reference Costs 2017/1834). The PROPEL intervention costs were incurred within
a 12-month period, so a discount rate was not applied. The costs were reported in 2017/18 Great British
pounds (GBP) (Table 25). The original POPPY trial costs base year was 2009. Longitudinal follow-up data
were adjusted using UK gross domestic product deflators (2017 base year).35
Health-related quality-of-life data
The EQ-5D-5L data were collected at baseline and at the 6- and 12-month follow-ups. The EQ-5D-5L
provides a single utility-index score for use in analysis.36 Average scores were calculated at each time
point for the whole participant sample and by site using the index calculator tool from EuroQol.37
Changes in scores between baseline and 6 months were calculated and tested using the parametric
paired t-test for statistically significant differences in health-related quality-of-life (HRQoL) scores,
before and after PFMT. This time scale was in line with the primary outcome analysis.
Statistical analyses were performed using IBM SPSS Statistics version 24.0 (IBM Corporation, Armonk,
NY, USA) and Microsoft Excel® 2010 (Microsoft Corporation, Redmond, WA, USA). Conventional levels
of significance (5%) were used.




NHS health-care resource use
Consultant referral to
physiotherapy
Visit 158 NHS Reference Costs 2017/18,34 WF01B consultant-led,
non-admitted, face-to-face attendance, first
Triage appointment PWH 55 Assumes cost of band 7 specialist physiotherapist




17 Scottish Health Service Costs33 (R046)
Staff involved in delivery of PFMTa
Band 7 specialist physiotherapist PWH 55 PSSRU Unit Costs of Health and Social Care 2018,32
table 12. Hospital-based scientific and professional staff
Band 6 physiotherapist specialist PWH 46 PSSRU Unit Costs of Health and Social Care 2018,32
table 12. Hospital-based scientific and professional staff
Band 7 physiotherapist PWH 55 PSSRU Unit Costs of Health and Social Care 2018,32
table 12. Hospital-based scientific and professional staff
Band 6 physiotherapist PWH 46 PSSRU Unit Costs of Health and Social Care 2018,32
table 12. Hospital-based scientific and professional staff
Band 5 physiotherapist PWH 35 PSSRU Unit Costs of Health and Social Care 2018,32
table 12. Hospital-based scientific and professional staff
Band 6 district nurse PWH 45 PSSRU Unit Costs of Health and Social Care 2018,32
table 13. Hospital-based nurses
Band 5 staff nurse PWH 37 PSSRU Unit Costs of Health and Social Care 2018,32
table 13. Hospital-based nurses
Community health-care resource use
GP Per surgery
consultation
28 PSSRU Unit Costs of Health and Social Care 2018,32
table 10. 3b General Practitioner – unit costs
Practice nurse PWH 36 PSSRU Unit Costs of Health and Social Care 2018,32
table 10. 2 Nurse (GP practice)
PWH, per working hour.
a Initial assessment appointment and follow-up treatment sessions, face to face. Staff mix varies by clinical site.
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Results
Costs of each delivery model
To calculate the costs for one cycle of PFMT treatment, data about the band and specialism of staff
members delivering the treatment were used. The average cost for the delivery pathway at each site
was calculated, as shown in Table 26, using available data for 70 participants. The total cost comprised
the average staff costs for referral, triage and treatment, and a proportional allocation of overheads to
reflect that all services within a hospital share facilities. An allocated cost of £17.00 per attendance
for physiotherapy (table R046)33 was used for overheads. The estimated mean cost per patient for
an episode of PFMT (2017–18 GBP) was £438.91 in site A; it was £464.43 in site D, £434.97 in site B,
£353.53 in site C and £339.36 in site E. The costs per site assume that each patient attends all of their
PFMT treatment sessions. Excluding overheads, the mean costs were £353.91 in site A, £349.97 in
site B, £268.53 in site C, £362.43 in site D and £288.36 in site E.
There was no difference between sites in terms of resource use for referral to physiotherapy triage.
Site C was the only site that operated direct referral to initial appointment without triage, and had
the lowest average cost to deliver PFMT as part of the PROPEL intervention. The total clinical
time to deliver PFMT per patient was 180 minutes for sites A, B and C, 190 minutes for site D and
105 minutes for site E. It should be noted that site C increased its treatment follow-up sessions from












Referral cost (£): consultant 157.53 157.53 157.53 157.53 157.53
Triage cost (£): band 7 specialist physiotherapist 55.00 55.00 0.00a 55.00 55.00
PFMT treatment cycle
Initial appointment time (minutes) 60 60 60 40 45
Number of treatment sessions 4 4 4 5 2
Duration of treatment sessions (minutes) 30 30 30 30 30
Total average clinic time per woman (minutes)b 180 180 180 190 105
PFMT delivery by staff
Band 7 specialist physiotherapist (n) 3
Band 6 physiotherapist specialist (n) 21
Band 7 physiotherapist (n) 2 1
Band 6 physiotherapist (n) 13 12 5
Band 5 physiotherapist (n) 3
Band 6 nurse (district nurse) (n) 3
Band 5 nurse (staff nurse), (n) 7
Average cost per patient (£)c 141.38 137.44 111.00 149.90 75.83
Total cost per patient excluding overheads allocation (£) 353.91 349.97 268.53 362.43 288.36
Overheads allocated cost (by number of attendances) 85.00 85.00 85.00 102.00 51.00
Total cost per patient including overheads (£) 438.91 434.97 353.53 464.43 339.36
a Not applicable (direct from referral to initial appointment).
b Calculated as initial appointment time+ (number of treatment sessions × duration of treatment sessions).
c Average cost per patient treatment cycle (assumption that each woman completes all treatment sessions).
Costs sourced from Curtis and Burns.32
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
65
three (usual care) to four sessions (the PROPEL intervention) per patient. This increased the time per
treatment cycle from 150 minutes (usual care) to 180 minutes (the PROPEL intervention), which
increased the average staff cost for a treatment cycle from £92.50 to £111.00 during the research
study, and increased the total cost from £335.03 to £353.53. The average staff cost per patient during
the PROPEL intervention was £141.38 in site A, £137.44 in site B, £111.00 in site C, £149.90 in site D
and £75.83 in site E.
For a small number of participants at each site, the information about which clinical specialist had
provided treatment was unavailable (two participants in site A, three in site B, one in site D and three in
site E); a sensitivity analysis to test the impact of this on the average costs was conducted. To generate
a range of the average cost, it was first calculated presuming that all ‘unknown’ were treated by the
lowest-cost clinical staff member, and was next recalculated presuming that the highest-cost clinical staff
member delivered the treatment. The average cost per patient ranges were £141.00–144.00 in site A,
£136.50–137.65 in site B, £149.24–152.81 in site D and £70.00–84.00 in site E.
Health service costs
Participants reported their use of health-service resources for further pelvic prolapse treatment. Between
baseline and 6 months, 71 participants provided this information (Table 27). Between baseline and 6 months,
participants sought further treatment for POP from a GP a total of 44 times and from a practice nurse
a total of 17 times. All of the visits were accounted for by 29 (41%) participants. The combined number
of visits per participant ranged from 1 to 4. By site, the number of GP appointments for POP was
17 (median 0) in site A, 11 (median 0) in site B, 6 (median 1) in site C, 5 (median 0.5) in site D and 5 (median 0)
in site E. By site, the number of practice nurse appointments for POP was 2 (median 0) in site A, 7 (median 0)
in site B, 1 (median 0) in site C, 2 (median 0) in site D and 5 (median 0) in site E. In total, 37 (52%) participants
TABLE 27 Costs for further pelvic prolapse treatment reported at 6 months (n = 71)
Category Unit cost (£) Unit (n) Cost (£)
Prolapse treatment
Pessarya 204.97 3 615
Physiotherapyb – 55 –
POP consultation with GP 28 44 1408
POP consultation with practice nurse 36 17c 153
Urinary incontinence
Physiotherapyb – 17 –
Drug treatmentd – 5 Unknown
Surgery
Vaginal repaire 1630 2 3260
Abdominal hysterectomyf 2649 1 2649
Vaginal hysterectomyf 2649 1 2649
Total 10,733
a Cost based on one pessary (£21.45 for ring pessary. Information Services Division Scottish Drug Tariff Part 338)
and attendance at a gynaecology outpatient appointment to have the pessary fitted (£183.52. NHS Reference Costs
2017/18, MA23Z).34
b No cost allocated for physiotherapy (prolapse or urinary incontinence treatment) to avoid double-counting the
PROPEL intervention costs.
c 15-minute appointment assumed.
d Not costed: specific details about participant medications not available.
e NHS Reference Costs 2017/18, MA03D Elective Inpatient.34
f NHS Reference Costs 2017/18, MA28Z Elective Inpatient.34
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did not visit a GP or practice nurse for POP.Very small differences were seen between delivery sites;
these were very unlikely to be statistically or clinically significant.
Participants reported if they had attended physiotherapy appointments. However, as it was not clear
if these were related to their PROPEL intervention appointments, these were not included in the
cost calculations, to prevent double-counting. Other costs incurred by the PROPEL intervention
participants were reported, which included consultations for non-POP-related matters with their GP
(80 appointments) or practice nurse (39 appointments). Seven participants reported that they had
taken days off work: two participants as a result of POP (1 day and 35 days) and five for non-POP
issues (1 day, 1 day, 4 days, 5 days and 30 days). Although these are relevant to the analysis from a
societal perspective, they are not part of the current analysis.
Health-related quality-of-life outcomes
The EQ-5D-5L data were available for 84 participants at baseline, 68 participants at 6 months and
30 participants at 12 months. Around half of all participants indicated that they had slight or moderate
problems on the EQ-5D-5L domains of pain, anxiety/depression and usual activities. Mean utility
increased over time: baseline, mean 0.791 (SD 0.179); 6 months, mean 0.827 (SD 0.160); and 12 months,
mean 0.866 (SD 0.117). The EuroQol visual analogue scale (EQ-VAS) demonstrated the same trend:
baseline, mean 77.4 (SD 18.3); 6 months, mean 79.6 (SD 18.2); and 12 months, mean 82.9 (SD 11.5).
Table 28 shows the mean utilities by time point for all participants and by site. A paired-samples
t-test was conducted to compare utility at baseline with utility at 6 months, and to compare utility at
baseline with utility at 12 months, for all of the PROPEL intervention participants. Differences were
not statistically significant between baseline and 6 months [paired t(df = 60) = 1.163; p = 0.25, two-
tailed] or between baseline and 12 months [paired t(df = 25) = 0.113; p = 0.911, two-tailed]. With the
exception of site C, a large proportion of participants at each site reported a maximum health-state
utility value (1.000) at baseline. This may account for the inability of mean utility scores to significantly
improve over time. Paired-sample t-tests of longitudinal differences between baseline and 6 months
for participants within each research site were not statistically significant: site A t(df = 19) = 1.418
(p = 0.172), two-tailed; site B t(df = 18) = 0.655 (p = 0.521), two-tailed; site C t(df = 4) = 0.875
(p = 0.431), two-tailed; site D t(df = 6) = 0.121 (p = 0.907), two-tailed; and site E t(df = 9) = 0.959
(p = 0.363), two-tailed.
For change over time, 61 participants completed the EQ-5D-5L at baseline and at 6 months [mean utility
gain n(61) = 0.019 (95% CI –0.006 to 0.043)]. Comparing participants receiving specialist physiotherapist
care (n = 20) with participants receiving care from other clinical staff (n = 41), the mean utility gain for
the participants receiving specialist physiotherapist care was higher [n(20) = 0.035 (95% CI –0.011 to
0.082)] than for others [n(41) = 0.012 (95% CI –0.019 to 0.041)]. The differences were not statistically
significant [t(df = 59) = 0.817; p = 0.417, two-tailed].
TABLE 28 Mean EQ-5D-5L scores at baseline and at 6 and 12 months
Site
Maximum utility reported
at baseline, % (n)
Mean EQ-5D-5L score (n participants)
Baseline 6 months 12 months
Total PROPEL intervention participants 25 (21) 0.791 (84) 0.827 (68) 0.866 (30)
A 32 (8) 0.830 (25) 0.825 (23) 0.883 (6)
B 29 (7) 0.836 (24) 0.857 (21) 0.846 (15)
C 0 (0) 0.753 (6) 0.805 (5) 1.000 (1)
D 27 (4) 0.702 (15) 0.721 (7) 0.888 (6)
E 14 (2) 0.758 (14) 0.852 (12) 0.827 (2)
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A total of 25 participants completed the EQ-5D-5L at baseline, 6 months and 12 months. Utility scores
for those who had received specialist physiotherapist treatment (n = 5) were compared with those who
received treatment from other clinical staff (n = 20). An independent-samples t-test indicated that
there was no statistically significant difference in improvement in HRQoL from baseline to 12 months
between the groups [t(df = 23) = –0.602; p = 0.553, two-tailed].
The POPPY trial longitudinal outcomes
Long-term costs that were associated with accessing further pelvic prolapse treatment were estimated
using follow-up data for 293 women involved in the POPPY trial. NHS Scotland Scottish Morbidity
Record (SMR) data for F2 Gynaecology and CB Urology health-care utilisation was accessed for the
period 2007–18. For the SMR-00 data set, no F2 and CB episodes had a main condition recorded;
therefore, it was not possible to filter in or out only POP-relevant episodes on that basis. The main
operation codes were used and were predefined as P18, P22–P24, P26, Q07–Q08, Q54, M51–M58,
A70 and H57. It should be noted that operation code is a non-mandatory code field for SMR-00.
No relevant operation code for POP was recorded in CB episode data for either SMR-00 or SMR-01.
No further analysis was carried out for CB specialty. Resource use costs for each episode’s main
operation were valued in prices using the UK NHS Reference Costs 2017/18.34
Table 29 presents the resource use costs for available data regarding F2 gynaecology outpatient and
inpatient episodes of care. Owing to issues of confidentiality, SMR-01 data cannot be broken down
further. Information is presented in aggregate to meet the data protection requirements of the NHS
National Services Scotland’s Statistical Disclosure Control Protocol Version 3.0.39 Resource use costs were
estimated for 111 F2 outpatient episodes of care, using the main operation code of interest. Resource
use costs were estimated for 109 F2 inpatient episodes, using the main operation code of interest
recorded. Inpatient costs (2017–18 prices), excluding excess bed-days, were higher for the control
group (£172,458.70; 53%) than for the intervention group (£154,544.02; 47%). Including excess
bed-days, the difference in costs between the groups was £21,480.26, retaining a 53% and 47% split.
Longitudinal follow-up data about health-care resource use for prolapse treatment by the POPPY
trial participants indicated that the overall total costs for the control group were higher than for
the intervention group (53% and 47%, respectively). The difference is potentially an artefact of the
adjustment of 2017–18 prices, using the UK deflator series.35
Outpatient (SMR-00)
In total, 5004 episodes of outpatient care was recorded for all participants. A total of 1419 F2
episodes were recorded between 2007 and 2018. No main condition code was recorded. A total of
84% of records had no main operation or other operation code recorded. Of 226 F2 records with a
main operation code, 129 F2 records had an operation code of interest recorded as a main or other
operation. Excluding ‘did not attend’ episodes, resource use costs were estimated for 111 episodes of
care that had a procedure of interest recorded as main operation.
TABLE 29 The POPPY trial participants’ health-care utilisation costs for procedures of interest (F2 gynaecology),
from 2007 to 2018 (GBP 2017–18 prices)
SMR record type Physiotherapist (treatment) costs (£) Leaflet (control) costs (£)
SMR-00: outpatienta 9112.08 10,200.04
SMR-01: inpatient 154,544.02 172,458.70
SMR-01: inpatient – excess bed-daysb 8723.24 12,288.82
Total 172,379.36 194,947.56
a 16% of SMR-00 records had procedure codes recorded.
b Excess bed-days calculated as the difference from the average number of bed-days of the POPPY trial participants
with same main operation code.
Cost sources: NHS Reference Costs 2017/18;34 gross domestic product deflators.35
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Figure 16 compares all episodes of care between POPPY trial groups, and compares identifiable
POP-relevant episodes of care between groups (2007 to 2010 are supressed because of low numbers).
The numbers of episodes of health-care treatment shown in Figure 16 indicate a broadly similar pattern
of resource use by both groups.
New appointments accounted for 41% of the intervention group and 30% of the control group
episodes of care. Table 30 summarises the POP-relevant outpatient resource use costs.
The total estimated outpatient resource use costs were lower for the intervention group than for the
control group: £9112.08 and £10,200.04, respectively (2017–18 GBP prices). Given that it was not
possible to use a condition code to filter records in or out, and that 84% of records did not have any
procedure codes recorded, it was not possible to determine how many data were missing. It is not
possible to conclude whether or not there is a difference in the absolute number or timing of use of
outpatient health-care resources between groups since the POPPY trial.
Surgery (SMR-01)
In total, 1153 episodes of inpatient care had been recorded for all participants, including 166 F2
episodes. Of 166 episodes, 137 episodes recorded a main condition code and 126 a main operation
code. A total of 109 F2 episodes recorded at least one procedure code of interest. Table 31 indicates
that, overall, the control group received more procedures of interest than the intervention group.
Comparison between groups indicates that patterns of admission were broadly similar during the
period 2007–18, with a total of 50 health-care episodes for the intervention group and 59 for the
control group. The total number of excess bed-days (based on the average stay of the POPPY trial































FIGURE 16 Comparison of the health-care resource utilisation between the POPPY trial control and treatment group
participants, gynaecology specialty: all episodes of care vs. POP-relevant coded episodes of care. Note that lines start at
different points owing to small numbers within years.
DOI: 10.3310/hsdr08470 Health Services and Delivery Research 2020 Vol. 8 No. 47
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Maxwell et al. under the terms of a commissioning contract issued by the Secretary of State
for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
69
The timing of more expensive procedures, cost-adjusted to 2017–18 prices using the UK deflator
series,35 drives some of the difference in total cost. For the physiotherapy group, 35% of the main
operation codes were for expensive operations (> £4000), most of which had occurred in earlier years
and, therefore, were deflated for cost-adjustment. In contrast, 21% of the main operation codes for
the control group were for expensive operations carried out in later years and, therefore, costs were
subject to less adjustment.
Discussion
The economic analysis assessed the costs of each clinical site’s delivery model of PFMT. The total cost
of the specialist physiotherapist delivery model was calculated at £434.13 per woman attending for
PFMT during the PROPEL intervention (2017/18 GBP). This includes the cost of consultant referral,
specialist physiotherapist triage, the initial assessment appointment and treatment sessions delivered
by specialist physiotherapists (AfC band 7 or band 6), and proportional overheads. At the other
PROPEL intervention sites, delivery varied in terms of referral pathway, the amount of clinical contact
time to deliver PFMT that women could access and the mix of clinical staff delivering PFMT. Services
that were delivered using higher-band physiotherapists only were more costly than services delivered
by other staff mixes.
The headline costs indicated that, generally, services that were delivered using higher-band
physiotherapists only were more costly. In common with other clinical studies, the introduction of the
PROPEL intervention was accompanied in some clinical sites by an increase in staff for the duration of the
project. Changes in resources may provide the opportunity to reduce waiting lists, as was the case for site D
during the PROPEL intervention, or to enable access to treatment for more patients. Future research into
sustainable changes to resources is advised.
Changes in utility, measured using the EQ-5D-5L (secondary outcome), indicated that the PROPEL
intervention participants had a high self-reported level of HRQoL, with 31% of participants reporting
maximum utility at 6 months (37% at 12 months). This was also reflected in the participants’ responses to
the EQ-VAS. Utility improved by 0.019, on average, over 6 months: 0.035 for specialist physiotherapists
TABLE 30 Costs for outpatient appointments (GBP 2017–18 prices)
POPPY trial group SMR-00 Units (n) Unit cost (£) Total (£)a
Intervention P26 procedure (MA23Z, outpatient) 52 183.52 9112.08
Control P26 procedure (MA23Z, outpatient) 59 183.52 10,200.04
a Unit costs adjusted for year using gross domestic product deflators.35 Costs source: NHS Reference Costs 2017/18.34
TABLE 31 Procedures of interest (F2 gynaecology), number per POPPY trial group
Procedures of interest
Number of proceduresa
Intervention group Control group
Colporrhaphy/repair (P22, P23, P24, Q54) 52 67
Hysterectomy (Q07, Q08) 5 5
Incontinence (M53) < 5 8
a Number of procedures (tally count of all operation codes of interest recorded). Not equivalent to individuals. Some
patients will have received more than one procedure of interest during a single health-care episode.
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and 0.012 for other clinicians (with no significant difference between these groups). The primary
outcome indicated that statistically significant differences in POP-SSs were found in sites A and C,
comparing baseline with 6 months. Comparison between sites was not possible. The economic outcomes
indicated that no statistically significant difference was found between baseline and 6 months within
any site. There was a greater magnitude of improvement in EQ-5D-5L scores for women who received
PFMT treatment from specialist physiotherapists than for women who received the treatment from
other HCPs, but this was not a statistically significant difference.
During the POPPY trial, the mean cost of PFMT was £306.86 (95% CI £250.74 to £368.29) for one
woman taking part (2009 prices) [mean cost £349.45 (95% CI £285.54 to £419.41) for 2018 prices].6
Longer-term benefits were not considered as part of the study. Longitudinal follow-up data of the
POPPY trial participants did not indicate a difference in the use of health-care resources between
the groups. Interpretation of outpatient health-care resource use between the groups is limited by
the absence of coding reference information. On the basis of the available follow-up data obtained
from the administrative data sets, there is no observed difference in resource use between the groups
at 11 years post PFMT.
Limitations
The intention had been to use site A as a comparator site to compare the costs and benefits of the different
mixes of staff (band and specialism) delivering PFMT. Changes to the number of clinical sites involved,
to recruitment and to the follow-up period for participants precluded this analysis comparing sites.
The allocation of overheads was carried out by a simple multiplication of the number of attendances
by the NHS Reference Costs34 for overheads. This may not be accurate for all clinical sites, particularly
where clinical space may not be immediately accessible and identification of a facility may incur
additional costs. Adjustment to reflect local service delivery conditions should take this into account.
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Chapter 9 Dissemination for impact
Introduction and methods
The PROPEL intervention aimed to deliver an evidence base for alternative models of care to increase
the capacity within services for delivering the evidence-based PFMT intervention for POP (as supported
by the POPPY trial). To support further dissemination of this evidence (from the POPPY trial and the
PROPEL intervention), we included dissemination activities that would also extend opportunities for
further data collection on potential barriers and facilitators beyond the PROPEL intervention sites to a
wide range of interested stakeholders across the UK.
Two ‘dissemination for implementation’ workshops were held: one in London and one in Glasgow, with
72 participants and 48 participants, respectively. The participants constituted specialist physiotherapists,
physiotherapists, consultant urogynaecologists, women’s health fitness instructors and nurses. The
majority of participants rated the workshop as meeting their objectives extremely well/very well, with
a small minority (n = 6 across two events) rating the workshop as average in meeting their objectives.
Most of the participants had attended the workshop to ‘identify how services may be changed to reach
more women’ and to ‘find out about the results of PROPEL’. Following the workshop, the majority
thought that their service could initiate some change and could identify actions to take forward.
Workshops consisted of sharing the preliminary findings of the PROPEL intervention but also
included an ‘action-planning’ component for service managers and those responsible for the delivery of
non-surgical interventions for prolapse, which allowed them to start planning a local service redesign that
could deliver PFMT to larger numbers of women. These events also acted as ‘data gathering’ opportunities:
gathering further data on the potential opposition and barriers to implementation, and how services can
make sense of the study findings and apply them to their own services.We encouraged all participants to
leave with an action plan.
The dissemination and implementation workshops were delivered according to a theoretically driven
structure that detailed problems, solutions (mechanisms for action) and actions. We have used this
theory-driven workshop structure previously.
Individual and group perceived barriers to and facilitators of delivering PFMT and delivery using
non-specialist roles were mainly recorded using sticky notes posted on group boards, alongside group
feedback of key points at several intervals during the day-long workshops. The sticky notes were gathered
and collated at the event by the research team and were collectively reported back to the event audience
to reflect the broad consensus on the barriers to and facilitators of delivering PFMT. These sticky notes
were retained and their key themes were confirmed in a secondary coding exercise by ED, KB and MM,
with specific attention given to understanding the levels of opposition and action, the discussion of barriers
and whether or not the study findings influenced the development of solutions to these barriers, what
other study findings are likely to influence adoption and implementation (e.g. financial data) and which
models of delivery seem more favourable for wider adoption and implementation.
It is not surprising that most of the barriers, often representing the absence of something, were also
noted as facilitators when the same thing was present or available. The same themes were evident
across both workshops; therefore, the data from both events were combined. The main themes are
presented and their content is briefly described in the following sections.
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Workshop findings
Awareness-raising in primary care
Awareness-raising in primary care was one of the prominent themes from the workshops and was seen
as an essential starting point in making changes to women’s care pathways. It was suggested that GPs
lacked knowledge of PFMT and the default action was to refer patients to urogynaecology, where
the outcome was more likely to be less conservative options. The GP-to-consultant treatment route
bypassed the most conservative treatment options, such as PFMT and pessaries.
Several participants thought that they could use the PROPEL study findings to talk to GPs in their local
area, and some participants proposed this as a first step in an action plan. There were suggestions of
training GPs in pelvic health and using the evidence base for PFMT to raise their awareness that
something can be implemented to improve the lives of women and that a prolapse is not something to
‘put up with’.
Awareness-raising among women
Raising awareness among women was referred to as a barrier, in the sense that women would not
know that they could opt for more conservative treatment options and, therefore, they would not be
able to discuss alternative preferences with their GP. The discussions on raising awareness among
women were mostly concerned with ideas as to how this could be carried out. It was recognised that
there were many health-care encounters for women where the issue of pelvic health could be raised
(e.g. when undergoing a smear test, especially for raising awareness among young women, or antenatal
and postnatal appointments). This could be as both general advice (do you know about PFMT? Do you
understand why PFMT is important? Do you know how to do PFMT?) and possible identification of
prolapse or pelvic problems.
The promotion of continence products (e.g. television advertising) was seen as something that needed
to be counteracted, as it ‘normalised’ bladder problems and prevented women from considering
alternative solutions. Campaigns that promote pelvic health are needed in order to educate and inform
women and raise awareness of prolapse and alternative treatment options. It was also suggested that
women should be able to self-refer and that this might increase the uptake of PFMT for prolapse as a
first-line treatment.
Staffing resources and staff time
As with the findings of the PROPEL intervention, the availability of staff and staff time was seen by
workshop participants as the main barrier to initiating service change, such as that carried out within
the PROPEL intervention. Each potential staff group was noted as already having a full workload/
caseload and their time available for new patient groups and interventions was seen to be limited.
However, it was also recognised that there were larger numbers of nurses and musculoskeletal
physiotherapists; therefore, if services for PFMT were to increase, then these staff groups did seem
more likely to have availability to account for this. There were also examples of current services being
unable to recruit specialist physiotherapists and posts being left unfilled.
Resources: funding and space
In addition to staffing resources, other resources, such as clinic space, were also mentioned. There
were general comments around funding, which could be for posts, other resources needed to run
a PFMT clinic or resources for enabling training. The PROPEL intervention had reported that some
staff had difficulty in sourcing rooms to see women, and that workshop participants similarly told of
a lack of availability of rooms to deliver their current services. If these problems were limiting current
services, any further service provision was, therefore, even more limited. There was some discussion of
seeking to deliver more services in the community where space may be available.
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Training
The PROPEL intervention had informed workshop participants about the PFMT training and how this
was delivered. However, this was an area of concern for specialist physiotherapists, who raised concerns
about the availability of specialists to provide support to staff and provide any further education needed
post training. There were also concerns that other staff groups (non-specialists) would not be able to
manage complex cases or the multitude of issues that prolapse patients can present with. Many thought
that 1 day of training was not enough and that this should be accompanied by clinical supervision or
‘shadowing’ in clinics to increase experience. There were also some suggestions that additional virtual
training and update sessions could be provided. (This was also raised by participants on the training
course, and additional support was accessed at most sites, even if this was peer support from other
newly trained colleagues.)
Educating other professionals (e.g. GPs and consultants) to understand other HCP roles was also seen
as enabling referrals to other types of services.
Funding for training and training opportunities was seen as being limited within the NHS at present.
Champions/enthusiasts
It was acknowledged that, even with the PROPEL intervention, the successful implementation of the
different models had often relied on a local enthusiast or a champion who had led the way to make
it happen. This included identifying who could be trained and convincing them and others (their
managers) that this would be a good thing, and liaising with the research team to help organise the
training locally. They were also involved in helping to triage women locally, to help the new referral
system work. Although the workshops enabled participants to consider even small initial steps that
they could take to move towards change, participants saw a person with some degree of seniority
or access to decision-makers as being a strong facilitator to change happening at a strategic and
service level.
Multidisciplinary team working and clinical pathways
Some of the reasons for limited referrals to some roles within the PROPEL intervention were
disjointed teamworking and a lack of clarity on referral pathways, or overly complicated referral
pathways. To overcome these problems, there needs to be more multidisciplinary teamworking and
everyone in the team needs to be on the same page with regard to the appropriate clinical pathways.
This also includes the primary care team having a better understanding of all of the possible clinical
pathways and roles of others.
Management support
For substantial change to happen, there always has to be management support.Without this, training could
be wasted, as staff time may not subsequently become available to enable working with women with
prolapse, and resources such as treatment rooms may not be made available. Although many workshop
participants were ready to consider change and to take some immediate action, this could get them only so
far without the additional support and actions from others. There was also recognition that, although one
manager may agree with the need to change, what needs to change and how change could be achieved,
managers work in sectors that do not necessarily communicate to each other (e.g. hospital and community).
Options to develop new services could be seen as one sector trying to offload burden to another sector.
The transfer of potential savings from one sector to another never happens and, therefore, even robust
financial evidence will do little to convince sectors to carry out things differently.
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Conclusion
These workshops have added to the knowledge that was generated in the PROPEL intervention,
confirming and identifying additional barriers to and facilitators of introducing new models of delivery
for PFMT for increasing the capacity and availability of PFMT for women with prolapse. The following
activities could follow on from this study to begin to address some of the concerns and raise the
potential for change on a wider scale across the NHS:
l Develop awareness-raising training for GPs and information for urogynaecologists about the
benefits of PFMT as a first-line treatment.
l Develop new guidelines for practice nurses, midwives and continence services to capitalise on
existing opportunities for early identification and intervention, for example by advising women
about PFMT during routine smear tests and perinatal appointments.
l Develop public health campaigns for women of all ages (including teenagers), including, for example,
a digital versatile disc (DVD) or animation to encourage understanding of pelvic health and exercises.
l Engage with gynaecological service leads to reconfigure care pathways that include PFMT as a
first-line treatment option.
l Undertake work to improve care pathways for women with prolapse, including self-referral
pathways for PFMT.
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Chapter 10 Discussion, conclusions
and implications
The overall aims of the PROPEL intervention were to study the implementation and outcomes(including costs) of different models of delivery of PFMT for women with POP, in order to increase
the service provision of PFMT across contrasting NHS sites. This was conducted using a realist evaluation,
alongside the collection of robust outcomes similar to those utilised in the original POPPY trial of PFMT
for prolapse. The economic evaluation for the PROPEL intervention was concerned with the associated
costs and outcomes of different service delivery models for delivering PFMT. In addition, an economic
assessment of the long-term costs associated with accessing further pelvic prolapse treatment over
time was conducted for the original POPPY trial participants resident in Scotland.
Implementation and outcome studies
The models of delivery included a specialist WHP-delivered service, which was used as a gold-standard
comparison for other models. It was also seen as important to understand the delivery of such
specialist-delivered services outside the trial conditions, in the real world of the NHS. All other services
across four other sites implemented various models, with musculoskeletal physiotherapists, other
physiotherapists and nurses delivering PFMT. All services except one operated a model whereby
women were triaged by a specialist or consultant and referred, as appropriate, for PFMT delivery by
the newly trained staff groups.
A realist evaluation was conducted alongside a robust PROMs study to understand ‘what works’, taking
into account the impact that the local context has in influencing what works. The realist evaluation
was based on multiple case studies of the implementation and outcomes of PFMT delivery in three
contrasting NHS settings, sites A, B and C (see Chapter 4) (with the PROMs study involving five sites:
sites A–E). The realist evaluation methods allowed for engagement of local stakeholders from the outset,
which permitted a detailed exploration of how local sites made decisions on how to deliver PFMT
(e.g. using different skills mixes) and how these were implemented. This enabled an understanding of
what helped or hindered service delivery, of how the services integrated or affected other services or
HCPs and of any potential influences on outcomes for women. The focus of ‘what works and for whom’
included the views of service managers, consultants/referral agents and those delivering PFMT, as well
as the views of the women in receipt of PFMT services. However, given the overall positive outcomes
for women (all models were effective for women), the presentation of findings focused more on the
different models and HCPs delivering PFMT and what worked for ‘implementation’.
When there is a perceived need for services (as a result of a lack of an existing service), this is a
driver for change. The service with the most established model of specialist physiotherapist-delivered
PFMT was the service that was the most resistant to trying alternative models, regardless of need
(e.g. staff absences and increasing waiting times for women were reported during this study). The lack
of available services in rural areas was a driver for training many different staff types and initiating
‘workarounds’ to enable triage and referrals to the new services.
Staff who were newly trained within the PROPEL intervention and who had some level of prior
knowledge of women’s health issues and of the physiology of the pelvic region were more comfortable
with this new role and were more likely to feel confident following the 1-day training.
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The following are required to successfully implement PFMT for prolapse:
l The provision of adequate training that is tailored to needs of different staff skill mixes.
l An increased awareness of PFMT among GPs and other HCPs.
l Well-co-ordinated and flexible referral systems.
l Wider (multidisciplinary) team support and/or buy-in.
l Organisational and managerial support with effective leadership.
l A receptive setting (some community nursing and acute wards may not be appropriate).
For the PROMs study, five NHS sites were recruited to deliver PFMT using a range of delivery models.
Site A constituted an exclusively WHP-specialist service model that then acted as a comparator for
models involving delivery by ‘other’ staff groups (i.e. nurses, physiotherapists), as developed by sites B–E.
A total of 102 women were recruited to the PROMs study from across the five sites and a total of
65 women provided both baseline and 6-month POP-SSs (the primary outcome measure). The mean
POP-SS at 6-month follow-up was significantly lower than that at baseline, indicating that prolapse
symptom severity had reduced. The mean difference between baseline and 6 months represented a
clinically meaningful difference. A significant improvement was still observed when comparing baseline
with 12-month POP-SSs (although numbers were low).
There was no statistically significant difference in the improvement of symptoms obtained from
PFMT delivery by specialist physiotherapists (mean change in POP-SS = –3.95) compared with PFMT
delivery by other HCPs (mean change in POP-SS –2.81 points) (mean difference 1.14 points, t = 0.89,
df = 63; p = 0.37).
Additional (secondary) outcomes showed that there was a significant reduction in the number of
health-care visits after the start of the intervention (mean of 1.73 appointments in the 6 months prior
to baseline compared with 0.96 appointments between baseline and 6-month follow-up, Wilcoxon
signed-rank test z = 3.663; p < 0.001).
The economic evaluation found that the key difference between models in determining costs was the staff
grade (NHS band) and the overall length of time practitioners spent with the women (hours). The baseline
HRQoL score was already high in this population, which may have affected our ability to improve this. There
were no significant differences in HRQoL between women seen by specialist physiotherapists and women
seen by other practitioners. The average EQ-5D-5L scores did not indicate a deterioration in HRQoL for any
model of delivery. The limited participant numbers precluded assessment of cost-effectiveness for the
models of delivery.
The headline costs indicated that, generally, services delivered using higher-band physiotherapists only
were more costly. In common with other clinical studies, the introduction of the PROPEL intervention
was accompanied in some clinical sites by an increase in staff for the duration of the project. Changes
in resources may provide the opportunity to reduce waiting lists, as was the case for site D during
the PROPEL intervention, or to enable access to treatment for more patients. Future research into
sustainable changes to resources is advised.
In an analysis of the long-term follow-up data of 293 of the original POPPY trial participants
(both intervention and control participants), the main outcome measure was any related secondary
care treatment during follow-up using routinely collected individually linked hospital episode data.
This showed (using a mixed-effects logistic regression on any treatment during follow-up with random
effect of centre) that the effect of the intervention (PFMT) is statistically significant and is associated
with a reduction in the log odds of any treatment during follow-up. People in the intervention group
had a lower hazard for any treatment.
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Longitudinal follow-up data of the POPPY trial participants did not indicate a difference in the use of
health-care resources between the groups. Interpretation of outpatient health-care resource use between
groups is limited by the absence of coding reference information. On the basis of the available follow-up
data obtained from the administrative data sets, there is no observed difference in resource use between
the groups at 11 years post PFMT.
The dissemination and implementation workshops were attended by 120 participants (72 in London and
48 in Glasgow) and identified key barriers (and facilitators) in line with those observed in the realist
evaluation. The presentation of the PROPEL intervention findings allowed for the discussion of the possibility
of different ways to deliver PFMT. This ‘evidence base’ helped the majority of participants to shift into
thinking that ‘change’ was possible and to begin developing action plans to discuss with their local services.
Limitations of the study
This study allowed for local services in three areas (one in England and two in Scotland) to determine how
they would implement/deliver PFMT. It was originally anticipated that all sites might implement PFMT
delivered by a mix of specialists and other HCPs, and that there would be more higher-level co-ordination
of referral pathways to fit seamlessly with referrals (from primary care), triage and treatment with PFMT.
The reluctance of one site to train non-specialist physiotherapists meant that we had to find other sites
that were, or were willing to start, delivering alternative models. However, this did then provide a strong
specialist service against which to evaluate the outcomes compared with other staff delivery.
The negotiation of implementation of different models in other sites and the availability of staff for
training incurred delays in implementation, which inevitably affected the recruitment of participants
to the outcome study and, therefore, long-term follow-up of women beyond 6 months. The ‘failure’ to
pursue some proposed models meant that we needed to re-think how PFMT could be delivered in the
face of these barriers; this, in turn, has contributed to our understanding of such barriers. This study
has also been conducted in the everyday world of the NHS, where staff absences and shortages are
common. The fact that staff could be identified and trained, and that PFMT was implemented with
successful outcomes, bodes well for other services being able to attempt similar changes.
The number of women recruited to the PROMs study was lower than anticipated (target: 120 women)
and the recruitment rates varied across sites, which hampered cross-site comparisons. The slow rate of
recruitment also affected our ability to continue with 12-month follow-up for a large proportion of the
women. However, there were sufficient women recruited to enable the key research questions to be
answered in relation to the effectiveness of PFMT in improving prolapse symptoms and in determining
whether or not the use of non-specialist physiotherapists would result in significantly reduced
beneficial outcomes for women.
Logistically, it was not possible to make widespread use of the POP-Q in this study. The use of this
measure requires a high level of skill in conducting a physical examination and may also require
additional visits by women in studies using the POP-Q. The use of non-specialist physiotherapists
working in different settings and geographical locations meant that POP-Q assessments required the
additional availability of someone trained in its use to travel to different locations, often to assess one
woman. This provision was not possible for most sites.
We have endeavoured to follow up women in the longer term using routinely available and linked
health data. Whereas inpatient records are robust indicators of treatment outcomes, outpatient
records are more variable in their availability and their accuracy of recording of treatments and
procedures. The majority of the POPPY trial participants were resident in Scotland, which made
accessing and linking hospital-based activity possible, but did not make accessing and linking primary
care data possible. However, the number of original POPPY trial participants (n = 293) available for
long-term follow-up was sufficient to enable a robust analysis.
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Implications for policy
An NHS review has revealed that there are currently hundreds of women now undergoing surgery to have
mesh implants removed. Although a repair using mesh is not the only surgical procedure for prolapse, it
has constituted a common procedure in favour of more traditional procedures. Most mesh devices were
launched without clinical trials to support their effectiveness, meaning that complication rates were never
established prospectively. The National Institute for Health and Care Excellence banned the use of vaginal
mesh to treat prolapse in December 2017. Recognising the potential scale of the problem, and in response
to lobbying, the UK government announced a review into how the NHS addresses concerns about medical
treatments, including vaginal mesh devices. This review is led by Baroness Cumberlege.40 Following
presentation of the PROPEL intervention findings at our dissemination and implementation workshops,
the Chartered Society of Physiotherapists approached the PROPEL intervention team to input its findings
to this review. These were submitted in February 2019. The PROPEL study was discussed at an oral
hearing.41 Informed by the PROPEL study, the Chartered Society of Physiotherapists made the following
recommendations to the review:
l Women who have had a prolapse or stress urinary incontinence should be referred for PFMT as a
first line of treatment.
l Increase the specialist physiotherapy workforce and train non-specialists to provide PFMT.
Similarly, the Scottish government has initiated its own response to the mesh concerns. A Scottish
independent review42 of the use, safety and efficacy of transvaginal mesh implants in the treatment of
stress urinary incontinence and POP in women was initiated in response to growing public concern
about the number of women experiencing serious complications. At this time, the Cabinet Secretary for
Health and Wellbeing asked NHS Scotland to consider suspension of transvaginal mesh procedures
pending the outcome of this review.42 Concluding this review in 2017, its chairperson expressed the
hope that their report would go some way to ensuring that the voices of patients continue to be
valued, and that they could be assured that future NHS prolapse interventions would be evidence
based and audited in order to deliver the best possible outcome with minimum adverse effect.42
The PROPEL intervention began by listening to women in our three case study sites and gave this
information to the local teams to consider in their development and delivery of services.We have ensured
that the implementation of PFMTusing different models of delivery was subject to a robust outcomes
evaluation (using the same primary and secondary outcomes as the original POPPY trial). This has
provided a strong evidence base, on which other NHS sites can build, to deliver an evidence-based
intervention for women with prolapse that does indeed minimise the potential for adverse effects.
The independent review (Scotland)42 found that current research studies on safety and effectiveness
have not provided sufficient evidence on the long-term impact of mesh surgery. They recommended
that the lack of long-term follow-up and related outcome data, including information on quality of life
and activities of daily living, should be addressed.
The POPPY trial and the PROPEL intervention have both focused on robust outcomes data and the
primary outcome has been based on a measure that captures women’s views of their prolapse symptoms
and quality of life. This study has also conducted more long-term follow-up of the original POPPY trial
participants. We believe that this adds to the strength of evidence for PFMT.
Following an invitation to the Chief Medical Officer for Scotland to our dissemination and implementation
workshop in Glasgow, the Scottish government responded with an invitation to present our findings
at a meeting that took place in February 2019. These findings were shared with the Consultant in
Public Health Medicine, the Government’s Oversight Group and the Senior Medical Officer. The level
of interest in our findings at national policy level indicates the relevance of our work for both policy
and practice.
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Conclusions
It is possible to train different staff types/skill mixes to effectively deliver PFMT to women. Women’s
self-reported outcomes significantly improved across all service models delivering PFMT. The PROPEL
intervention has demonstrated how different models and service contexts can affect implementation,
but, if these are addressed in advance, then there will be a greater likelihood of successful integration
with existing health-care pathways and greater opportunities for ensuring that (non-specialist) staff
delivering PFMT are supported to deliver PFMT with appropriately triaged patients and appropriate
clinical supervision. Services delivered by higher-band physiotherapists only were more costly than
services delivered by other staff mixes. No statistically significant difference in the improvement of
HRQoL between baseline and 6 months within any site, or from baseline to 12 months between
participants treated by specialist physiotherapists and participants treated by other clinical staff, was
found. Small participant numbers prevented an assessment of cost-effectiveness.
The realist evaluation combined with the robust outcomes data confirms that PFMT can be successfully
delivered using a range of staff/skill mixes and in different NHS settings, and that outcomes are not
compromised by different delivery models. This study provides examples of delivery of PFMT (beyond
delivery by specialist physiotherapists) by clinicians (i.e. nurses, other physiotherapists) who have an
interest in women’s health.
Implications for practice
The evidence supports training a broader range of HCPs with an interest in women’s health and/or
with a knowledge of physiology/body muscles to deliver PFMT to women.
Delivery of PFMT by other clinicians was supported by specialist physiotherapists undertaking triage of
women to determine their suitability for PFMT. The role of the specialist physiotherapist could then be
enhanced, to provide education and support to other HCPs to enable them to safely deliver PFMT to
women while managing more complex cases of POP themselves.
Increasing the use of and referral to PFMT as a first-line treatment was facilitated by improved
multidisciplinary team working across urogynaecology services and improved communication with
primary care. A review of existing pathways to PFMT could identify areas for improvement.
Primary care referrals to PFMT as a first-line treatment for POP would probably increase with more
awareness-raising (of POP and PFMT) and education for GPs and other primary HCPs.
The following activities could follow on from this study to begin to address some of the concerns
above and raise the potential for change on a wider scale across the NHS:
l Develop awareness-raising training for GPs and information for urologists and urogynaecologists
about the benefits of PFMT as a first-line treatment.
l Develop new information for practice nurses, midwives and continence services to capitalise on
existing opportunities for early identification and intervention, for example by advising women
about PFMT during routine smear tests and perinatal appointments.
l Develop public health campaigns for women of all ages (including teenagers), including, for example,
a DVD or animation, to encourage understanding of pelvic health and exercises.
l Engage with gynaecological service leads to reconfigure care pathways that include PFMT as a
first-line option.
l Undertake work to improve care pathways for women with prolapse, including self-referral
pathways for PFMT.
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Research recommendations
This evaluation provides a toolkit of outcomes that could be used in routine service delivery, especially
the POP-SS outcome measure, which is a relatively easy-to-use, self-complete measure that has now
been widely evaluated. Routine evaluation of outcomes could provide more widespread evidence for
PFMT delivery by HCPs.
Logistically, it was not possible to make widespread use of the POP-Q in this study. A study comparing
the ability of the self-complete POP-SS tool to correlate with the (physical) changes in POP severity
(as measured by a clinical assessment using the POP-Q) could help further studies to determine whether
the POP-SS is sufficient or we need to input further resources in pelvic health research to ensure that
there is more robust completion of the POP-Q examination.
The follow-up study included inpatient and outpatient attendances for a large proportion of original
POPPY trial participants. Further studies might explore the information available in primary care and
whether or not this has a bearing on assessing the impact of PFMT in the longer term.
The ‘activities’ outlined in Implications for practice would benefit from being grounded in ‘intervention
development’ research, which includes input from HCPs (across sectors) and women with POP to ensure
that the content of interventions and the formats of delivery are optimised for maximum impact and
reach. This would include ‘implementation’ research associated with intervention delivery.
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Appendix 1 The PROPEL TIDieR checklist
Pelvic floor muscle training
Intervention
The intervention was PFMT. The aim of this implementation study was to assess whether or not PFMT
delivered by different skill mixes of clinicians would elicit the same outcomes in women with stages I–III
prolapse as those seen in the POPPY trial.
Materials
A 1-day training course for intervention providers.
Procedures
The anatomy/function of pelvic floor muscles were explained. Training was given in ‘the knack’ –
correctly contracting pelvic floor muscles and precontracting against increases in abdominal pressure.
An internal assessment of pelvic floor muscles was carried out to correct exercise technique and assess
muscles [using the Pressure, Endurance, Repetitions, Fast contractions, Every Contraction Timed
(PERFECT) scheme43]. Tailored lifestyle advice was given when appropriate.
Provision
Provided by POGP registered trainers. Training outlined in Appendix 2.
Delivery
Face-to-face, one-to-one delivery. Home-based practice and outpatient clinics.
Regimen
Home pelvic floor muscle exercises plus 3–6 appointments with clinician delivering PFMT. Duration of
physiotherapy appointments unclear.
Tailoring
Yes, home exercise programme modified at each appointment on basis of examination findings and
diary recordings. Clinicians decided how many appointments each participant needed.
Modification
No modifications were made.
Adherence
Clinic appointments monitored by clinicians delivering the intervention.
Control
There was no control as this was an implementation study.
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Appendix 2 The PROPEL intervention
training outline
The training for the PROPEL intervention clinicians was carried out by experienced pelvic healthphysiotherapists and tutors on the Pelvic, Obstetric and Gynaecological Physiotherapy Professional
Network workshops of the Chartered Society of Physiotherapy. There was a mixture of professions and
grades participating in the workshops.
The content of this 1-day programme was a modification of the 3-day ‘POGP Pelvic Health
Physiotherapy female urinary dysfunction’ entry-level course and the 1-day ‘POGP Pelvic Health
Physiotherapy POP, advancing your practice, better understanding of POP’ course. These workshops
are designed to be carried out sequentially, as the first provides general background plus practical
training in vaginal examination, and the second develops further knowledge in the specialty. Mentoring
post workshop is recommended.
Pre-course reading was recommended. See below.
Vaginal assessment practicals included tutor demonstration, participant assessment on a tutor and,
when applicable, peer-to-peer examinations. Consent was documented.
A skills checklist for the PROPEL intervention training pelvic floor and vaginal assessment practical
session was also completed for each participant. See below.
Programme
Time Topic Tutor








15.30–16.15 Treatment planning, advice and exercises
16.15–16.45 Questions
Recommended pre-attendance learning
Professional issues learning tasks:
1. Familiarise yourself with the consent policy used within your organisation.
Ensure that you are aware of the key components of valid consent, including capacity, the
requirements relating to information-sharing, as well as the documentation requirements of
your organisation.
Reflect on the process you use when seeking consent for a vaginal examination and consider
whether or not this fulfils your statutory and professional obligations.
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2. Familiarise yourself with your organisation’s chaperone policy.
Consider the process used by you/your organisation in order to establish whether or not a
chaperone is required for vaginal examination and reflect on whether or not this fulfils your
professional/organisational obligations.
3. Familiarise yourself with the confidentiality requirements of your organisation, including those
relating to recently enacted legislation such as the Female Genital Mutilation Act (2003)44 or the
Prohibition of Female Genital Mutilation (Scotland) Act (2005).45
Ensure that you know how to disclose or escalate any concerns you have relating to patient
confidentiality issues.
4. Familiarise yourself with the relevant sections of your organisation’s infection prevention/
control policy.
Ensure that you know how to apply the infection prevention/control policy to ensure safe and
effective practice in relation to patients attending as part of the PROPEL intervention.
Additional background learning/knowledge update
The tutor team also recommends that you review the anatomy of the pelvic floor prior to attending
the study day. The following YouTube (YouTube, LLC, San Bruno, CA, USA) link is a useful 10-minute
tutorial showing the three-dimensional arrangement of the pelvic floor complex: www.youtube.com/
watch?v=P3BBAMWm2Eo (accessed 30 January 2020).
Other useful resources relating to POP include:
l www.nhs.uk/conditions/prolapse-of-the-uterus/Pages/Introduction.aspx (accessed 30 January 2020).
l www.rcog.org.uk/en/patients/menopause/pelvic-organ-prolapse/ (accessed 30 January 2020).
Relevant pages of the Royal College of Obstetricians and Gynaecologists, with good links to other sites
and surgical options:
l http://pogp.csp.org.uk/publications/pelvic-organ-prolapse-physiotherapy-guide-women
(accessed 30 January 2020).
The POP patient information leaflet of the POGP, which will be given to all women in the PROPEL
intervention:
l www.yourpelvicfloor.org/conditions/pelvic-organ-prolapse/ (accessed 30 January 2020) – The pelvic
organ prolapse patient information leaflet of the International Urogynaecology Association (IUGA),
providing a concise overview of the condition.
l www.csp.org.uk/videos/customized-pelvic-organ-prolapse-quantification-exercise-quick-score-entry
(accessed 30 January 2020).
Demonstration of a POP-Q measurement; note: this is for information only.
Important information about the practical session on vaginal examination:
This training day includes a practical session on vaginal examination. The aim of the session is for you
(as a participant) to practise the examination that you will perform on patients as part of the PROPEL
intervention assessment.
Format of the teaching session: one tutor will demonstrate the vaginal examination, using the other
tutor as a model. Following this you will be able to practise the examination by peer or tutor
examination in small groups. There will be no more than four participants per group.
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Tutor examination will involve a tutor acting as the model. Peer examination involves one or more
participants acting as the model. Each participant makes their own decision whether or not they act as
a model. If you choose to act as a model, you will decide whether this is for one or more examinations
and you have the right to opt in or out of the practical sessions at any time.
It is recognised that peer examination can be advantageous. Participants on similar courses who have
acted as a model often recommend it as a valuable learning experience, but it is not a requirement.
The advantages of acting as a model include you developing a personal insight into the patient
experience, including comfort and/or dignity issues. This may allow better communication with your
patients as to what they may experience when you examine them in clinical practice. The disadvantages
are likely to vary on an individual basis. There may be no disadvantages to you personally; however,
such disadvantages may include feelings of discomfort, embarrassment or lack of modesty, as well as
relationship boundary issues with fellow learners and/or an exacerbation of legacy of prior sexual abuse
and/or trauma. There should be no perception of coercion to participate as a model and you will not be
asked to justify your decision.
If you choose to act as a model, you have the right to decline to be examined by any specific course
participants owing to embarrassment or other factors. In the case of a participant declining to
complete at least one vaginal examination on a model, it will not be possible to complete the skills
checklist and the participant will not be able to complete the programme.
You will be provided with a consent form, which must be printed and brought with you to the PROPEL
intervention training day. Further information will be given at the training day and you will have the
opportunity to observe a demonstration of the examination before you decide on the extent of your
involvement in the practical session. Once you have a better understanding of what is required and
have had the opportunity to ask any questions you may have about the session, you will be asked to
complete the form.
If you would like the opportunity to talk to one of the tutors prior to the training, regarding any aspect
of the practical session (including any health issues), then please contact the PROPEL intervention
team who will put you in touch with one of the tutors.
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Appendix 3 The PROPEL intervention
training skills checklist
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Appendix 4 The PROPEL intervention Pelvic
Organ Prolapse Quantification System
assessment form
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Appendix 5 Project timeline
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